- Mô tả
- Chuẩn USP từ A - C
- Chuẩn USP từ D - G
- Chuẩn USP từ H - N
- Chuẩn USP từ O - R
- Chuẩn USP từ S - Z
- Đánh giá (3)
Chuẩn dược điển USP hay chuẩn đối chiếu USP được phân phối theo chỉ định của Dược điển Mỹ (US Pharmacopeia). Đựợc sử dụng để xác định thành phần, hoạt tính, chất lượng, độ tinh khiết của thuốc, thực phẩm chức năng và thành phần thực phẩm.
Dược điển Mỹ được Hội đồng Dược điển Mỹ xuất bản hàng năm. Bao gồm các tiêu chuẩn của từng loại chất hóa học, hoạt chất sinh học làm thuốc. Các tài liệu của dược điển Mỹ đang được sử dụng tại nhiều quốc gia khác như dược điển chính thức khi các nước này chưa có dược điển hay tại các nước chưa có chuyên luận hoặc phương pháp kiểm tra chất lượng khi cần tham khảo.
Các tài liệu chuyên luận của USP và các chuẩn dược điển USP đã và đang giúp tạo ra những nền tảng cơ bản để các sản phẩm chăm sóc sức có được sự tin cậy và điều kiện tốt để tiếp cận mọi người.
Công ty Nam Phong (NP Scientific) là đại diện phân phối chính thức chuẩn dược điển USP tại Viêt nam.
Chuẩn dược điển USP cho thuốc
Dược điển USP đề ra phương pháp thử nghiệm, kiểm tra chất lượng của thuốc và hoạt chất. Bao gồm:
- Các phương pháp thử nghiệm thuốc và hoạt chất
- Các hóa chất, thuốc thử, chất chuẩn đối chiếu và dụng cụ cần cho phép thử,
- Máy móc áp dụng cho phương pháp kiểm tra.
Gần 4000 chất chuẩn dược điển USP đang được cung cấp như chuẩn đối chiếu, hoạt chất tiêu chuẩn cho thuốc. Các chất chuẩn dược điển USP làm tăng sự thuận lợi cho áp dụng tiêu chuẩn USP.
Các chuẩn dược điển USP đang được các cơ quan quản lý và các nhà sản xuất sử dụng. Để đảm bảo rằng các sản phẩm dược phẩm và thực phẩm chức năng có đủ hoạt tính, chất lượng, độ tinh khiết và tính đồng đều.
Danh mục chi tiết chuẩn dược điển USP bao gồm:
- Chuẩn USP từ A đến C
- Chuẩn USP từ D đến G
- Chuẩn USP từ H đến N
- Chuẩn USP từ O đến R
- Chuẩn USP từ S đến Z
Chuẩn dược điển USP cho thực phẩm chức năng
Các tiêu chuẩn dược điển USP về thực phẩm chức năng và thành phần bổ xung được công bố trong Food Chemicals Codex (FCC). USP đã tiếp quản FCC từ Viện Y học Mỹ vào năm 2006.
FCC cung cấp tóm lược các tiêu chuẩn được sử dụng quốc tế kiểm soát chất lượng và độ tinh khiết của thành phần thực phẩm chức năng và thực phẩm bổ xung. Bao gồm chất bảo quản, hương liệu, chất tạo màu và chất dinh dưỡng.
Chương trình xác minh thực phẩm chức năng và thực phẩm bổ xung
USP cũng tiến hành các chương trình xác minh cho các sản phẩm thực phẩm chức năng và thành phần bổ sung trong thực phẩm. Đây là những chương trình kiểm tra và kiểm toán. Các sản phẩm đáp ứng các yêu cầu của chương trình sẽ được gắn nhãn “USP Verified Supplementary Supplement” Mark trên bao bì.
Chuẩn dược điển USP được nhập khẩu và phân phối bởi:
CÔNG TY TNHH KHOA HỌC KỸ THUẬT NAM PHONG
Tel: (024) 322 020 66 (3 lines) Fax: (024) 322 02 065
Hotline: 0982 919 651 / Email: sales@npsc.vn
Chuẩn USP từ A - C
Chuẩn dược điển USP từ A đến C
| Mã code | Tên chuẩn dược điển | Mã CAS# |
| 1000408 | Abacavir Sulfate (200 mg) | 188062-50-2 |
| 1000419 | Abacavir Sulfate Racemic (20 mg) (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1)) | 188062-50-2 |
| 1000420 | Abacavir Related Compound A (20 mg) ([4-(2,6-diamino-9H-purin-9-yl)cyclopent-2-enyl]methanol) | 124752-25-6 |
| 1000437 | Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamine) | N/A |
| 1000441 | Abacavir Related Compound B (20 mg) ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol) | N/A |
| 1000452 | Abacavir Related Compound C (20 mg) ([(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-enyl]methanol hydrochloride) | 172015-79-1 |
| 1000485 | Abacavir Related Compounds Mixture (15 mg) | N/A |
| 1000496 | Abacavir Stereoisomers Mixture (15 mg) | N/A |
| 1000500 | Abacavir System Suitability Mixture (15 mg) (A mixture containing abacavir sulfate and trans-abacavir) | N/A |
| 1000521 | Acarbose (200 mg) (COLD SHIPMENT REQUIRED) | 56180-94-0 |
| 1000532 | Acarbose System Suitability Mixture (2 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1000554 | Acamprosate Calcium (200 mg) | 77337-73-6 |
| 1000565 | Acamprosate Related Compound A (15 mg) (3-aminopropane-1-sulfonic acid) | 3687-18-1 |
| 1000576 | Acamprosate Related Compound B (20 mg) | N/A |
| 1000601 | Acebutolol Hydrochloride (125 mg) | 34381-68-5 |
| 1000612 | Acebutolol Related Compound A (20 mg) (N-(3-acetyl-4-hydroxyphenyl) butanamide) | 40188-45-2 |
| 1000623 | Acebutolol Related Compound B (20 mg) (N-{3-Acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}acetamide) | 22568-64-5 |
| 1000699 | Acebutolol Related Compound I (20 mg) (N-{3-Acetyl-4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}butyramide) | 441019-91-6 |
| 1000818 | Abiraterone Acetate (200 mg) | 154229-18-2 |
| 1000829 | Abiraterone System Suitability Mixture (20 mg) | N/A |
| 1001003 | Acenocoumarol (200 mg) | 152-72-7 |
| 1001502 | Acepromazine Maleate (250 mg) | 3598-37-6 |
| 1002505 | Acesulfame Potassium (200 mg) | 55589-62-3 |
| 1002811 | Acetaldehyde (3 x 1.1 mL) | 75-07-0 |
| 1003009 | Acetaminophen (400 mg) | 103-90-2 |
| 1003010 | Acetaminophen Related Compound A (15 mg) (4-(acetylamino)phenyl acetate) | 2623-33-8 |
| 1003027 | Acetaminophen Related Compound B (30 mg) (N-(4-hydroxyphenyl)propanamide) | 1693-37-4 |
| 1003031 | Acetaminophen Related Compound C (50 mg) (N-(2-hydroxyphenyl)acetamide) | 614-80-2 |
| 1003042 | Acetaminophen Related Compound D (50 mg) (N-phenylacetamide) | 103-84-4 |
| 1003064 | Acetaminophen Related Compound F (50 mg) (p-nitrophenol) | 100-02-7 |
| 1003100 | Acetaminophen Related Compound J (50 mg) (N-(4-chlorophenyl)acetamide) | 539-03-7 |
| 1004001 | Acetanilide Melting Point Standard (1g) (Approximately 114 degrees) | 103-84-4 |
| 1005004 | Acetazolamide (2 g) | 59-66-5 |
| 1005048 | Acetazolamide Related Compound D (25 mg) (5-Amino-1,3,4-thiadiazole-2-sulfonamide) | 14949-00-9 |
| 1005059 | Acetazolamide Related Compound E (25 mg) (5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt) | N/A |
| 1005706 | Glacial Acetic Acid (1.5 mL/ampule; 3 ampules) | 64-19-7 |
| 1006007 | Acetohexamide (250 mg) | 968-81-0 |
| 1006506 | Acetohydroxamic Acid (200 mg) | 546-88-3 |
| 1006801 | Acetone (1.5 mL/ampule; 3 ampules) | 67-64-1 |
| 1008002 | Propoxyphene Related Compound B (50 mg) (alpha-d-2-Acetoxy-4-dimethylamino-1,2-diphenyl-3-methylbutane) | 53990-51-5 |
| 1008501 | Acetylcholine Chloride (200 mg) | 60-31-1 |
| 1009005 | Acetylcysteine (200 mg) | 616-91-1 |
| 1009479 | 2-Acetylpyridine (1 g) | 1122-62-9 |
| 1009901 | Acetyltributyl Citrate (3 x 200 mg) | 77-90-7 |
| 1009923 | Acetyltriethyl Citrate (500 mg) | 77-89-4 |
| 1009978 | N-Acetyl-D,L-Methionine (100 mg) | 1115-47-5 |
| 1010022 | N-Acetylglucosamine (200 mg) | 7512-17-6 |
| 1010081 | N-Acetyl-L-Leucine (100 mg) (Acetyl-L-leucine) | 1188-21-2 |
| 1010106 | N-Acetyl-L-Tyrosine (100 mg) | 537-55-3 |
| 1010208 | Acetyl Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | 145576-25-6 |
| 1011007 | Acitretin (200 mg) | 55079-83-9 |
| 1011018 | Acitretin Related Compound A (20 mg) ((2Z,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid) | 69427-46-9 |
| 1011029 | Acitretin Related Compound B (20 mg) (ethyl (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate) | 54350-48-0 |
| 1011709 | Adapalene (200 mg) | 106685-40-9 |
| 1011710 | Adapalene Related Compound A (50 mg) (Methyl 6-bromo-2-naphthoate) | 33626-98-1 |
| 1011721 | Adapalene Related Compound B (50 mg) (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate) | 106685-41-0 |
| 1011732 | Adapalene Related Compound C (25 mg) (2-(adamant-1-yl)methoxybenzene) | 43109-77-9 |
| 1011743 | Adapalene Related Compound D (25 mg) (4,4′-dimethoxy-3,3′-di(adamant-1-yl)biphenyl) | 932033-57-3 |
| 1011754 | Adapalene Related Compound E (25 mg) (2,2′-binaphthyl-6,6′-dicarboxylic acid) | 932033-58-4 |
| 1011878 | Adrenalone Hydrochloride (25 mg) (3′,4′-Dihydroxy-2-(methylamino)acetophenone hydrochloride) | 62-13-5 |
| 1011889 | Advantame (200 mg) | 714229-20-6 |
| 1011890 | Advantame Acid (20 mg) (N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]aspartyl]phenylalanine) | 713524-95-9 |
| 1012032 | Actein (20 mg) | 18642-44-9 |
| 1012054 | Acyclovir Related Compound F (50 mg) (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide) | 110104-37-5 |
| 1012065 | Acyclovir (300 mg) | 59277-89-3 |
| 1012076 | Acyclovir Related Compound A (50 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate) | 102728-64-3 |
| 1012087 | Acyclovir Related Compound G (50 mg) (2-{[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate) | 75128-73-3 |
| 1012101 | Adenine (200 mg) | 73-24-5 |
| 1012112 | S-Adenosyl-L-Homocysteine (50 mg) | 979-92-0 |
| 1012123 | Adenosine (200 mg) | 58-61-7 |
| 1012134 | Ademetionine Disulfate Tosylate (500 mg) (S-Adenosyl-L-Methionine Disulfate Tosylate) | 97540-22-2 |
| 1012145 | Agigenin (25 mg) | 55332-76-8 |
| 1012178 | 5′-Adenylic Acid (500 mg) | 61-19-8 |
| 1012190 | Adipic Acid (100 mg) | 124-04-9 |
| 1012203 | Agnuside (25 mg) | 11027-63-7 |
| 1012214 | Agar (500 mg) | N/A |
| 1012288 | Carotenes (3 x 100 mg) | N/A |
| 1012495 | Beta Alanine (100 mg) | 107-95-9 |
| 1012509 | L-Alanine (200 mg) | 56-41-7 |
| 1012517 | L-Alanyl-L-Glutamine (200 mg) | 39537-23-0 |
| 1012531 | L-Alanyl-L-Alanine (200 mg) | 1948-31-8 |
| 1012553 | Albendazole (200 mg) | 54965-21-8 |
| 1012595 | rAlbumin Human (6 mg) (Recombinant Human Albumin) (COLD SHIPMENT REQUIRED) | N/A |
| 1012600 | Albuterol (200 mg) | 18559-94-9 |
| 1012611 | Albuterol Related Compound F (15 mg) (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol) | 1221742-55-7 |
| 1012633 | Albuterol Sulfate (200 mg) | 51022-70-9 |
| 1012644 | Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate) | 18910-68-4 |
| 1012655 | Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) | 156547-62-5 |
| 1012688 | Alcohol Determination–Alcohol (5 mL/ampule; 5 ampules) | 64-17-5 |
| 1012689 | Albuterol Related Compound E (10 mg) (2,2′-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) | N/A |
| 1012699 | Alcohol Determination–Acetonitrile | N/A |
| 1012746 | Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate) | N/A |
| 1012757 | Alclometasone Dipropionate (300 mg) | 66734-13-2 |
| 1012768 | Alcohol (1.2 mL/ampule; 5 ampules) | 64-17-5 |
| 1012772 | Dehydrated Alcohol (1.2 mL/ampule; 5 ampules) | 64-17-5 |
| 1012780 | Alendronate Sodium (200 mg) | 121268-17-5 |
| 1012799 | Aleuritic Acid (50 mg) | 533-87-9 |
| 1012848 | Alitame (250 mg) | 99016-42-9 (hydrate); 80863-62 |
| 1012859 | Alitame – Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) | 80875-07-6 |
| 1012871 | Alfuzosin System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E) | N/A |
| 1012906 | Alfentanil Hydrochloride CII (500 mg) | 70879-28-6 |
| 1012917 | Alfuzosin Hydrochloride (150 mg) | 81403-68-1 |
| 1012928 | Alfuzosin System Suitability Mixture (15 mg) | N/A |
| 1012939 | Allantoin (200 mg) | 97-59-6 |
| 1012950 | Alliin (25 mg) | 556-27-4 |
| 1013002 | Allopurinol (250 mg) | 315-30-0 |
| 1013013 | Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H-pyrazole-4-carboxamide) | 22407-20-1 |
| 1013024 | Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) | 27511-79-1 |
| 1013035 | Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide) | 1346604-13-4 |
| 1013046 | Allopurinol Related Compound D (35 mg) (ethyl 5-amino-1H-pyrazole-4-carboxylate) | 6994-25-8 |
| 1013057 | S-Allyl-L-cysteine (25 mg) | N/A |
| 1013068 | Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) | 31055-19-3 |
| 1013079 | Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate) | 321571-07-7 |
| 1013206 | Almond Oil (1 g) | 8007-69-0 |
| 1013512 | Almotriptan Malate (200 mg) | 181183-52-8 |
| 1013523 | Almotriptan Related Compound A (20 mg) ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol) | 1018676-02-2 |
| 1013534 | Almotriptan System Suitability (20 mg) (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) | N/A |
| 1013545 | Almotriptan Related Compound B (15 mg) (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) | 1246860-65-0 |
| 1013556 | Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) | 334981-12-3 |
| 1013567 | Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) | N/A |
| 1013727 | Aloin (25 mg) (Aloin A; (S)-10-Beta-D-Glucopyranosyl-1,8-dihydroxy-3-hydroxymethylanthracen-9(10H)-one) | 1415-73-2 |
| 1013909 | Alpha-Lactalbumin (400 mg) (COLD SHIPMENT REQUIRED) | 9051-29-0 |
| 1015008 | Alprazolam CIV (200 mg) | 28981-97-7 |
| 1015019 | Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine) | 28910-89-6 |
| 1016000 | Alprostadil (25 mg) | 745-65-3 |
| 1017105 | Altretamine (500 mg) | 645-05-6 |
| 1017364 | Aluminum Sulfate (2 g) (AS) | 17927-65-0 |
| 1017502 | Dried Aluminum Hydroxide Gel (200 mg) | 21645-51-2 |
| 1018505 | Amantadine Hydrochloride (200 mg) | 665-66-7 |
| 1018516 | Amantadine Related Compound A (25 mg) (1-Chloroadamantane) | 935-56-8 |
| 1018527 | Amantadine Related Compound B (25 mg) (N-(Adamantan-1-yl)acetamide) | 880-52-4 |
| 1019202 | Amcinonide (200 mg) | 51022-69-6 |
| 1019406 | Amifostine (150 mg) | 112901-68-5; |
| 20537-88-6 (anhyd | ||
| 1019417 | Amifostine Disulfide (100 mg) | 112901-68-5 |
| 1019428 | Amifostine Thiol (50 mg) (2-[(3-aminopropyl)amino]ethanethiol, dihydrochloride) | 14653-77-1 |
| 1019494 | Amikacin Sulfate (100 mg) | 39831-55-5 |
| 1019508 | Amikacin (300 mg) | 37517-28-5 |
| 1019701 | Amiloride Hydrochloride (500 mg) | 17440-83-4 |
| 1019712 | Amiloride Related Compound A (30 mg) (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate) | 1458-01-1 |
| 1019756 | Aminobenzoate Potassium (200 mg) | 138-84-1 |
| 1019767 | Aminobenzoate Sodium (200 mg) | 555-06-6 |
| 1019803 | Aminobenzoic Acid (200 mg) (p-aminobenzoic acid) | 150-13-0 |
| 1019870 | 4-Aminobenzoylglutamic Acid (50 mg) | 4271-30-1 |
| 1020008 | Aminobutanol (500 mg) (1-Butanol, 2-amino-, (+/-)-) | 96-20-8 |
| 1020023 | Gamma-Aminobutyric Acid (50 mg) | 56-12-2 |
| 1021000 | Aminocaproic Acid (200 mg) | 60-32-2 |
| 1021204 | 4-Aminophenol (100 mg) | 123-30-8 |
| 1021292 | Aminotriazinone (300 mg) (3-Amino-1,2,4-triazin-5(2H)-one) | 1121-90-0 |
| 1021703 | Nitrofurantoin Related Compound A (20 mg) (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine) | N/A |
| 1022808 | 2-Amino-5-chlorobenzophenone (25 mg) | 719-59-5 |
| 1023403 | Diazepam Related Compound B (25 mg) (3-Amino-6-chloro-1-methyl-4-phenylcarbostyril) | 5220-02-0 |
| 1025205 | Aminoglutethimide (200 mg) | 125-84-8 |
| 1025307 | m-Aminoglutethimide (100 mg) | N/A |
| 1025351 | Aminohippuric Acid (200 mg) | 61-78-9 |
| 1025602 | Amino Methacrylate Copolymer (1.5 g) | 24938-16-7 |
| 1025715 | Aminolevulinic Acid Hydrochloride (200 mg) | 5451-09-2 |
| 1025726 | Aminolevulinic Acid Related Compound A (25 mg) (3,3′-(Pyrazine-2,5-diyl)dipropionic acid) | 77479-02-8 |
| 1025737 | Aminolevulinic Acid Related Compound B (25 mg) (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4-oxopentanoate) | 109258-71-1 |
| 1025908 | Aminopentamide Sulfate (200 mg) | 20701-77-3 |
| 1026004 | m-Aminophenol (300 mg) | 591-27-5 |
| 1026401 | Aminosalicylic Acid (125 mg) | 65-49-6 |
| 1026605 | 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) | 3119-15-1 |
| 1027007 | 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) | 2280-89-9 |
| 1027302 | Amiodarone Hydrochloride (200 mg) | 19774-82-4 |
| 1027346 | Amiodarone Related Compound D (20 mg) ((2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone) | 1951-26-4 |
| 1027357 | Amiodarone Related Compound E (25 mg) ((2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 52490-15-0 |
| 1027380 | Amiodarone Related Compound H (20 mg) (2-chloro-N,N-diethylethanamine hydrochloride) | 869-24-9 |
| 1028000 | Amitraz (200 mg) (COLD SHIPMENT REQUIRED) | 33089-61-1 |
| 1028019 | Amitraz Related Compound A (40 mg) (N-(2,4-Dimethylphenyl)formamide) | 60397-77-5 |
| 1028028 | Amitraz Related Compound B (40 mg) (N’-(2,4-Dimethylphenyl)-N-methylformimidamide) (COLD SHIPMENT REQUIRED) | 33089-74-6 |
| 1028032 | Amitraz Related Compound C (40 mg) (N,N’-Bis(2,4-dimethylphenyl)formimidamide) (COLD SHIPMENT REQUIRED) | 16596-04-6 |
| 1029002 | Amitriptyline Hydrochloride (200 mg) | 549-18-8 |
| 1029013 | Amitriptyline Related Compound A (25 mg) (dibenzosuberone) | 1210-35-1 |
| 1029024 | Amitriptyline Related Compound B (25 mg) (5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-ol) | 1159-03-1 |
| 1029501 | Amlodipine Besylate (350 mg) | 111470-99-6 |
| 1029512 | Amlodipine Related Compound A (25 mg) (3-Ethyl, 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate] fumarate) | 113994-41-5 |
| (base) | ||
| 1029534 | Amlodipine Related Compound C (25 mg) (Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate) | 43067-01-2 |
| 1029545 | Amlodipine Related Compound D (25 mg) (3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxoisoindolin-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | 88150-62-3 |
| 1029614 | Amlodipine Related Compound K (25 mg) (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate) | N/A |
| 1029909 | Ammonio Methacrylate Copolymer Type A (500 mg) | 33434-24-1 |
| 1029910 | Ammonio Methacrylate Copolymer Type B (500 mg) | 33434-24-1 |
| 1029929 | Ammonium Glycyrrhizate (100 mg) | 53956-04-0 |
| 1029942 | Ammonium Carbonate (2 g) (AS) | 8000-73-5 |
| 1029953 | Ammonium Chloride (200 mg) | 12125-02-9 |
| 1029986 | Ammonium Phosphate Dibasic (1 g) (AS) | 7783-28-0 |
| 1029997 | Ammonium Salts of Phosphatidic Acid (1.5 g) | N/A |
| 1030001 | Amobarbital CII (200 mg) | 57-43-2 |
| 1031004 | Amodiaquine Hydrochloride (500 mg) | 6398-98-7 |
| 1031401 | Amoxapine (200 mg) | 14028-44-5 |
| 1031445 | Amoxapine Related Compound D (50 mg) (2-Chlorodibenzo[b,f]-[1,4]-oxazepin-11-one) | N/A |
| 1031478 | Amoxapine Related Compound G (50 mg) (3-Chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | N/A |
| 1031503 | Amoxicillin (200 mg) | 61336-70-7 |
| 1031514 | Amoxicillin Related Compound A (15 mg) ((2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | 551-16-6 |
| 1031525 | Amoxicillin Related Compound B (15 mg) (L-amoxicillin) | 26889-93-0 |
| 1031536 | Amoxicillin Related Compound C (15 mg) ((4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid) | 94659-47-9 |
| 1031547 | Amoxicillin Related Compound D (50 mg) ((4S)-2-{[(R)-2-amino-2-(4-hydroxyphenyl)acetamido](carboxy)methyl}-5,5-dimethylthiazolidine-4-carboxylic acid, monosodium salt) | 1642559-71-4 |
| 1031558 | Amoxicillin Related Compounds D and E Mixture (15 mg) | N/A |
| 1031569 | Amoxicillin Related Compound F (15 mg) (3-(4-Hydroxyphenyl)pyrazin-2-ol; phenylpyrazinediol) | 126247-63-0 |
| 1031570 | Amoxicillin Related Compound G (15 mg) ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | 188112-75-6 |
| 1031591 | Amoxicillin Related Compound I (25 mg) ((R)-2-Amino-2-(4-hydroxyphenyl)acetic acid) | 22818-40-2 |
| 1031605 | Amoxicillin Related Compound J (15 mg) (Mixture of amoxicillin and amoxicillin related compound J (open ring dimer)) | N/A |
| 1031616 | Amoxicillin Related Compound H (15 mg) ((R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid) | 205826-86-4 |
| 1032007 | Amphotericin B (125 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 1397-89-3 |
| 1033000 | Ampicillin (200 mg) | 69-53-4 |
| 1033203 | Ampicillin Sodium (125 mg) | 69-52-3 |
| 1033247 | Ampicillin System Suitability Mixture (10 mg) | N/A |
| 1033407 | Ampicillin Trihydrate (200 mg) | 7177-48-2 |
| 1034002 | Amprolium (200 mg) | 121-25-5 |
| 1034308 | Amrinone (500 mg) (Inamrinone) | 60719-84-8 |
| 1034320 | Amrinone Related Compound A (100 mg) (5-carboxamide[3,4′-bipyridin]-6(1H)-one) (Inamrinone Related Compound A) | 62749-46-6 |
| 1034341 | Amrinone Related Compound B (100 mg) (N-(1,6-dihydro-6-oxo-(3,4′-bipyridine)-5-yl)-2-hydroxypropanamide) (Inamrinone Related Compound B) | N/A |
| 1034363 | Amrinone Related Compound C (50 mg) (1,6-dihydro-6-oxo-(3,4′-bipyridine)-5-carbonitrile) (Inamrinone Related Compound C) | N/A |
| 1034498 | alpha-Amylcinnamaldehyde Dimethyl Acetal (500 mg) | 91-87-2 |
| 1034501 | alpha-Amylcinnamyl Acetate (500 mg) | 7493-78-9 |
| 1034512 | alpha-Amylcinnamyl Alcohol (500 mg) | 101-85-9 |
| 1034523 | alpha-Amylcinnamyl Formate (500 mg) | 7493-79-0 |
| 1034738 | Anagrelide Hydrochloride (100 mg) | 823178-43-4 |
| 1034749 | Anagrelide Related Compound A (25 mg) (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate) | 85325-12-8 |
| 1034750 | Anagrelide Related Compound B (25 mg) ((2-amino-5,6-dichloroquinazolin-3(4H)-yl)acetic acid) | N/A |
| 1034771 | Anagrelide Related Compound C (25 mg) (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate) | 70381-75-8 |
| 1034807 | Anastrozole (200 mg) | 120511-73-1 |
| 1034818 | Anastrozole Related Compound A (20 mg) (2,2′-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile)) | 120511-72-0 |
| 1034862 | Andrographolide (50 mg) | 5508-58-7 |
| 1034873 | Powdered Andrographis Extract (500 mg) | 90244-84-1 |
| 1035005 | Anethole (4 x 0.5 mL) | 4180-23-8 |
| 1035300 | 1,6-anhydro-D-glucose (50 mg) | 498-07-7 |
| 1035402 | Anhydro Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | 210980-68-0 |
| 1035708 | Anhydrotetracycline Hydrochloride (25 mg) ((4S ,4aS ,12aS )-4-(Dimethylamino)-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide monohydrochloride) | 13803-65-1 |
| 1036008 | Anileridine Hydrochloride CII (250 mg) | 126-12-5 |
| 1036110 | Aniline (250 mg) | 62-53-3 |
| 1036507 | 3-Anilino-2-(3,4,5-trimethoxybenzyl) acrylonitrile (25 mg) (AS) | 30078-48-9 |
| 1036937 | p-Anisaldehyde (3 x 500 mg) | 123-11-5 |
| 1036948 | o-Anisaldehyde (3 x 0.5 mL) | 135-02-4 |
| 1037011 | Anisole (1.2 mL/ampule; 3 ampules) | 100-66-3 |
| 1037022 | Anisyl Butyrate (5 x 0.5 mL) | 6963-56-0 |
| 1037033 | Anisyl Propionate (5 x 0.5 mL) | 7549-33-9 |
| 1037044 | Anisyl Phenylacetate (5 x 0.5 mL) | 102-17-0 |
| 1038003 | Antazoline Phosphate (200 mg) | 154-68-7 |
| 1038025 | Antazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) | 26953-37-7 |
| 1039006 | Anthralin (200 mg) | 1143-38-0 |
| 1039152 | Allyl Anthranilate (0.5 mL/ampule; 5 ampules) | 7493-63-2 |
| 1040005 | Antipyrine (200 mg) | 60-80-0 |
| 1040016 | Antipyrine Related Compound A (25 mg) (3-methyl-1-phenyl-1H-pyrazol-5(4H)-one) | 89-25-8 |
| 1040504 | Antithrombin III Human (4.38 IU) | 9000-94-6 |
| 1040683 | Apigenin (30 mg) (5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone) | 520-36-5 |
| 1040708 | Apigenin-7-glucoside (30 mg) | 578-74-5 |
| 1040854 | Apocarotenal (3 x 50 mg) (Beta-Apo-8′-Carotenal) | 1107-26-2 |
| 1041008 | Apomorphine Hydrochloride (250 mg) | 41372-20-7 |
| 1041609 | Apraclonidine Hydrochloride (100 mg) | 73218-79-8 |
| 1041904 | Aprepitant (150 mg) | 170729-80-3 |
| 1041915 | Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | 1148113-53-4 |
| 1041926 | Aprepitant Related Compound B (10 mg) (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | 172822-29-6 |
| 1041992 | Desfluoro Aprepitant (15 mg) (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) | 170729-76-7 |
| 1042055 | Arabinose (50 mg) | 87-72-9 |
| 1042102 | L-Arabinitol (250 mg) | 7643-75-6 |
| 1042270 | Arachidyl Alcohol (125 mg) | 629-96-9 |
| 1042408 | Argatroban (350 mg) | 141396-28-3 |
| 1042419 | Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | N/A |
| 1042420 | Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride) | N/A |
| 1042437 | Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) | N/A |
| 1042500 | L-Arginine (200 mg) | 74-79-3 |
| 1042554 | Arginine Ethyl Ester Dihydrochloride (250 mg) | 36589-29-4 |
| 1042601 | Arginine Hydrochloride (125 mg) | 1119-34-2 |
| 1042634 | Aripiprazole (200 mg) | 129722-12-9 |
| 1042645 | Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) | 889443-20-3 |
| 1042656 | Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) | 119532-26-2 |
| 1042689 | Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) | 573691-09-5 |
| 1042690 | Aripiprazole Related Compound G (25 mg) (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) | 129722-25-4 |
| 1042703 | Arsanilic Acid (25 mg) | 98-50-0 |
| 1042714 | Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one) | N/A |
| 1042747 | Artemisinin (50 mg) ((3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one) | 63968-64-9 |
| 1042780 | Artemether (100 mg) | 71963-77-4 |
| 1042805 | Artemether Related Compound B (15 mg) ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) | 71939-51-0 |
| 1042850 | Artesunate (200 mg) | 88495-63-0 |
| 1042907 | Articaine (40 mg) | 23964-58-1 |
| 1042918 | Articaine Hydrochloride (125 mg) | 23964-57-0 |
| 1042929 | Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate) | N/A |
| 1042930 | Articaine Related Compound B (25 mg) (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid) | 114176-52-2 |
| 1042962 | Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate) | N/A |
| 1043003 | Ascorbic Acid (1 g) (Vitamin C) | 50-81-7 |
| 1043105 | Ascorbyl Palmitate (500 mg) | 137-66-6 |
| 1043149 | Ascorbyl Stearate (500 mg) | 10605-09-1 |
| 1043309 | Powdered Ashwagandha Root Extract (1 g) | 90147-43-6 |
| 1043331 | Asiaticoside (30 mg) | 16830-15-2 |
| 1043502 | Asparagine Anhydrous (200 mg) | 70-47-3 |
| 1043513 | Asparagine Monohydrate (200 mg) | 5794-13-8 |
| 1043706 | Aspartame (200 mg) | 22839-47-0 |
| 1043728 | Aspartame Related Compound A (25 mg) ([(2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid) | 5262-10-2 |
| 1043750 | Aspartame Acesulfame (200 mg) | 106372-55-8 |
| 1043819 | Aspartic Acid (100 mg) | 56-84-8 |
| 1044006 | Aspirin (500 mg) | 50-78-2 |
| 1044108 | Astragaloside IV (100 mg) ((3beta,6alpha,9beta,16beta,20R,24S)-16,25-Dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside) | 84687-43-4 |
| 1044119 | Astragalus Root Dry Extract (1 g) | N/A |
| 1044200 | Astaxanthin (Synthetic) (3 x 30 mg) (3,3′-dihydroxy-Beta,Beta-Carotene-4,4′-dione) | 7542-45-2 |
| 1044210 | Astaxanthin Esters from Haematococcus pluvialis (5 x 100 mg) | N/A |
| 1044301 | Astemizole (200 mg) | 68844-77-9 |
| 1044334 | Atazanavir Sulfate (200 mg) | 229975-97-7 |
| 1044345 | Atazanavir System Suitability Mixture (25 mg) (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer) | N/A |
| 1044356 | Atazanavir Related Compound A (25 mg) ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid) | 162537-11-3 |
| 1044403 | Atenolol (200 mg) | 29122-68-7 |
| 1044469 | Atomoxetine Hydrochloride (200 mg) | 82248-59-7 |
| 1044470 | Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1-phenylpropan-1-ol) | 42142-52-9 |
| 1044488 | Atomoxetine Related Compound B (10 mg) (N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine hydrochloride) | 873310-28-2 |
| 1044491 | Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) | 873310-31-7 |
| 1044516 | Atorvastatin Calcium (100 mg) | 344423-98-9 |
| 1044527 | Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) | 433289-83-9 |
| 1044538 | Atorvastatin Related Compound B (20 mg) (Calcium (3S,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | 887196-25-0 |
| 1044549 | Atorvastatin Related Compound C (20 mg) (Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) | 693793-53-2 |
| 1044550 | Atorvastatin Related Compound D (10 mg) (Epoxide impurity, or 3-(4-Fluorobenzoyl)-2-isobutyryl-3-phenyl-oxirane-2-carboxylic acid phenylamide) | 148146-51-4 |
| 1044571 | Atorvastatin Related Compound E (10 mg) (3S, 5S enantiomer of Atorvastatin Calcium) | 1105067-88-6 |
| 1044582 | Atorvastatin Related Compound H (20 mg) (Lactone Impurity, 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide) | N/A |
| 1044593 | Atorvastatin Related Compound I (20 mg) (tert-Butyl 2-((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl)acetate) | N/A |
| 1044651 | Atovaquone (200 mg) | 95233-18-4 |
| 1044662 | Atovaquone Related Compound A (25 mg) (cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone) | N/A |
| 1044800 | Atracurium Besylate (100 mg) | 64228-81-5 |
| 1044913 | Atomoxetine S-Isomer (10 mg) ((S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride) | 82857-39-4 |
| 1044990 | Atropine (50 mg) (1alphaH,5alphaH-Tropan-3alpha-ol (+/-)-tropate (ester)) | 51-55-8 |
| 1045009 | Atropine Sulfate (500 mg) | 5908-99-6 |
| 1045337 | Avobenzone (500 mg) | 70356-09-1 |
| 1045508 | Aurothioglucose (100 mg) | 12192-57-3 |
| 1045520 | Azacitidine (150 mg) | 320-67-2 |
| 1045539 | Azacitidine Related Compound A (25 mg) (4-Amino-1,3,5-triazin-2(1H)-one) | 931-86-2 |
| 1045541 | Azacitidine Related Compound B (15 mg) (1-O-Acetyl-2,3,5-tri-O-benzoyl-Beta-D-ribofuranose) | 6974-32-9 |
| 1045574 | Azacitidine Related Compound C (15 mg) (1-beta-D-Ribofuranosyl-3-guanylurea picrate) | 931-86-2 |
| 1045600 | Azaerythromycin A (100 mg) (9-Deoxo-9a-aza-9a-homoerythromycin A) | 76801-85-9 |
| 1045756 | Azaperone (200 mg) | 1649-18-9 |
| 1045803 | Azatadine Maleate (200 mg) | 3978-86-7 |
| 1045938 | Azathioprine Related Compound G (15 mg) (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine) | 5581-52-2 |
| 1045993 | Azathioprine Related Compound A (15 mg) (1-methyl-4-nitro-1H-imidazol-5-amine) | 4531-54-8 |
| 1046001 | Azathioprine (200 mg) | 446-86-6 |
| 1046012 | Azithromycin Identification Mixture (75 mg) | N/A |
| 1046023 | Azithromycin Related Compound H (15 mg) (3′-N-[[4-(acetylamino)phenyl]sulfonyl]-3′-N-demethylazithromycin) | 612069-30-4 |
| 1046045 | Azithromycin Related Compound F (25 mg) (3′-N-demethyl-3′-N-formylazithromycin) | 612069-28-0 |
| 1046056 | Azithromycin (200 mg) | 117772-70-0 |
| 1046067 | Azithromycin Identity (75 mg) | N/A |
| 1046078 | Desosaminylazithromycin (15 mg) | N/A |
| 1046089 | N-Demethylazithromycin (15 mg) | N/A |
| 1046090 | Azithromycin N-Oxide (15 mg) | 90503-06-3 |
| 1046147 | Azo-Aminoglutethimide (100 mg) | N/A |
| 1046158 | Azelastine Hydrochloride (300 mg) | 79307-93-0 |
| 1046170 | Azelastine Related Compound B (20 mg) (N’-(1-methylazepan-4-yl)benzohydrazide hydrochloride) | 117078-69-0 |
| 1046191 | Azelastine Related Compound D (20 mg) (4-(4-chlorobenzyl)phthalazin-1(2H)-one) | 53242-88-9 |
| 1046202 | Azelastine Related Compound E (20 mg) (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one) | N/A |
| 1046205 | Aztreonam (200 mg) | 78110-38-0 |
| 1046213 | Azelastine Related Compound F (20 mg) (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide) | 640279-88-5 |
| 1046307 | Aztreonam E-Isomer (15 mg) | N/A |
| 1046351 | Azure B (50 mg) (3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride) | 531-55-5 |
| 1046409 | Open Ring Aztreonam (10 mg) | 87500-74-1 |
| 1047300 | Bacampicillin Hydrochloride (200 mg) | 37661-08-8 |
| 1048007 | Bacitracin Zinc (200 mg) | 1405-89-6 |
| 1048200 | Baclofen (350 mg) | 1134-47-0 |
| 1048222 | Baclofen Related Compound A (50 mg) (4-(4-Chlorophenyl)-2-pyrrolidinone) | N/A |
| 1048233 | Bacoside A3 (15 mg) | N/A |
| 1048244 | Powdered Bacopa Extract (500 mg) | 93164-89-7 |
| 1048255 | Balsalazide Disodium (200 mg) | 150399-21-6 |
| 1048266 | Balsalazide Related Compound A (100 mg) ((E)-5-[(p-carboxyphenyl)azo]-2-salicylic acid, disodium salt) | N/A |
| 1048277 | Balsalazide Related Compound B (25 mg) ((E)-5-((m-[(2-carboxyethyl)carbamoyl]phenyl)azo)-2-salicylic acid) | N/A |
| 1048288 | Beta Glucan (1 g) (Beta Glucan from Baker’s Yeast (Saccharomyces cerevisiae) | 9012-72-0 |
| 1048415 | Lagerstroemia speciosa Leaf Dry Extract (1g) | N/A |
| 1048506 | Beclomethasone Dipropionate (200 mg) | 5534-09-8 |
| 1048550 | Behenoyl Polyoxylglycerides (500 mg) | N/A |
| 1048572 | Bemotrizinol (200 mg) | 187393-00-6 |
| 1048583 | Bemotrizinol Impurity Mixture (100 mg) | N/A |
| 1048619 | Benazepril Hydrochloride (125 mg) | 86541-74-4 |
| 1048620 | Benazepril Related Compound A (25 mg) ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) | N/A |
| 1048630 | Benazepril Related Compound B (15 mg) ((3S)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride) | N/A |
| 1048641 | Benazepril Related Compound C (50 mg) ((3S)-3-[[(1S)-1-carboxy-3-phenylpropyl]amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine]-1-acetic acid) | 86541-78-8 |
| 1048652 | Benazepril Related Compound D (15 mg) (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride) | N/A |
| 1048663 | Benazepril Related Compound E (25 mg) (3-amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid, monohydrochloride) | N/A |
| 1048674 | Benazepril Related Compound F (15 mg) (tert-butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate) | 109010-60-8 |
| 1048685 | Benazepril Related Compound G (15 mg) (COLD SHIPMENT REQUIRED) ((3-(1-Ethoxycarbonyl-3-phenyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine)-1-acetic acid, ethyl ester) | 103129-58-4 |
| 1049000 | Bendroflumethiazide (200 mg) | 73-48-3 |
| 1050009 | Benoxinate Hydrochloride (200 mg) | 5987-82-6 |
| 1050905 | Benzaldehyde (3 X 1 mL) (List Chemical) | 100-52-7 |
| 1050949 | Benzaldehyde Propylene Glycol Acetal (5 x 0.5 mL) | 2568-25-4 |
| 1050982 | Benzalkonium Bromide (C12) (150 mg) | 7281-04-1 |
| 1051001 | Benzalkonium Chloride (5 mL of approx. 10% aqueous solution) | 8001-54-5 |
| 1051500 | Benzethonium Chloride (500 mg) | 121-54-0 |
| 1051602 | Benzhydrol (50 mg) | 91-01-0 |
| 1054000 | Benzocaine (500 mg) | 94-09-7 |
| 1055002 | Benzoic Acid (300 mg) | 65-85-0 |
| 1056005 | Benzonatate (1 g) | 32760-16-0 |
| 1056130 | Benzophenone (25 mg) (Diphenylmethanone) | 119-61-9 |
| 1056504 | 1,4-Benzoquinone (200 mg) | 106-51-4 |
| 1057507 | Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) | 121-30-2 |
| 1059003 | Benzphetamine Hydrochloride CIII (200 mg) | 5411-22-3 |
| 1061005 | Benztropine Mesylate (200 mg) | 132-17-2 |
| 1061901 | Benzyl Alcohol (500 mg/ampule) | 100-51-6 |
| 1062008 | Benzyl Benzoate (5 g) | 120-51-4 |
| 1062020 | Benzyl Disulfide (200 mg) | 150-60-7 |
| 1062074 | Benzyl Mercaptan (5 x 0.5 mL) | 100-53-8 |
| 1062085 | Benzyl Methyl Sulfide (5 x 0.5 mL) | 766-92-7 |
| 1064058 | 3-Benzyl-4-Heptanone (5 x 0.5 mL) | 7492-37-7 |
| 1064122 | N-Benzyl-N-methyl-ethanolamine (3 x 0.2 mL) (2-[benzyl(methyl)amino]ethanol) | 101-98-4 |
| 1065210 | Berberine Chloride (50 mg) | 633-65-8 |
| 1065221 | Bendamustine Hydrochloride (200 mg) | 3543-75-7 |
| 1065232 | Bendamustine Related Compound A (25 mg) (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride) | 109882-29-3 |
| 1065243 | Bendamustine Related Compound B | N/A |
| 1065254 | Bendamustine Related Compound C (20 mg) (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | 3545-74-6 |
| 1065265 | Bendamustine Related Compound D (20 mg) (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride) | 1797881-48-1 |
| 1065276 | Bendamustine Related Compound E (20 mg) (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid) | 109882-27-1 |
| 1065287 | Bendamustine Related Compound F (20 mg) (Mannitol-1-yl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate) | 1869075-89-7 |
| 1065298 | Bendamustine Related Compound G (20 mg) (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride) | N/A |
| 1065301 | Bendamustine Related Compound H (25 mg) (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid) | 1228551-91-4 |
| 1065312 | Bendamustine Related Compound I (25 mg) (Ethyl 4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoate) | 87475-54-5 |
| 1065480 | Beta Carotene (7 x 100 mg) (COLD SHIPMENT REQUIRED) | 7235-40-7 |
| 1065491 | Beta Carotene System Suitability (200 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1065550 | Betadex Sulfobutyl Ether Sodium (500 mg) | 182410-00-0 |
| 1065618 | Betahistine Hydrochloride (200 mg) | 5579-84-0 |
| 1065695 | Betaine (1 g) | 107-43-7 |
| 1065709 | Betaine Hydrochloride (200 mg) | 590-46-5 |
| 1066009 | Betamethasone (200 mg) | 378-44-9 |
| 1067001 | Betamethasone Acetate (500 mg) | 987-24-6 |
| 1067034 | Betamethasone Acetate Related Compound C (20 mg) (9-Fluoro-11Beta,17,21-trihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 11,21-diacetate) | 330157-05-6 |
| 1067045 | Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate) | 912-38-9 |
| 1067307 | Betamethasone Benzoate (200 mg) | 22298-29-9 |
| 1067704 | Betamethasone Dipropionate (125 mg) | 5593-20-4 |
| 1068004 | Betamethasone Sodium Phosphate (500 mg) | 151-73-5 |
| 1069007 | Betamethasone Valerate (200 mg) | 2152-44-5 |
| 1069018 | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-21-yl valerate) | 2240-28-0 |
| 1069903 | Betaxolol Hydrochloride (200 mg) | 63659-19-8 |
| 1071009 | Bethanechol Chloride (200 mg) | 590-63-6 |
| 1071202 | Bicalutamide (200 mg) | 90357-06-5 |
| 1071213 | Bicalutamide Related Compound A (25 mg) (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide) | N/A |
| 1071224 | Bicalutamide Related Compound B (10 mg) ((RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide) | N/A |
| 1071268 | Powdered Bilberry Extract (500 mg) | 84082-34-8 |
| 1071304 | Bile Salts (10 g) | 145-42-6 |
| 1071381 | Biochanin A (20 mg) | 491-80-5 |
| 1071508 | Biotin (200 mg) | 58-85-5 |
| 1073423 | Biphenyl (500 mg) | 92-52-4 |
| 1073718 | Beta-Bisabolol (2 x 100 mg) | 15352-77-9 |
| 1074007 | Bisacodyl (125 mg) | 603-50-9 |
| 1074030 | Bisacodyl Related Compound A (20 mg) (4,4′-(Pyridin-2-ylmethylene)diphenol) | 603-41-8 |
| 1074042 | Bisacodyl Related Compound B (20 mg) (2,4′-(Pyridin-2-ylmethylene)diphenol) | 16985-05-0 |
| 1074051 | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 72901-16-7 |
| 1074073 | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 111664-35-8 |
| 1075203 | Bis(2-ethylhexyl)maleate (2 g) (Maleic acid, bis(2-ethylhexyl)ester) | 142-16-5 |
| 1075305 | Bisdesmethoxycurcumin (30 mg) | 24939-16-0 |
| 1075531 | Bismuth Citrate (100 mg) | 813-93-4 |
| 1075553 | Bismuth Subsalicylate (100 mg) | 14882-18-9 |
| 1075600 | Bismuth Subcarbonate (1 g) (AS) | 5892-10-4 |
| 1075622 | Bismuth Subgallate (2 g) (AS) | 99-26-3 |
| 1075644 | Bismuth Subnitrate (1.5 g) (AS) | 1304-85-4 |
| 1075677 | Bisoctrizole (200 mg) | 103597-45-1 |
| 1075688 | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol) | 3147-75-9 |
| 1075699 | Bisoctrizole Resolution Mixture (50 mg) | N/A |
| 1075757 | Bisoprolol Fumarate (200 mg) | 104344-23-2 |
| 1075892 | Bisphenol A (200 mg) | 80-05-7 |
| 1076013 | Bivalirudin | N/A |
| 1076024 | Asp9-Bivalirudin | N/A |
| 1076035 | des-Glu13 Bivalirudin | N/A |
| 1076057 | Borage Seed Oil (1 g) | 84012-16-8 |
| 1076115 | Bosentan (200 mg) | 157212-55-0 |
| 1076126 | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl] benzenesulfonamide) | 150727-06-3 |
| 1076137 | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl]benzenesulfonamide) | 174227-14-6 |
| 1076148 | Bosentan Related Compound C (15 mg) (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2′-bipyrimidin]-4-yl}oxy)ethane) | 1097263-60-9 |
| 1076159 | Bosentan Related Compound D (15 mg) (4,6-dichloro-5-(2-methoxyphenoxy)-2,2′-bipyrimidine) | 150728-13-5 |
| 1076160 | Bosentan Related Compound E (15 mg) (4-(tert-butyl)benzenesulfonamide) | 6292-59-7 |
| 1076192 | BSA for Protein Quantitation (5 x 1 mL) | 9048-46-8 |
| 1076206 | Powdered Black Cohosh Extract (1.5 g) | 84776-26-1 |
| 1076250 | Boswellia Serrata Extract (1 g) | N/A |
| 1076261 | 3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) | 67416-61-9 |
| 1076308 | Bleomycin Sulfate (15 mg) | 9041-93-4 |
| 1076341 | Boric Acid (1 g) | 10043-35-3 |
| 1076352 | Bretylium Tosylate (200 mg) | 61-75-6 |
| 1076363 | Brinzolamide (200 mg) | 138890-62-7 |
| 1076374 | Brinzolamide Related Compound A (50 mg) ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer)) | 154127-19-2 |
| 1076385 | Brinzolamide Related Compound B (50 mg) ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate) | N/A |
| 1076400 | Brimonidine Tartrate (250 mg) | 70359-46-5 |
| 1076419 | Brimonidine Related Compound A (50 mg) (5-Bromoquinoxalin-6-amine) | 50358-63-9 |
| 1076421 | Brimonidine Related Compound B (50 mg) (1-(5-Bromoquinoxalin-6-yl)thiourea) | 842138-74-3 |
| 1076454 | Brimonidine Related Compound E (15 mg) (2-(5-Bromoquinoxalin-6-yl)guanidine) | 168329-48-4 |
| 1076465 | Bromazepam CIV (100 mg) (AS) | 1812-30-2 |
| 1076501 | Bromocriptine Mesylate (150 mg) | 22260-51-1 |
| 1077005 | Bromodiphenhydramine Hydrochloride (200 mg) | 1808-12-4 |
| 1077708 | 8-Bromotheophylline (400 mg) | 10381-75-6 |
| 1077887 | Bromperidol Decanoate (15 mg) | 75067-66-2 |
| 1078008 | Brompheniramine Maleate (125 mg) | 980-71-2 |
| 1078201 | Budesonide (200 mg) | 51333-22-3 |
| 1078245 | Budesonide Related Compound E (25 mg) (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) | 131918-64-4 |
| 1078267 | Budesonide Related Compound G (25 mg) (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) | 137174-25-5 |
| 1078289 | Budesonide Related Compound L (25 mg) (16alpha,17-[butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione) | 216453-74-6 |
| 1078303 | Bumetanide (125 mg) | 28395-03-1 |
| 1078325 | Bumetanide Related Compound A (10 mg) (3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid) | N/A |
| 1078336 | Bumetanide Related Compound B (25 mg) (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid) | 28328-53-2 |
| 1078507 | Bupivacaine Hydrochloride (300 mg) | 14252-80-3 (an); |
| 73360-54-0 (M | ||
| 1078518 | Bupivacaine Related Compound A (50 mg) (6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide) (AS) | N/A |
| 1078529 | Bupivacaine Related Compound B (50 mg) (N-(2,6-dimethylphenyl)piperidine-2-carboxamide) | 65797-42-4 |
| 1078573 | Buspirone Related Compound A (75 mg x 2) (2-(Piperazin-1-yl)pyrimidine) | 20980-22-7 |
| 1078642 | Buspirone Related Compound K (50 mg) (8-azaspiro[4.5]decane-7,9-dione) | 1075-89-4 |
| 1078700 | Buprenorphine Hydrochloride CIII (50 mg) | 53152-21-9 |
| 1078711 | Buprenorphine Related Compound A CII (25 mg) ((S)-2-[17-(But-3-en-1-yl)-4,5alpha-epoxy-3-hydroxy-6-methoxy-6alpha,14-ethanomorphinan-7alpha-yl]- 3,3-dimethylbutan-2-ol) | 457071-73-7 |
| 1078722 | Buprenorphine System Suitability Mixture CII (50 mg) (Mixture of Buprenorphine and about 0.5% of Ethenobuprenorphine) | N/A |
| 1078733 | Bupropion Hydrochloride (200 mg) | 31677-93-7 |
| 1078744 | Bupropion Hydrochloride Related Compound A (15 mg) (2-(tert-butylamino)-4′-chloropropiophenone hydrochloride) | N/A |
| 1078755 | Bupropion Hydrochloride Related Compound B (10 mg) (2-(tert-butylamino)-3′-bromopropiophenone hydrochloride) | N/A |
| 1078766 | Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxypropan-1-one) (COLD SHIPMENT REQUIRED) | N/A |
| 1078799 | Bupropion Hydrochloride Related Compound F (40 mg) (1-(3-chlorophenyl)-1-hydroxy-2-propanone) (COLD SHIPMENT REQUIRED) | N/A |
| 1078802 | Buspirone Hydrochloride (200 mg) | 33386-08-2 |
| 1078813 | Buspirone Related Compound G (50 mg) (1,4-Di(pyrimidin-2-yl)piperazine) | 84746-24-7 |
| 1078824 | Buspirone Related Compound L (75 mg x 2) (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione) | 21098-11-3 |
| 1078835 | Buspirone Related Compound N (50 mg) (8,8′-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione) | 257877-44-4 |
| 1078846 | Bupropion Hydrobromide (200 mg) | 905818-69-1 |
| 1079000 | Butabarbital CIII (200 mg) | 125-40-6 |
| 1081002 | Butalbital CIII (200 mg) | 77-26-9 |
| 1081501 | Butamben (200 mg) | 94-25-7 |
| 1081807 | 1-Butanol (1.2 mL/ampule; 3 ampules) | 71-36-3 |
| 1081829 | 2-Butanol (1.2 mL/ampule; 3 ampules) | 78-92-2 |
| 1081842 | 2,3-Butanedithiol (3 x 1 g) | 4532-64-3 |
| 1082300 | Butoconazole Nitrate (200 mg) | 64872-77-1 |
| 1082504 | Butorphanol Tartrate CIV (350 mg) | 58786-99-5 |
| 1082592 | Butyl Anthranilate (1 mL) (List Chemical) | 7756-96-9 |
| 1082606 | Butyl Acetate (1.2 mL/ampule; 3 ampules) | 123-86-4 |
| 1082617 | Butyl Cinnamate (500 mg) | 538-65-8 |
| 1082628 | Butyl Heptanoate (5 x 0.5 mL) | 5454-28-4 |
| 1082639 | Butyl Stearate (500 mg) | 123-95-5 |
| 1082640 | Butyl Isothiocyanate (1 mL) | 592-82-5 |
| 1082672 | Butyl Valerate (1 ml) | 591-68-4 |
| 1082708 | Butylated Hydroxytoluene (500 mg) | 128-37-0 |
| 1082901 | Butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate (25 mg) | N/A |
| 1082956 | Butane-1,3-diol (1 mL) | 107-88-0 |
| 1082967 | Butyl Hexanoate (3 x 500 mg) | 626-82-4 |
| 1083008 | 2-tert-Butyl-4-hydroxyanisole (200 mg) | 88-32-4 |
| 1083100 | 3-tert-Butyl-4-hydroxyanisole (200 mg) | 121-00-6 |
| 1083303 | tert-Butylmethyl ether (1.2 mL/ampule; 3 ampules) | 1634-04-4 |
| 1083529 | Butyl Palmitate (500 mg) | 111-06-8 |
| 1084000 | Butylparaben (200 mg) | 94-26-8 |
| 1084215 | Allyl Butyrate (5 x 0.5 mL) | 2051-78-7 |
| 1084259 | Butyraldehyde (3 x 1.2 mL) | 123-72-8 |
| 1084292 | CD34+ Cell Enumeration System Suitability (1.24 x 10^4 CD34+ Cells) | N/A |
| 1084306 | Cabergoline (125 mg) | 81409-90-7 |
| 1084995 | Caffeic Acid (100 mg) | 331-39-5 |
| 1085003 | Caffeine (200 mg) | 58-08-2 |
| 1086006 | Caffeine Melting Point Standard (1 g) (Approximately 236 degrees) | 58-08-2 |
| 1086039 | Caftaric Acid (20 mg) | 67879-58-7 |
| 1086108 | Calcifediol (75 mg) | 63283-36-3 |
| 1086141 | Calcipotriene (200 mg) | 112965-21-6 |
| 1086152 | Calcipotriene Related Compound C (15 mg) ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1alpha,3beta,24-triol) | 113082-99-8 |
| 1086200 | Calcitonin Salmon (20 mg) (COLD SHIPMENT REQUIRED) | 47931-85-1 |
| 1086210 | Calcitonin Salmon Related Compound A (20 mg) (N-acetyl-Cys(1)-calcitonin salmon) (COLD SHIPMENT REQUIRED) | N/A |
| 1086221 | Calcitonin Salmon Related Compound B (0.34 mg) (calcitonin salmon-glycine) (COLD SHIPMENT REQUIRED) | N/A |
| 1086301 | Calcitriol (10 mg) (COLD SHIPMENT REQUIRED) | 32222-06-3 |
| 1086312 | Calcitriol Solution (5 mL) (COLD SHIPMENT REQUIRED) | N/A |
| 1086334 | Calcium Acetate (500 mg) | 62-54-4 |
| 1086356 | Calcium Ascorbate (200 mg) | 5743-28-2 |
| 1086378 | Calcium Benzoate (200 mg) | 5743-30-6 |
| 1086403 | Calcium Carbonate (1 g) | 471-34-1 |
| 1086425 | Calcium Citrate Malate (200 mg) | 142606-53-9 |
| 1086436 | Calcium Chloride (1 g) (AS) | 10035-04-8 |
| 1086447 | Calcium Cyclamate (200 mg) | 5897-16-5 (dihydrate); 139-06- |
| 1086800 | Calcium Gluceptate (200 mg) | 29039-00-7 |
| 1086822 | Calcium Gluconate Anhydrous (200 mg) | 299-28-5 |
| 1086833 | Calcium Gluconate Monohydrate (200 mg) | 66905-23-5 |
| 1086855 | Calcium Hydroxide (1 g) (AS) | 1305-62-0 |
| 1086866 | Calcium (-)-Hydroxycitrate (150 mg) | N/F |
| 1086888 | Calcium Lactate (1 g) | 63690-56-2 |
| 1086902 | Calcium Lactobionate (200 mg) | 110638-68-1 |
| 1086935 | Calcium Levulinate (1 g) (AS) | 5743-49-7 |
| 1086957 | Calcium Lignosulfonate (40-65) (2 g) | 8061-52-7 |
| 1087009 | Calcium Pantothenate (200 mg) (Vitamin B5) | 137-08-6 |
| 1087031 | Tribasic Calcium Phosphate (1 g) (AS) | 12167-74-7 |
| 1087202 | Calcium Saccharate (200 mg) | 5793-89-5 |
| 1087359 | Calcium Stearate (2 g) (AS) | 1592-23-0 |
| 1087360 | Calcium Succinate (200 mg) | 159389-75-0 |
| 1087406 | Calcium Sulfate (1 g) (AS) | 10101-41-4 |
| 1087472 | Calycosin (50 mg) (7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one) | 20575-57-9 |
| 1087483 | Calycosin 7-O-beta-D-Glucopyranoside (50 mg) (3-(3-Hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) | 20633-67-4 |
| 1087508 | Camphor (1 g) | 464-49-3 |
| 1087520 | D-camphor sulfonic acid (100 mg) | 3144-16-9 |
| 1087701 | Candelilla Wax (250 mg) | 8006-44-8 |
| 1087803 | Candesartan Cilexetil (100 mg) | 145040-37-5 |
| 1087814 | Candesartan Cilexetil Related Compound A (10 mg) (Ethyl 1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) | N/A |
| 1087825 | Candesartan Cilexetil Related Compound B (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 1-{[2′-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydrobenzimidazole-7-carboxylate) | 869631-11-8 |
| 1087847 | Candesartan Cilexetil Related Compound D (10 mg) (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2′-(2-ethyl-2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate) | N/A |
| 1087869 | Candesartan Cilexetil Related Compound F (10 mg) (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2′-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate) | N/A |
| 1087870 | Candesartan Cilexetil Related Compound G (10 mg) (1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) | 139481-59-7 |
| 1090014 | Exo-tetrahydrocannabinol (1 mL) | N/A |
| 1090150 | Canola Oil (1 g) | 120962-03-0 |
| 1090706 | Capecitabine (200 mg) | 154361-50-9 |
| 1090717 | Capecitabine Related Compound A (15 mg) (5′-deoxy-5-fluorocytidine) | 66335-38-4 |
| 1090728 | Capecitabine Related Compound B (20 mg) (5′-deoxy-5-fluorouridine) | 3094-09-5 |
| 1090739 | Capecitabine Related Compound C (10 mg) (2′,3′-O-carbonyl-5′-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine) (COLD SHIPMENT REQUIRED) | N/A |
| 1091006 | Capreomycin Sulfate (250 mg) | 1405-37-4 |
| 1091028 | Capric Alcohol (5 x 30 mg) | 112-30-1 |
| 1091039 | Caprolactam (1 g) | 105-60-2 |
| 1091040 | Caprylic Acid (300 mg) | 124-07-2 |
| 1091108 | Capsaicin (100 mg) | 404-86-4 |
| 1091200 | Captopril (200 mg) | 62571-86-2 |
| 1091221 | Captopril Disulfide (100 mg) | 64806-05-9 |
| 1091505 | Caprylocaproyl Polyoxylglycerides (200 mg) | N/A |
| 1092009 | Carbachol (200 mg) | 51-83-2 |
| 1093001 | Carbamazepine (100 mg) | 298-46-4 |
| 1093012 | Carbamazepine Related Compound A (30 mg) (10,11-dihydrocarbamazepine) | 3564-73-6 |
| 1093023 | Carbamazepine Related Compound B (50 mg) (5H-Dibenz[b,f]azepine) | 256-96-2 |
| 1093500 | Carbenicillin Indanyl Sodium (300 mg) | 26605-69-6 |
| 1095506 | Carbidopa (400 mg) | 38821-49-7 |
| 1095517 | Carbidopa Related Compound A (25 mg) (3-O-Methylcarbidopa) | N/A |
| 1096000 | Carbinoxamine Maleate (200 mg) | 3505-38-2 |
| 1096019 | Carbinoxamine Related Compound A (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanone) | 6318-51-0 |
| 1096021 | Carbinoxamine Related Compound B (25 mg) ((4-Chlorophenyl)(pyridin-2-yl)methanol) | 27652-89-7 |
| 1096032 | Carbinoxamine Related Compound C (25 mg) (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) | N/A |
| 1096407 | Carboplatin (100 mg) | 41575-94-4 |
| 1096509 | Carboprost Tromethamine (30 mg) | 58551-69-2 |
| 1096510 | Carglumic Acid Related Compound A (30 mg) ((S)-3-(2,5-dioxoimidazolidin-4-yl)propanoic acid) | 17027-50-8 |
| 1096529 | Carglumic Acid Related Compound B (30 mg) ((S)-2,7-dioxo-1,3-diazepane-4-carboxylic acid) | N/A |
| 1096531 | Carboxymethylcellulose Calcium (1.5 g) (AS) | 9050-04-8 |
| 1096553 | Carboxymethylcellulose Sodium (1.5 g) | 9004-32-4 |
| 1096564 | D-Carglumic Acid (30 mg) (N-Carbamoyl-D-glutamic acid) | 26117-15-7 |
| 1096586 | Carglumic Acid (200 mg) | 1188-38-1 |
| 1096597 | Carisoprodol Related Compound A (10 mg) (2-hydroxymethyl-2-methylpentyl carbamate) | 1471-56-3 |
| 1096600 | Carisoprodol CIV (1 g) | 78-44-4 |
| 1096611 | Carmellose (500 mg) | 9000-11-7 |
| 1096622 | Carvedilol (200 mg) | 72956-09-3 |
| 1096633 | Carvedilol Related Compound A (15 mg) (1-(4-(2-hydroxy-3-(2-(2-methoxyphenoxy)ethylamino)propoxy)-9H-carbazol-9-yl)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol) | 1198090-73-1 |
| 1096644 | Carvedilol Related Compound B (15 mg) (3,3′-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol)) | 918903-20-5 |
| 1096655 | Carvedilol Related Compound C (20 mg) (1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol) | 72955-94-3 |
| 1096666 | Carvedilol Related Compound D (15 mg) (4-(Oxiran-2-ylmethoxy)-9H-carbazole) | 51997-51-4 |
| 1096677 | Carvedilol Related Compound E (15 mg) (2-(2-Methoxyphenoxy)ethyl amine hydrochloride monohydrate) | N/A |
| 1096688 | Carvedilol System Suitability Mixture (25 mg) (carvedilol spiked with carvedilol related compound F) | N/A |
| 1096699 | Carprofen (200 mg) | 53716-49-7 |
| 1096702 | Carprofen Related Compound A (50 mg) (carbazole) | 86-74-8 |
| 1096724 | Carmustine (75 mg) (COLD SHIPMENT REQUIRED) | 154-93-8 |
| 1096735 | Carmustine Related Compound A (25 mg) (1,3-bis(2-chloroethyl)urea) | 2214-72-4 |
| 1096746 | Carnosic acid (20 mg) | 3650-09-7 |
| 1096757 | Carteolol Hydrochloride (200 mg) | 51781-21-6 |
| 1096779 | Casticin (25 mg) | 479-91-4 |
| 1096790 | (+)-Catechin (25 mg) | 154-23-4 |
| 1096804 | Cathinone Hydrochloride CI (50 mg) (alpha-Aminopropiophenone Hydrochloride) | 16735-19-6 |
| 1096826 | Castor Oil (3 x 100 mg) (Mixture containing about 92% of Triricinolein) | 8001-79-4 |
| 1096837 | Hydrogenated Castor Oil (250 mg) (Mixture containing about 83% triglyceride of 12-hydroxystearic acid) | 8001-78-3 |
| 1096848 | Powdered Cat’s Claw Extract (1 g) | 289626-41-1 |
| 1096860 | Carnauba Wax (200 mg) | 8015-86-9 |
| 1096906 | Cefaclor (400 mg) | 70356-03-5 |
| 1096917 | Cefaclor Delta-3 Isomer (15 mg) | N/A |
| 1096994 | Cefadroxil System Suitability Mixture (25 mg) (Mixture of cefadroxil and O-ethoxycarbonyl cefadroxil) | N/A |
| 1097104 | Cefadroxil (200 mg) | 66592-87-8 |
| 1097126 | Cefadroxil Related Compound B (25 mg) ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 22252-43-3 |
| 1097148 | Cefadroxil Related Compound D (25 mg) ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 144790-28-3 |
| 1097192 | Cefadroxil Related Compound I (25 mg) ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | 147103-94-4 |
| 1097400 | Cefamandole Nafate (250 mg) | 42540-40-9 |
| 1097589 | Cefdinir Related Compound B (10 mg) ((6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid) | 79350-10-0 |
| 1097590 | Cefditoren Pivoxil (350 mg) | 117467-28-4 |
| 1097603 | Cefazolin (200 mg) | 25953-19-9 |
| 1097614 | Cefdinir (300 mg) | 91832-40-5 |
| 1097625 | Cefdinir Related Compound A (10 mg) (2(R)-2-[(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamido]-2-[(2RS,5RS)-5-methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid) | 178422-42-9 |
| 1097636 | Cefepime Hydrochloride (500 mg) | 123171-59-5 |
| 1097658 | Cefixime (500 mg) | 125110-14-7 |
| 1097680 | Cefepime Related Compound D (20 mg) ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid) | 65872-41-5 |
| 1097691 | Cefepime Related Compound E (20 mg) (1-{[(6R,7R)-7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1-methylpyrrolidin-1-ium chloride) | 103121-85-3 |
| 1097705 | Cefoperazone Dihydrate (200 mg) | 113826-44-1 |
| 1097727 | Cefetamet (15 mg) | 65052-63-3 |
| 1097750 | Cefonicid Sodium (1 g) (COLD SHIPMENT REQUIRED) | 61270-78-8 |
| 1097771 | Cefmenoxime Hydrochloride (350 mg) | 75738-58-8 |
| 1097782 | Cefmetazole (200 mg) | 56796-20-4 |
| 1097807 | Ceforanide (200 mg) | 60925-61-3 |
| 1097909 | Cefotaxime Sodium (500 mg) | 64485-93-4 |
| 1097953 | Cefotaxime Related Compound E (15 mg) ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide) | 66340-33-8 |
| 1097975 | Cefotetan (500 mg) | 69712-56-7 |
| 1097986 | Cefprozil Related Compound D (30 mg) ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 106447-44-3 |
| 1097997 | Cefprozil L-Epimer (30 mg) ((6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | 110764-35-7 |
| 1098005 | Cefotiam Hydrochloride (350 mg) | 66309-69-1 |
| 1098027 | Cefpodoxime Proxetil (350 mg) | 87239-81-4 |
| 1098049 | Cefprozil (E)-Isomer (50 mg) | 92676-86-3 |
| 1098050 | Cefprozil (Z)-Isomer (200 mg) | 121412-77-9 |
| 1098062 | Cefprozil (200 mg) | 121123-17-9 |
| 1098071 | Ceftiofur Hydrochloride (100 mg) | 103980-44-5 |
| 1098093 | Ceftiofur System Suitability Mixture (50 mg) (Mixture of about 93% of ceftiofur and total of about 2% of ceftiofur delta-3 isomer and ceftiofur E-isomer) | N/A |
| 1098107 | Cefoxitin (500 mg) | 35607-66-0 |
| 1098118 | Cefpiramide (300 mg) | 70797-11-4 |
| 1098129 | Ceftazidime, Delta-3-Isomer (15 mg) | N/A |
| 1098130 | Ceftazidime Pentahydrate (300 mg) | 78439-06-2 |
| 1098165 | Ceftiofur Sodium Trihydrate (100 mg) | N/A |
| 1098173 | Ceftizoxime (350 mg) | 68401-81-0 |
| 1098184 | Ceftriaxone Sodium (350 mg) | 104376-79-6 |
| 1098195 | Ceftriaxone Sodium E-Isomer (25 mg) | 97164-54-0 |
| 1098209 | Cefuroxime Sodium (200 mg) | 56238-63-2 |
| 1098220 | Cefuroxime Axetil (350 mg) | 64544-07-6 |
| 1098231 | Cefuroxime Axetil Delta-3-Isomers (10 mg) ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate) | N/A |
| 1098253 | Cefuroxime Axetil E-isomers (15 mg) (1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate) | 97232-96-7 |
| 1098300 | Cellulose Acetate (125 mg) | 9004-35-7 |
| 1098322 | Cellaburate (350 mg) (Cellulose Acetate Butyrate) | 9004-36-8 |
| 1098355 | Cellacefate (125 mg) (Cellulose Acetate Phthalate) | 9004-38-0 |
| 1098388 | Microcrystalline Cellulose (1 g) (AS) | 9004-34-6 |
| 1098399 | Silicified Microcrystalline Cellulose (1 g) | N/A |
| 1098402 | Powdered Cellulose (1 g) (AS) | 9004-34-6 |
| 1098504 | Celecoxib (200 mg) | 169590-42-5 |
| 1098515 | Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-01-1 |
| 1098526 | Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 331943-04-5 |
| 1098537 | Celecoxib Related Compound C (25 mg) (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-09-9 |
| 1098570 | Celecoxib Related Compound D (25 mg) ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide) | 1061214-06-9 |
| 1098708 | Cephaeline Hydrobromide (200 mg) | N/A |
| 1099008 | Cephalexin (400 mg) | 23325-78-2 |
| 1099041 | Cephalexin Related Compound D (25 mg) (3-Hydroxy-4-methylthiophen-2(5H)-one) | 34876-35-2 |
| 1099063 | Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid, dihydrate) | N/A |
| 1102000 | Cephalothin Sodium (200 mg) | 58-71-9 |
| 1102408 | Cephapirin Benzathine (100 mg) | 97468-37-6 |
| 1102500 | Cephapirin Sodium (500 mg) | 24356-60-3 |
| 1102805 | Cephradine (300 mg) | 75975-70-1 |
| 1102929 | Cetirizine Hydrochloride (250 mg) | 83881-52-1 |
| 1102930 | Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate) | 246870-46-2 |
| 1102941 | Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride) | 108983-83-1 |
| 1102952 | Cetirizine Related Compound C (25 mg) (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | 83881-37-2 |
| 1102963 | Cetirizine Related Compound G (50 mg) (2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol dihydrochloride) | N/A |
| 1102974 | Cetrimonium Bromide (1 g) | 57-09-0 |
| 1103003 | Cetyl Alcohol (100 mg) | 36653-82-4 |
| 1103105 | Cetyl Palmitate (50 mg) | 540-10-3 |
| 1104006 | Cetylpyridinium Chloride (500 mg) | 6004-24-6 |
| 1105009 | Powdered Chaste Tree Extract (1.5 g) | 91722-47-3 |
| 1105280 | Chia Seed Oil (3 x 1 g) | 93384-40-8 |
| 1105315 | Chicoric Acid (20 mg) | 70831-56-0 |
| 1105417 | Powdered Chinese Salvia Extract (1 g) | 115939-25-8 |
| 1105508 | Chitosan (500 mg) | 9012-76-4 |
| 1106001 | Chlorambucil (125 mg) | 305-03-3 |
| 1106078 | Chlorambucil System Suitability Mixture (25 mg) (A mixture containing 4-[p-[Bis(2-chloroethyl)amino]phenyl]butyric acid and a small amount of 4-[m-[Bis(2-chloroethyl)amino]phenyl]butyric acid) | N/A |
| 1107004 | Chloramphenicol (200 mg) | 56-75-7 |
| 1107300 | Chloramphenicol Palmitate (200 mg) | 530-43-8 |
| 1107401 | Chloramphenicol Palmitate Nonpolymorph A (200 mg) | 530-43-8 |
| 1107503 | Chloramphenicol Palmitate Polymorph A (100 mg) | 530-43-8 |
| 1109000 | Chlordiazepoxide CIV (200 mg) | 58-25-3 |
| 1110009 | Chlordiazepoxide Hydrochloride CIV (200 mg) | 438-41-5 |
| 1110020 | Chlordiazepoxide Related Compound A (25 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) | 963-39-3 |
| 1111001 | Chlorhexidine (200 mg) | 55-56-1 |
| 1111012 | Chlorhexidine System Suitability Mixture (50 mg) | N/A |
| 1111103 | Chlorhexidine Acetate (200 mg) | 56-95-1 |
| 1111908 | P-Chloroaniline (200 mg) | 106-47-8 |
| 1112299 | 3-Chlorobenzoic Acid (25 mg) | 535-80-8 |
| 1112311 | Chlorobenzhydryl Piperazine (75 mg) | 300543-56-0 |
| 1112423 | Indomethacin Related Compound B (25 mg) (4-chlorobenzoic acid) | 74-11-3 |
| 1112467 | 4-Chlorobenzophenone (30 mg) | 134-85-0 |
| 1112503 | Chlorobutanol (200 mg) | 6001-64-5 |
| 1115545 | Chlorogenic Acid (50 mg) | 327-97-9 |
| 1115556 | beta-Chlorogenin (20 mg) | N/A |
| 1115705 | Chloromethyl Isopropyl Carbonate (100 mg) | 35180-01-9 |
| 1116774 | Chlorophyll A (15 mg) | 479-61-8 |
| 1117008 | Chloroprocaine Hydrochloride (200 mg) | 3858-89-7 |
| 1117110 | Chloropropyl Vanillin (25 mg) (4-(3-Chloropropoxy)-3-methoxybenzaldehyde) | 151719-92-5 |
| 1118000 | Chloroquine Phosphate (500 mg) | 50-63-5 |
| 1118317 | Chloroquine Sulfate (500 mg) | 6823-83-2 |
| 1118328 | Chloroquine Related Compound A (25 mg) (4,7-dichloroquinoline) | 86-98-6 |
| 1118350 | Chloroquine Related Compound D (15 mg) (7-Chloro-4-{[4-(ethylamino)-1-methylbutyl] amino} quinoline) | 1476-52-4 |
| 1118361 | Chloroquine Related Compound E (10 mg) (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate) | N/A |
| 1118394 | Chloroquine Related Compound G (15 mg) (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate) | N/A |
| 1119309 | Chlorthalidone Related Compound A (10 mg) (4′-Chloro-3′-sulfamoyl-2-benzophenone Carboxylic Acid) | 5270-74-6 |
| 1121005 | Chlorothiazide (200 mg) | 58-94-6 |
| 1122700 | Chloroxylenol (125 mg) | 88-04-0 |
| 1122722 | Chloroxylenol Related Compound A (25 mg) (2-chloro-3,5-dimethylphenol) | 5538-41-0 |
| 1123000 | Chlorpheniramine Maleate (125 mg) | 113-92-8 |
| 1123135 | Chlorpheniramine Related Compound B (25 mg) (di(pyridin-2-yl)amine) | 1202-34-2 |
| 1123146 | Chlorpheniramine Related Compound C (10 mg) (3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine maleate) | 22630-25-7 |
| 1125006 | Chlorpromazine Hydrochloride (200 mg) | 69-09-0 |
| 1126009 | Chlorpropamide (200 mg) | 94-20-2 |
| 1129007 | Chlortetracycline Hydrochloride (200 mg) | 64-72-2 |
| 1130006 | Chlorthalidone (200 mg) | 77-36-1 |
| 1130505 | Chlorzoxazone (350 mg) | 95-25-0 |
| 1130527 | Chlorzoxazone Related Compound A (50 mg) (2-Amino-4-chlorophenol) | 95-85-2 |
| 1131009 | Cholecalciferol (30 mg/ampule; 5 ampules) (Vitamin D3) | 67-97-0 |
| 1131803 | Delta-4,6-cholestadienol (30 mg) | 14214-69-8 |
| 1131858 | Cholestanol (200 mg) | 80-97-7 |
| 1131960 | Cholesterol (125 mg) | 57-88-5 |
| 1132001 | Cholesteryl Caprylate (200 mg) | 1182-42-9 |
| 1133004 | Cholestyramine Resin (500 mg) | 11041-12-6 |
| 1133503 | Cholic Acid (2 g) | 81-25-4 |
| 1133536 | Choline Bitartrate (200 mg) | 87-67-2 |
| 1133547 | Choline Chloride (500 mg) | 67-48-1 |
| 1133558 | Choline Fenofibrate (50 mg)(2-Hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate) | 856676-23-8 |
| 1133569 | Chondroitin Sulfate Sodium, Shark (300 mg) | 9082-07-9 |
| 1133570 | Chondroitin Sulfate Sodium (300 mg) | 9082-07-9 |
| 1133580 | Oversulfated Chondroitin Sulfate (10 mg) | N/A |
| 1133638 | Chromium Picolinate (100 mg) | 14639-25-9 |
| 1133842 | L-Citrulline (200 mg) | 372-75-8 |
| 1133853 | Cidofovir (100 mg) | 149394-66-1 |
| 1133864 | Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) | N/A |
| 1133875 | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine) | 1312776-50-3 |
| 1133886 | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride) | N/A |
| 1133897 | Cinnamaldehyde (3 x 100 mg) | 14371-10-9 |
| 1133900 | Cinnamomum Cassia Twig Powder (5 g) | 84961-46-6 |
| 1133922 | Cinacalcet Related Compound C (50 mg) ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1428118-39-1 |
| 1133933 | Cinnamic Acid (100 mg) | 140-10-3 |
| 1133966 | Cinacalcet Related Compound D (50 mg) ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1217809-88-5 |
| 1133977 | Cinacalcet Hydrochloride (250 mg) | 364782-34-3 |
| 1133999 | Allyl Cinnamate (0.5 mL/ampule; 5 ampules) | 1866-31-5 |
| 1134007 | Chymotrypsin (300 mg) (COLD SHIPMENT REQUIRED) | 9004-07-3 |
| 1134018 | Ciclopirox (50 mg) | 29342-05-0 |
| 1134029 | Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid) | N/A |
| 1134030 | Ciclopirox Olamine (125 mg) | 41621-49-2 |
| 1134040 | Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) | 14818-35-0 |
| 1134051 | Cilastatin Ammonium Salt (100 mg) | N/A |
| 1134062 | Cimetidine (200 mg) | 51481-61-9 |
| 1134073 | Cimetidine Hydrochloride (200 mg) | 70059-30-2 |
| 1134084 | Ciclopirox Related Compound C (10 mg) (6-Cyclohexyl-4-methylpyridin-2(1H)-one) | 67587-24-0 |
| 1134118 | Cisatracurium Besylate (350 mg) | 96946-42-8 |
| 1134120 | Cisapride (200 mg) | 260779-88-2 |
| 1134131 | Cisatracurium Besylate System Suitability Mixture (20 mg) | N/A |
| 1134142 | R-Citalopram Oxalate (10 mg), (R-1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate) | 219861-53-7 |
| 1134153 | Cilostazol (200 mg) | 73963-72-1 |
| 1134164 | Cilostazol Related Compound A (50 mg) (6-hydroxy-3,4-dihydro-1H-quinolin-2-one) | 54197-66-9 |
| 1134175 | Cilostazol Related Compound B (50 mg) (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one) | 73963-62-9 |
| 1134186 | Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) | 865792-18-3 |
| 1134197 | Citalopram Related Compound G (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane hydrobromide) | N/A |
| 1134200 | Cladribine (200 mg) | 4291-63-8 |
| 1134211 | Cladribine Related Compound A (20 mg) (2-methoxy-2′-deoxyadenosine) | 24757-70-8 |
| 1134222 | Citalopram Related Compound H (25 mg) (1-(4′-fluorophenyl)-1-(3-dimethylaminopropyl)-5-bromophthalane hydrobromide) | 479065-02-6 |
| 1134233 | Citalopram Hydrobromide (200 mg) | 59729-32-7 |
| 1134244 | Citalopram Related Compound A (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide) | 64372-56-1 |
| 1134255 | Citalopram Related Compound B (25 mg) (1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile oxalate) | N/A |
| 1134266 | Citalopram Related Compound C (25 mg) (3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate) | N/A |
| 1134277 | Citalopram Related Compound D (15 mg) 1-(4-Fluorophenyl)-1-(3-methylaminopropyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide | N/A |
| 1134288 | Citalopram Related Compound E (25 mg) (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride) | 62498-71-9 |
| 1134299 | Citalopram Related Compound F (200 mg) (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine hydrochloride) | 55011-89-7 |
| 1134305 | Citicoline Sodium (2 x 350 mg) | 33818-15-4 |
| 1134313 | Ciprofloxacin (200 mg) | 85721-33-1 |
| 1134324 | Ciprofloxacin Ethylenediamine Analog (25 mg) (1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-[(2-aminoethyl)-amino]-3-quinolinecarboxylic acid hydrochloride) | N/A |
| 1134335 | Ciprofloxacin Hydrochloride (400 mg) | 86393-32-0 |
| 1134346 | Ciprofloxacin Related Compound A (25 mg) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt) (AS) | N/A |
| 1134357 | Cisplatin (100 mg) | 15663-27-1 |
| 1134368 | Citric Acid (200 mg) | 77-92-9 |
| 1134379 | Clarithromycin (100 mg) | 81103-11-9 |
| 1134380 | Clarithromycin Related Compound A (25 mg) (6,11-di-O-methylerythromycin A) | 81103-14-2 |
| 1134390 | Clarithromycin Identity (10 mg) | 81103-11-9 |
| 1134404 | Clavam-2-carboxylate Potassium (4.7 micrograms) | 2196185-67-6 |
| 1134426 | Clavulanate Lithium (200 mg) | N/A |
| 1134459 | Ciprofloxacin Formamide (125 mg) | 93594-39-9 |
| 1134506 | Clemastine Fumarate (250 mg) | 14976-57-9 |
| 1134619 | Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin) | 101666-68-6 |
| 1134620 | Clarithromycin Impurity H (10 mg) (N-formyl clarithromycin) | 127140-69-6 |
| 1134631 | Clarithromycin Impurity Q (10 mg) (N-oxide clarithromycin) | 118074-07-0 |
| 1134642 | Clarithromycin Impurity R (10 mg) (3″-N-Demethylerythromycin A) | 992-62-1 |
| 1134674 | Clenbuterol Hydrochloride (100 mg) | 21898-19-1 |
| 1134696 | Clenbuterol Related Compound B (10 mg) (1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone hydrochloride) | 37148-49-5 |
| 1135000 | Clidinium Bromide (500 mg) | 3485-62-9 |
| 1135021 | Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methylquinuclindinium Bromide) | 76201-95-1 |
| 1135600 | Climbazole (400 mg) | 38083-17-9 |
| 1136002 | Clindamycin Hydrochloride (200 mg) | 58207-19-5 |
| 1137005 | Clindamycin Palmitate Hydrochloride (500 mg) | 25507-04-4 |
| 1138008 | Clindamycin Phosphate (250 mg) | 24729-96-2 |
| 1138019 | Clindamycin Phosphate System Suitability (30 mg) | 24729-96-2 |
| 1138201 | Clioquinol (500 mg) | 130-26-7 |
| 1138405 | Clobetasol Propionate (200 mg) | 25122-46-7 |
| 1138427 | Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2′-[4′-chloro-5′-ethylfuran-3′(2’H)-one]) | N/A |
| 1138507 | Clocortolone Pivalate (200 mg) | 34097-16-0 |
| 1138904 | Clofazimine (200 mg) | 2030-63-9 |
| 1138926 | Clofazimine Related Compound B (25 mg) (5-(4-chlorophenyl)-3-(isopropylimino)-N-phenyl-3,5-dihydrophenazin-2-amine) | N/A |
| 1139000 | Clofibrate (1 g) | 637-07-0 |
| 1140000 | Clomiphene Citrate (500 mg) | 50-41-9 |
| 1140101 | Clomiphene Related Compound A (100 mg) ((E,Z)-2-[4-(1,2-diphenylethyl)phenoxy]-N,N-diethylethanamine hydrochloride (1:1)) | N/A |
| 1140247 | Clomipramine Hydrochloride (200 mg) | 17321-77-6 |
| 1140258 | Clomipramine Related Compound A (25 mg) (N^1-[3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N^1,N^3,N^3-trimethylpropane-1,3-diamine dihydrochloride) | N/A |
| 1140269 | Clomipramine Related Compound C (15 mg) (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate) | N/A |
| 1140270 | Clomipramine Related Compound D (15 mg) (3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) | 115189-28-1 |
| 1140292 | Clomipramine Related Compound F (15 mg) (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine) | 32943-25-2 |
| 1140305 | Clonazepam CIV (200 mg) | 1622-61-3 |
| 1140327 | Clonazepam Related Compound A (25 mg) (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) | N/A |
| 1140338 | Clonazepam Related Compound B (25 mg) (2-Amino-2′-chloro-5-nitrobenzophenone) | 2011-66-7 |
| 1140349 | Clonazepam Related Compound C (25 mg) (2-bromo-2′-(2-chlorobenzoyl)-4′-nitroacetanilide) | N/A |
| 1140393 | Clonidine (200 mg) | 4205-90-7 |
| 1140407 | Clonidine Hydrochloride (200 mg) | 4205-91-8 |
| 1140418 | Clonidine Related Compound A (25 mg) (1-acetyl-2-(2,6-dichlorophenylimino)imidazolidine) | 54707-71-0 |
| 1140429 | Clonidine Related Compound B (25 mg) (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine) | N/A |
| 1140430 | Clopidogrel Bisulfate (125 mg) | 120202-66-6 |
| 1140509 | Clorazepate Dipotassium CIV (125 mg) | 57109-90-7 |
| 1140586 | Clopidogrel Related Compound A (20 mg) ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride) | 144750-42-5 |
| 1140597 | Clopidogrel Related Compound B (20 mg) (Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride) | 144750-52-7 |
| 1140600 | Clopidogrel Related Compound C (20 mg) (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate) | 120202-71-3 |
| 1140666 | Cloprostenol Sodium (400 mg) | 55028-72-3 |
| 1140702 | Clorsulon (200 mg) | 60200-06-8 |
| 1141002 | Clotrimazole (200 mg) | 23593-75-1 |
| 1141024 | Clotrimazole Related Compound A (25 mg) ((o-chlorophenyl)diphenylmethanol) | 66774-02-5 |
| 1141909 | Cloxacillin Benzathine (200 mg) | 23736-58-5 |
| 1142005 | Cloxacillin Sodium (200 mg) | 7081-44-9 |
| 1142107 | Clozapine (100 mg) | 5786-21-0 |
| 1142108 | Clozapine Resolution Mixture (30 mg) | 5786-21-0 |
| 1143008 | Cocaine Hydrochloride CII (250 mg) | 53-21-4 |
| 1143802 | Codeine N-Oxide CI (30 mg) | 3688-65-1 |
| 1144000 | Codeine Phosphate CII (100 mg) | 41444-62-6 |
| 1144951 | Cloxacillin Related Compound D (15 mg) (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid) | 23598-72-3 |
| 1145003 | Codeine Sulfate CII (250 mg) | 6854-40-6 |
| 1145025 | Codeine System Suitability Mixture CI (25 mg) | N/A |
| 1145207 | Cod Liver Oil (1 g) | 8001-69-2 |
| 1145411 | Coffee Fruit Dry Extract (1 g) | N/A |
| 1145477 | Coix Seed Oil Extract (2 x 1 g) | 537-40-6 |
| 1146006 | Colchicine (350 mg) | 64-86-8 |
| 1146505 | Colestipol Hydrochloride (200 mg) | 37296-80-3 |
| 1147009 | Colistimethate Sodium (200 mg) | 8068-28-8 |
| 1148001 | Colistin Sulfate (200 mg) | 1264-72-8 |
| 1148089 | Collagenase I (2 x 0.5 mL) (COLD SHIPMENT REQUIRED) | 9001-12-1 |
| 1148090 | Collagenase II (2 x 0.5 mL) (COLD SHIPMENT REQUIRED) | 9001-12-1 |
| 1148238 | Color Related Compound 005 (20 mg) (3-hydroxy-2-naphthalenecarboxylic acid) | 92-70-6 |
| 1148249 | Color Related Compound 006 (20 mg) (3-hydroxy-4-[(4-methylphenyl)azo]-2-naphthalenecarboxylic acid) | 82896-77-3 |
| 1148250 | Color Related Compound 007 (20 mg) (1-[(4-methylphenyl)azo]-2-naphthalenol) | 6756-41-8 |
| 1148500 | Copovidone (100 mg) | 2586-89-9 |
| 1148737 | Corosolic Acid (50 mg) | 4547-24-4 |
| 1148806 | Corn Oil (5 x 200 mg) | 8001-30-7 |
| 1149004 | Corticotropin (5.9 Units/vial; 2 vials) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 9002-60-2 |
| 1149999 | Cortisone (20 mg) (17, 21-Dihydroxypregna-4-ene-3,11,20-trione) | 53-06-5 |
| 1150003 | Cortisone Acetate (150 mg) | 50-04-4 |
| 1150115 | Cosyntropin Acetate (1.69 mg) (alpha1-24-Corticotropin) | 16960-16-0 |
| 1150207 | Cottonseed Oil (1 g) | 8001-29-4 |
| 1150320 | Creatine (200 mg) | 6020-87-7 |
| 1150353 | Creatinine (100 mg) | 60-27-5 |
| 1150502 | Cromolyn Sodium (500 mg) | 15826-37-6 |
| 1150513 | Cromolyn Related Compound A (25 mg) (1,3-bis(2-acetyl-3-hydroxyphenoxy) propan-2-ol) | 16150-44-0 |
| 1150524 | Cromolyn Related Compound B (25 mg) (diethyl 5,5′-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)) | N/A |
| 1150706 | Crospovidone (100 mg) | 9003-39-8 |
| 1151006 | Crotamiton (200 mg) | 483-63-6 |
| 1151709 | Cumene (1.2 mL/ampule; 3 ampules) | 98-82-8 |
| 1151855 | Curcumin (30 mg) | 458-37-7 |
| 1151866 | Curcuminoids (300 mg) | N/A |
| 1151924 | Cyanidin Chloride (25 mg) | 528-58-5 |
| 1151935 | Cyanidin-3-O-glucoside Chloride (15 mg) | 7084-24-4 |
| 1152011 | Cyanocobalamin (Crystalline) (2 x 150 mg) | 68-19-9 |
| 1152600 | Cyclamic Acid (100 mg) | 100-88-9 |
| 1152701 | Cyclandelate (200 mg) | 456-59-7 |
| 1152814 | Cyclic Olefin Polymer (1 g) | N/A |
| 1152825 | Cyclic Olefin Copolymer (3 strips, 2′ x 2′ x 1 mm each) | 26007-43-2 |
| 1154004 | Cyclizine Hydrochloride (200 mg) | 303-25-3 |
| 1154015 | Cyclizine Related Compound A (50 mg) (1-methylpiperazine) | 109-01-3 |
| 1154503 | Cyclobenzaprine Hydrochloride (200 mg) | 6202-23-9 |
| 1154514 | Cyclobenzaprine Related Compound A (10 mg) (5-[3-(dimethylamino)propyl]-5H-dibenzo[a,d]-cyclohepten-5-ol) | 18029-54-4 |
| 1154525 | Cyclobenzaprine Related Compound B (10 mg) (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride) | 438-59-5 |
| 1154558 | Alpha Cyclodextrin (500 mg) | 10016-20-3 |
| 1154569 | Beta Cyclodextrin (500 mg) | 7585-39-9 |
| 1154591 | Gamma Cyclodextrin (200 mg) | 17465-86-0 |
| 1154605 | Cyclohexylmethanol (1 mL/ampule; 2 ampules) | 100-49-2 |
| 1154649 | Cyclohexanecarboxylic Acid (500 mg) | 98-89-5 |
| 1154650 | Allyl Cyclohexane Valerate (3 x 0.5 mL) | 7493-68-7 |
| 1154707 | Cyclomethicone 4 (200 mg) | 556-67-2 |
| 1154809 | Cyclomethicone 5 (200 mg) | 69430-24-6 |
| 1154900 | Cyclomethicone 6 (200 mg) | 540-97-6 |
| 1156000 | Cyclopentolate Hydrochloride (300 mg) | 5870-29-1 |
| 1157002 | Cyclophosphamide (500 mg) | 6055-19-2 |
| 1157013 | Cyclophosphamide Related Compound A (25 mg) (bis(2-chloroethyl)amine hydrochloride) | 821-48-7 |
| 1157024 | Cyclophosphamide Related Compound B (25 mg) (3-(2-chloroethyl)-2-oxo-2-hydroxy-1,3,6,2-oxadiazaphosphonane) | 158401-52-6 |
| 1157035 | Cyclophosphamide Related Compound C (25 mg) (3-aminopropyl dihydrogen phosphate) | 1071-28-9 |
| 1157046 | Cyclophosphamide Related Compound D (25 mg) (3-[2-(2-chloroethylamino)ethylamino]propyl dihydrogen phosphate dihydrochloride) | 158401-51-5 |
| 1158005 | Cycloserine (250 mg) | 68-41-7 |
| 1158504 | Cyclosporine (50 mg) | 59865-13-3 |
| 1158650 | Cyclosporine Resolution Mixture (25 mg) (This material is an approximate 100:1 (w/w) mixture of cyclosporine and cyclosporine U) | N/A |
| 1159008 | Cyclothiazide (200 mg) (AS) | 2259-96-3 |
| 1161000 | Cyproheptadine Hydrochloride (500 mg) | 41354-29-4 |
| 1161010 | Cyproheptadine Related Compound A (40 mg) (5H-dibenzo[a,d]cycloheptene) | 256-81-5 |
| 1161032 | Cyproheptadine Related Compound C (25 mg) (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol) | 3967-32-6 |
| 1161203 | Cyromazine (200 mg) | 66215-27-8 |
| 1161509 | L-Cysteine Hydrochloride (600 mg) | 7048-04-6 |
| 1161586 | Cystine (200 mg) | 56-89-3 |
| 1162002 | Cytarabine (250 mg) | 147-94-4 |
| 1162126 | 5′-Cytidylic Acid (500 mg) | 63-37-6 |
| 1162148 | Cytosine (100 mg) | 71-30-7 |
Chuẩn USP từ D - G
Chuẩn dược điển USP từ D đến G
| Mã code | Tên chuẩn dược điển | Mã CAS# |
| 1162308 | Dacarbazine (125 mg) | 4342-03-4 |
| 1162320 | Dacarbazine Related Compound A (50 mg) (5-aminoimidazole-4-carboxamide hydrochloride) | 72-40-2 |
| 1162330 | Dacarbazine Related Compound B (50 mg) (2-azahypoxanthine monohydrate) | 7151-03-3 |
| 1162400 | Dactinomycin (50 mg) | 50-76-0 |
| 1162421 | Daidzein (25 mg) | 486-66-8 |
| 1162432 | Daidzin (30 mg) | 552-66-9 |
| 1162443 | Dalfampridine Resolution Mixture (15 mg) | N/A |
| 1162454 | Dalfampridine (200 mg) | 504-24-5 |
| 1162487 | Dalteparin Sodium (300 mg) | 9041-08-1 |
| 1162501 | Danazol (200 mg) | 17230-88-5 |
| 1162545 | Dalfampridine Related Compound A (25 mg) (4-Aminopyridine 1-oxide) | 3535-75-9 |
| 1162556 | Dalfampridine Related Compound B (50 mg) (3,5-Dibromopyridin-4-amine) | 84539-34-4 |
| 1162567 | Dalfampridine Related Compound C (25 mg) (1,3-Di(pyridin-4-yl)urea) | 39642-87-0 |
| 1162626 | Alpha-Damascone (3 x 0.5 mL) | 43052-87-5 |
| 1162637 | Delta-Damascone (3 x 0.5 mL) | 57378-68-4 |
| 1162648 | Beta-Damascone (3 x 0.5 mL) | N/A |
| 1163140 | Dantrolene (200 mg) | 7261-97-4 |
| 1163151 | Dantrolene Sodium (100 mg) | 24868-20-0 |
| 1163162 | Dantrolene Related Compound A (50 mg) (1,2-Bis{[5-(4-nitrophenyl)furan-2-yl]methylene}hydrazine) | 301359-05-7 |
| 1163173 | Dantrolene Related Compound B (50 mg) (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone) | 57268-33-4 |
| 1163184 | Dantrolene Related Compound C (50 mg) ((5-(4-nitrophenyl)-2-furancarboxyaldehyde) | 7147-77-5 |
| 1164008 | Dapsone (200 mg) | 80-08-0 |
| 1164200 | Darifenacin Hydrobromide (150 mg) | 133099-07-7 |
| 1164211 | Darifenacin Chiral Peak ID Mixture (25 mg) (See USP Certificate for full Chemical Name) | N/A |
| 1164222 | Darifenacin Peak ID Mixture (25 mg) (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) | N/A |
| 1164697 | Daunorubicinone (25 mg) ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | 21794-55-8 |
| 1164700 | Daunorubicin Hydrochloride (200 mg) | 23541-50-6 |
| 1165408 | Decoquinate (200 mg) | 18507-89-6 |
| 1166003 | Deferoxamine Mesylate (300 mg) | 138-14-7 |
| 1166116 | Deflazacort (100 mg) | 14484-47-0 |
| 1166309 | Dehydroacetic Acid (200 mg) | 520-45-6 |
| 1166400 | Dehydrocarteolol Hydrochloride (100 mg) | N/A |
| 1166502 | Dehydrocholic Acid (200 mg) | 81-23-2 |
| 1169001 | Demecarium Bromide (250 mg) | 56-94-0 |
| 1170000 | Demeclocycline Hydrochloride (200 mg) (COLD SHIPMENT REQUIRED) | 64-73-3 |
| 1171003 | Denatonium Benzoate (200 mg) | 3734-33-6 |
| 1171207 | 23-EPI-26-Deoxyactein (20 mg) | 264624-38-6 |
| 1171251 | 2-Deoxy-D-Glucose (100 mg) | 154-17-6 |
| 1171273 | Deoxycholic Acid (Desoxycholic Acid) (100 mg) | 83-44-3 |
| 1171397 | Depramine (20 mg) (3-(5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) | N/A |
| 1171455 | Dermatan Sulfate (25 mg) (COLD SHIPMENT REQUIRED) | 54328-33-5 |
| 1171706 | Desacetyl Diltiazem Hydrochloride (50 mg) | 23515-45-9 |
| 1171819 | Desbenzyl Donepezil Hydrochloride (20 mg) (5,6-dimethoxy-2-(piperidin-4-ylmethyl)indan-1-one hydrochloride) | 120013-39-0 |
| 1171900 | Desflurane (0.5 mL) | 57041-67-5 |
| 1171910 | Desflurane Related Compound A (0.1 mL) (bis-(1,2,2,2-tetrafluoroethyl) ether) | N/A |
| 1172006 | Desipramine Hydrochloride (125 mg) | 58-28-6 |
| 1173009 | Deslanoside (200 mg) | 17598-65-1 |
| 1173042 | Desloratadine (200 mg) | 100643-71-8 |
| 1173053 | Desloratadine Related Compound A (20 mg) (8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | 117796-50-6 |
| 1173064 | Desloratadine Related Compound F (50 mg) (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | 117810-61-4 |
| 1173086 | Desloratadine Related Compound B (20 mg) (8-chloro-11-(1,2,3,6-tetrahydropyridin-4-yl)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride) | N/A |
| 1173100 | Desmethoxycurcumin (30 mg) | 24939-17-1 |
| 1173202 | Desmopressin Acetate (2.01 mg) (COLD SHIPMENT REQUIRED) | 62357-86-2 |
| 1173235 | Desogestrel (50 mg) | 54024-22-5 |
| 1173246 | Desogestrel Related Compound A (15 mg) (13-Ethyl-11-methylene-18, 19-dinor-5alpha, 17alpha-preg-3-en-20-yn-17-ol, desogestrel Delta-3 Isomer) | N/A |
| 1173257 | Desogestrel Related Compound B (25 mg) (3-Hydroxy-desogestrel) | N/A |
| 1173268 | Desogestrel Related Compound C (25 mg) (3-Ketodesogestrel) | 54048-10-1 |
| 1173279 | Desogestrel Related Compound D (25 mg) (13-Ethyl-11-methylenegon-4-en-17-one) | 54024-21-4 |
| 1173304 | Desonide (250 mg) | 638-94-8 |
| 1173315 | Desonide Impurities Mixture (25 mg) | N/A |
| 1173508 | Desoximetasone (200 mg) | 382-67-2 |
| 1174001 | Desoxycorticosterone Acetate (200 mg) | 56-47-3 |
| 1175004 | Desoxycorticosterone Pivalate (125 mg) | 808-48-0 |
| 1175762 | Desvenlafaxine Fumarate (200 mg) (1-[2-(Dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol trans-butenedioate monohydrate) | 313471-75-9 |
| 1175784 | Desvenlafaxine Related Compound A (25 mg) (4-[1-(Cyclohex-1-en-1-yl)-2-(dimethylamino)ethyl]phenol) | 1346600-38-1 |
| 1175795 | Desvenlafaxine Related Compound B (25 mg) (4-[1-(1-Hydroxycyclohexyl)-2-(methylamino)ethyl]phenol) | 135308-74-6 |
| 1176007 | Dexamethasone (125 mg) | 50-02-2 |
| 1176506 | Dexamethasone Acetate (200 mg) | 1177-87-3 |
| 1177000 | Dexamethasone Phosphate (500 mg) | 312-93-6 |
| 1177032 | Dexamethasone Sodium Phosphate (500 mg) | 2392-39-4 |
| 1178002 | Dexbrompheniramine Maleate (200 mg) | 2391-03-9 |
| 1179005 | Dexchlorpheniramine Maleate (300 mg) | 2438-32-6 |
| 1179118 | Dexketoprofen Tromethamine (200 mg) | 156604-79-4 |
| 1179333 | Dexmedetomidine Hydrochloride (200 mg) | 145108-58-3 |
| 1179344 | Levomedetomidine (25 mg) | 190000-46-5 |
| 1179504 | Dexpanthenol (500 mg) | 81-13-0 |
| 1179628 | Dextran 1 (50 mg) | 9004-54-0 |
| 1179650 | Dextran T-10 (200 mg) | 9004-54-0 |
| 1179708 | Dextran 40 (50 mg) | 9004-54-0 |
| 1179720 | Dextran 40 System Suitability (200 mg) | 9004-54-0 |
| 1179741 | Dextran 70 (50 mg) | 9004-54-0 |
| 1179763 | Dextran 70 System Suitability (100 mg) | 9004-54-0 |
| 1179800 | Dextran Vo Marker (100 mg) | 9004-54-0 |
| 1179854 | Dextran 4 Calibration (100 mg) | 9004-54-0 |
| 1179865 | Dextran 10 Calibration (100 mg) | 9004-54-0 |
| 1179876 | Dextran 40 Calibration (100 mg) | 9004-54-0 |
| 1179887 | Dextran 70 Calibration (100 mg) | 9004-54-0 |
| 1179898 | Dextran 250 Calibration (100 mg) | 9004-54-0 |
| 1180004 | Dextroamphetamine Sulfate CII (500 mg) | 51-63-8 |
| 1180015 | Dextroamphetamine Related Compound A (25 mg) (1-Phenyl-2-propanol) | 698-87-3 |
| 1180026 | Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) | 103-79-7 |
| 1180503 | Dextromethorphan (2 g) | 125-71-3 |
| 1181007 | Dextromethorphan Hydrobromide (500 mg) | 6700-34-1 |
| 1181302 | Dextrose (500 mg) | 50-99-7 |
| 1181506 | Diacetylated Monoglycerides (200 mg) | 68990-54-5 |
| 1182000 | Diacetylfluorescein (200 mg) | 596-09-8 |
| 1183002 | Diacetylmorphine Hydrochloride CI (25 mg) (AS) (Heroin Hydrochloride) | 1502-95-0 |
| 1184005 | Diatrizoic Acid (100 mg) | 50978-11-5 |
| 1184027 | Diatrizoic Acid Related Compound A (50 mg) (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid) | 1713-07-1 |
| 1184118 | Diaveridine (25 mg) (5-(3,4-Dimethoxybenzyl)pyrimidine-2,4-diamine) | 5355-16-8 |
| 1185008 | Diazepam CIV (100 mg) | 439-14-5 |
| 1185020 | Diazepam Related Compound A (25 mg) (2-methylamino-5-chlorobenzophenone) | 1022-13-5 |
| 1186000 | Diazoxide (200 mg) | 364-98-7 |
| 1187003 | Dibucaine Hydrochloride (500 mg) | 61-12-1 |
| 1187080 | Dibutyl Phthalate (200 mg) | 84-74-2 |
| 1187091 | Dibutyl Sebacate (1 mL) | 109-43-3 |
| 1187207 | Dichloralphenazone CIV (200 mg) | 480-30-8 |
| 1187954 | 2,4-Dichlorophenol (100 mg) | 120-83-2 |
| 1188006 | Dichlorphenamide (200 mg) | 120-97-8 |
| 1188301 | Dichlorvos (150 mg) (2,2-dichlorovinyl dimethyl phosphate) (AS) | 62-73-7 |
| 1188560 | Diclazuril (200 mg) | 101831-37-2 |
| 1188571 | Diclazuril System Suitability Mixture (50 mg) | N/A |
| 1188709 | Diclofenac Potassium (200 mg) | 15307-81-0 |
| 1188800 | Diclofenac Sodium (200 mg) | 15307-79-6 |
| 1188811 | Diclofenac Related Compound A (25 mg) (N-(2,6-dichlorophenyl)indolin-2-one) | 15362-40-0 |
| 1189009 | Dicloxacillin Sodium (300 mg) | 13412-64-1 |
| 1189053 | Dicloxacillin Related Compound D (15 mg) (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid) | 3919-76-4 |
| 1191000 | Dicyclomine Hydrochloride (125 mg) | 67-92-5 |
| 1191204 | Didanosine (200 mg) | 69655-05-6 |
| 1191215 | Didanosine System Suitability Mixture (10 mg) | 69655-05-6 |
| 1191226 | Didanosine Related Compound A (25 mg) (Hypoxanthine) | 68-94-0 |
| 1191237 | Didanosine Related Compound B (25 mg) (2′,3′-dideoxyadenosine) | 4097-22-7 |
| 1191554 | Didymin (30 mg) ((RS)-5-Hydroxy-2-(4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | N/A |
| 1192808 | Diethanolamine (3 mL) | 111-42-2 |
| 1193006 | Diethylcarbamazine Citrate (200 mg) | 1642-54-2 |
| 1193265 | Diethylene Glycol (5 x 0.2 mL) | 111-46-6 |
| 1193301 | Diethylene Glycol Monoethyl Ether (4 x 0.25 mL/ampule) | 111-90-0 |
| 1193356 | Iscotrizinol (200 mg) | 154702-15-5 |
| 1193378 | Iscotrizinol Related Compound B (25 mg) (4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) | N/A |
| 1193389 | Iscotrizinol Related Compound C (25 mg) (2-Ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-chloro-1,3,5-triazin-2-yl)amino]benzoate) | N/A |
| 1193390 | Iscotrizinol Related Compound D (25 mg) (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) | N/A |
| 1193414 | Iscotrizinol Related Compound F (25 mg) (Bis(2-ethylhexyl) 4,4′-({6-[(4-carbamoylphenyl)amino]-1,3,5-triazine-2,4-diyl}bis(azanediyl))dibenzoate) | N/A |
| 1193425 | Iscotrizinol Related Compound G (25 mg) (2-Ethylhexyl 4-{4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzamido}benzoate) | N/A |
| 1193447 | Iscotrizinol Related Compound I (25 mg) (Bis(2-ethylhexyl) 4,4′-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) | N/A |
| 1193505 | Diethyl Phthalate (200 mg) | 84-66-2 |
| 1194009 | Diethylpropion Hydrochloride CIV (200 mg) | 134-80-5 |
| 1194803 | Diethyl Sebacate (1 mL) | 110-40-7 |
| 1195001 | Diethylstilbestrol (200 mg) | 56-53-1 |
| 1197007 | Diethyltoluamide (3 g) | 134-62-3 |
| 1197018 | Diethyltoluamide Related Compound A (25 mg) (N,N-Diethyl-4-toluamide) | 2728-05-4 |
| 1197302 | Diflorasone Diacetate (200 mg) | 33564-31-7 |
| 1197506 | Diflunisal (200 mg) | 22494-42-4 |
| 1198000 | Digitalis (3 g) | 8031-42-3 |
| 1199002 | Digitoxin (200 mg) | 71-63-6 |
| 1199308 | Diglycine (glycylglycine) (50 mg) | 556-50-3 |
| 1200000 | Digoxin (250 mg) | 20830-75-5 |
| 1200520 | Dihydroartemisinin (200 mg) | 131175-87-6 |
| 1200600 | Dihydrocapsaicin (25 mg) | 19408-84-5 |
| 1200804 | Dihydrocodeine Bitartrate CII (200 mg) | 5965-13-9 |
| 1200881 | Dihydrodaunorubicin Hydrochloride (20 mg) ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) | N/A |
| 1201002 | 17alpha-Dihydroequilin (50 mg) (Estra-1,3,5(10),7-tetraene-3,17alpha-diol) | 651-55-8 |
| 1202005 | Dihydroergotamine Mesylate (500 mg) | 6190-39-2 |
| 1203008 | Dihydrostreptomycin Sulfate (200 mg) | 5490-27-7 |
| 1204000 | Dihydrotachysterol (30 mg/ampule; 4 ampules) | 67-96-9 |
| 1204102 | Dihydroxyacetone (250 mg) | 96-26-4 |
| 1204805 | Diloxanide Furoate (200 mg) | 3736-81-0 |
| 1205003 | Diltiazem Hydrochloride (200 mg) | 33286-22-5 |
| 1205014 | Diltiazem Related Compound A (AS) (25 mg) (trans-diltiazem hydrochloride) | N/A |
| 1206006 | Dimenhydrinate (200 mg) | 523-87-5 |
| 1206017 | Dimenhydrinate Related Compound E (15 mg) (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione) | 4921-49-7 |
| 1211006 | Dimethyl Sulfoxide (3 g) | 67-68-5 |
| 1211254 | 2,3-Dimethylaniline (50 mg) | 87-59-2 |
| 1211287 | 6,6′-Dinicotinic Acid (50 mg) | 1802-30-8 |
| 1213001 | Dinoprost Tromethamine (50 mg) | 38562-01-5 |
| 1213103 | Dinoprostone (125 mg) (COLD SHIPMENT REQUIRED) | 363-24-6 |
| 1213136 | Dinoprostone Related Compound C (20 mg) ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid) | 36150-00-2 |
| 1213318 | Diosmin (300 mg) | 520-27-4 |
| 1213329 | Diosmin for System Suitability (15 mg) | N/A |
| 1214004 | Dioxybenzone (150 mg) | 131-53-3 |
| 1217909 | Diphenhydramine Citrate (200 mg) | 88637-37-0 |
| 1218005 | Diphenhydramine Hydrochloride (200 mg) | 147-24-0 |
| 1218016 | Diphenhydramine Related Compound A (25 mg) (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride) | 53499-40-4 |
| 1218027 | Diphenhydramine Related Compound B (20 mg) (3-(benzhydryloxy)propane-1,2-diol) | 19574-66-4 |
| 1218050 | Diphenhydramine N-Oxide (25 mg) (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride) | 13168-00-8 |
| 1219008 | Diphenoxylate Hydrochloride CII (200 mg) | 3810-80-8 |
| 1219019 | Diphenoxylate Related Compound A CI (25 mg) (1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid) | 28782-42-5 |
| 1220302 | Dipivefrin Hydrochloride (200 mg) | 64019-93-8 |
| 1220357 | Dipivefrin Related Compound E (25 mg) (4-[(Methylamino)acetyl]-1,2-phenylene dipivalate hydrochloride) | N/A |
| 1220506 | Dipyridamole (200 mg) | 58-32-2 |
| 1220517 | Dipyridamole Related Compound A (25 mg) (2,2′-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | 16982-40-4 |
| 1220528 | Dipyridamole Related Compound B (25 mg) (2,2′,2”,2”’,2””,2””’-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol) | 16908-47-7 |
| 1220539 | Dipyridamole Related Compound C (25 mg) (2,2′-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol) | 54093-92-4 |
| 1220540 | Dipyridamole Related Compound D (25 mg) (2,2′-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol) | 1176886-12-6 |
| 1220559 | Dipyridamole Related Compound E (25 mg) (2,2′,2”,2”’-{[6,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4-diyl]bis(azanetriyl)}tetraethanol) | N/A |
| 1220561 | Dipyridamole Related Compound F (25 mg) (2,2′,2”,2”’-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol) | 60286-30-8 |
| 1220700 | Dirithromycin (200 mg) | 62013-04-1 |
| 1221000 | Disodium Guanylate (350 mg) | 5550-12-9 |
| 1222002 | Disodium Inosinate (500 mg) | 352195-40-5 |
| 1222400 | Disodium 5′-Uridylate (500 mg) | 3387-36-8 |
| 1222501 | Disopyramide Phosphate (200 mg) | 22059-60-5 |
| 1223005 | 2,4-Disulfamyl-5-Trifluoromethylaniline (50 mg) | 654-62-6 |
| 1223209 | Allyl Disulfide (5 x 0.5 mL) | 2179-57-9 |
| 1224008 | Disulfiram (200 mg) | 97-77-8 |
| 1224201 | Divalproex Sodium (200 mg) | 76584-70-8 |
| 1224507 | Dobutamine Hydrochloride (400 mg) | 49745-95-1 |
| 1224551 | Docetaxel (200 mg) | 148408-66-6 |
| 1224562 | Docetaxel Identification (50 mg) | N/A |
| 1224573 | Docetaxel System Suitability Mixture (15 mg) | N/A |
| 1224620 | Docosahexaenoic Acid Ethyl Ester (500 mg) | 84494-72-4 |
| 1224664 | Docosyl Ferulate (50 mg) | 101927-24-6 |
| 1224700 | Docusate Calcium (500 mg) | 128-49-4 |
| 1224802 | Docusate Sodium (1 g) | 577-11-7 |
| 1224824 | Docusate Sodium Related Compound B (40 mg) (disodium mono (2-ethylhexyl) sulfosuccinate) | N/A |
| 1224904 | Docusate Potassium (100 mg) | 7491-09-0 |
| 1224937 | Dofetilide (200 mg) | 115256-11-6 |
| 1224948 | Dofetilide Related Compound A (25 mg) (N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl]methanesulfonamide) | 176447-94-2 |
| 1224959 | Dolasetron Mesylate (125 mg) | 878143-33-0 |
| 1224960 | Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one hydrochloride) | N/A |
| 1224970 | Donepezil-N-Oxide (20 mg) | 120013-84-5 |
| 1224981 | Donepezil Hydrochloride (200 mg) | 884740-09-4 |
| 1224992 | Donepezil Related Compound A (25 mg) ((E)-2-[(1-benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one) | 145546-80-1 |
| 1225000 | Doxapram Hydrochloride (200 mg) | 7081-53-0 |
| 1225022 | Doxapram Related Compound B (25 mg) (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one, hydrochloride) | 100106-91-0 |
| 1225204 | Dopamine Hydrochloride (200 mg) | 62-31-7 |
| 1225281 | Dorzolamide Hydrochloride (200 mg) | 130693-82-2 |
| 1225292 | Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride) | 122028-36-8 |
| 1225306 | Dorzolamide Related Compound D (30 mg) ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | 164455-27-0 |
| 1225317 | Dorzolamide Related Compound B (15 mg) ((4R,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride) | 120279-37-0 |
| 1225419 | Doxazosin Mesylate (200 mg) | 77883-43-3 |
| 1225420 | Doxazosin Related Compound A (20 mg) (N-(1,4-benzodioxane-2-carbonyl)piperazine hydrochloride) | 70918-74-0 |
| 1225441 | Doxazosin Related Compound B (20 mg) (6,7-dimethoxyquinazoline-2,4-dione) | 28888-44-0 |
| 1225452 | Doxazosin Related Compound C (20 mg) (2-chloro-4-amino-6,7-dimethoxyquinazoline) | 23680-84-4 |
| 1225463 | Doxazosin Related Compound D (20 mg) (1,4-benzodioxane-2-carboxylic acid) | 3663-80-7 |
| 1225474 | Doxazosin Related Compound E (20 mg) (2,4-dichloro-6,7-dimethoxyquinazoline) | 27631-29-4 |
| 1225485 | Doxazosin Related Compound F (15 mg) (N,N’-bis(1,4-benzodioxane-2-carbonyl)piperazine) | 617677-53-9 |
| 1225500 | Doxepin Hydrochloride (500 mg) | 1229-29-4 |
| 1225511 | Doxepin Related Compound A (50 mg) (dibenzo[b,e]oxepin-11(6H)-one) | 4504-87-4 |
| 1225522 | Doxepin Related Compound B (50 mg) ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol) | 4504-88-5 |
| 1225533 | Doxepin Related Compound C (25 mg) ((E-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride) | 4504-96-5 |
| 1225601 | Doxercalciferol (2 x 20 mg) | 54573-75-0 |
| 1225703 | Doxorubicin Hydrochloride (50 mg) | 25316-40-9 |
| 1225758 | Doxorubicinone (25 mg) ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | 24385-10-2 |
| 1225984 | Doxycycline Monohydrate (100 mg) | 17086-28-1 |
| 1226003 | Doxycycline Hyclate (200 mg) | 24390-14-5 |
| 1226014 | Doxycycline Related Compound A (10 mg) ((4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide) | 3219-99-6 |
| 1227006 | Doxylamine Succinate (300 mg) | 562-10-7 |
| 1228009 | Drometrizole (25 mg) (2-(2H-Benzotriazol-2-yl)-p-cresol) | 2440-22-4 |
| 1228010 | Drometrizole Trisiloxane (200 mg) | 155633-54-8 |
| 1228029 | Drometrizole Trisiloxane Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) | 2170-37-8 |
| 1228031 | Drometrizole Trisiloxane Related Compound B (25 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-3-yl)-p-cresol) | 98809-58-6 |
| 1228042 | Drometrizole Trisiloxane Related Compound C (150 mg) (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) | N/A |
| 1228053 | Drometrizole Trisiloxane Related Compound D (25 mg) (2-(2H-Benzotriazol-2-yl)-6-isobutyl-p-cresol) | N/A |
| 1228064 | Drometrizole Trisiloxane Related Compound E (150 mg) (2-(2H-Benzotriazol-2-yl)-6-{3-[bis(trimethylsiloxy)methylsilyl]isobutyl}-O1-[bis(trimethylsiloxy)methylsilyl]-p-cresol) | N/A |
| 1228075 | Heptamethyl Trisiloxane (150 mg) (1,1,1,3,5,5,5-Heptamethyltrisiloxane) | 1873-88-7 |
| 1228530 | Dronedarone Hydrochloride (125 mg) | 141625-93-6 |
| 1228541 | Dronedarone Related Compound A (25 mg) (N-{2-Butyl-3-[4-(3-butylaminopropoxy)benzoyl]benzofuran-5-yl}methanesulfonamide, hydrochloride) | 197431-02-0 |
| 1228552 | Dronedarone Related Compound B (20 mg) ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride) | 1309476-91-2 |
| 1228563 | Dronedarone Related Compound C (20 mg) ((5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 1278585-68-4 |
| 1228574 | Dronedarone Related Compound D (20 mg) ((2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone) | 141645-16-1 |
| 1229001 | Droperidol (250 mg) | 548-73-2 |
| 1229409 | Drospirenone (200 mg) | 67392-87-4 |
| 1229410 | Drospirenone Related Compound A (15 mg) (17-Hydroxy-6beta,7beta:15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21-carboxylic acid, gamma-lactone) | 90457-65-1 |
| 1229817 | Duloxetine Hydrochloride (100 mg) | 136434-34-9 |
| 1229828 | Duloxetine Related Compound A (10 mg) ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine Hydrochloride) | 910138-96-4 |
| 1229872 | Duloxetine Related Compound F (10 mg) ((S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine hydrochloride) | 1104890-90-5 |
| 1229883 | Duloxetine Related Compound H (30 mg) ((S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino)-4-oxobutanoic acid) (COLD SHIPMENT REQUIRED) | 199191-66-7 |
| 1229922 | Dutasteride (200 mg) | 164656-23-9 |
| 1229931 | Dutasteride Resolution Mixture (20 mg) | N/A |
| 1230000 | Dyclonine Hydrochloride (200 mg) | 536-43-6 |
| 1231003 | Dydrogesterone (200 mg) | 152-62-5 |
| 1231502 | Dyphylline (200 mg) | 479-18-5 |
| 1231580 | Ecamsule Solution (0.5 mL) | N/A |
| 1231604 | Ecamsule Triethanolamine (200 mg) | 92841-53-7 |
| 1231615 | Ecamsule Related Compound A (50 mg) (1,4-Phenylenedimethanol) | 589-29-7 |
| 1231626 | Ecamsule Related Compound B (50 mg) (4-(hydroxymethyl)benzoic acid) | 3006-96-0 |
| 1231637 | Ecamsule Related Compound C (50 mg) (terephthalic acid) | 100-21-0 |
| 1231648 | Ecamsule Related Compound D (50 mg) (((1SR,4RS)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid) | 5872-08-2 |
| 1231659 | Ecamsule Related Compound E (25 mg) (sodium ((1SR,4SR,E)-3-(4-(hydroxymethyl)benzylidene)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate) | N/A |
| 1231660 | Ecamsule Related Compound F (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid) | N/A |
| 1231681 | Ecamsule Related Compound G (25 mg) (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt) | N/A |
| 1231706 | Powdered Echinacea Angustifolia Extract (1 g) | 84696-11-7 |
| 1231717 | Powdered Echinacea Pallida Extract (1 g) | 97281-15-7 |
| 1231728 | Powdered Echinacea Purpurea Extract (1 g) | 90028-20-9 |
| 1231750 | Echinacoside (15 mg) | 82854-37-3 |
| 1231808 | Econazole Nitrate (250 mg) | 24169-02-6 |
| 1231830 | Econazole Related Compound A (15 mg) (1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl)ethanol) | 24155-42-8 |
| 1231841 | Econazole Related Compound B (15 mg) (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate) | N/A |
| 1231852 | Econazole Related Compound C (15 mg) (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride) | N/A |
| 1232006 | Edetate Calcium Disodium (200 mg) | 6766-87-6 |
| 1233009 | Edetate Disodium (200 mg) | 6381-92-6 |
| 1233508 | Edetic Acid (200 mg) | 60-00-4 |
| 1234001 | Edrophonium Chloride (200 mg) | 116-38-1 |
| 1234103 | Efavirenz (200 mg) | 154598-52-4 |
| 1234114 | Efavirenz Racemic (20 mg) ((+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | 177530-93-7 |
| 1234125 | Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) | 209414-27-7 |
| 1234136 | Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline) | 391860-73-4 |
| 1234147 | Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) | 440124-96-9 |
| 1234249 | Eflornithine Hydrochloride (150 mg) | 96020-91-6 |
| 1234307 | Eicosapentaenoic Acid Ethyl Ester (500 mg) (All-cis-5,8,11,14,17-Eicosapentaenoic acid ethyl ester) | 86227-47-6 |
| 1234340 | European Elder Berry Dry Extract | N/A |
| 1234453 | Eletriptan Hydrobromide (200 mg) (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate) | 273211-28-2 |
| 1234475 | Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole) | 143322-57-0 |
| 1234522 | Eletriptan S-Enantiomer (20 mg) ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide) | N/A |
| 1234668 | Eleutheroside B (15 mg) (Syringin) | 118-34-3 |
| 1234680 | Eleutheroside E (15 mg) (syringaresinol diglucoside) | 96038-87-8 |
| 1234704 | Powdered Eleuthero Extract (1.5 g) | 84696-12-5 |
| 1234806 | Emedastine Difumarate (100 mg) | 87233-62-3 |
| 1235004 | Emetine Hydrochloride (300 mg) | 316-42-7 |
| 1235059 | Emodin (30 mg) (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) | 518-82-1 |
| 1235106 | Emtricitabine (200 mg) | 143491-57-0 |
| 1235128 | Emtricitabine System Suitability Mixture A (15 mg) | N/A |
| 1235139 | Emtricitabine System Suitability Mixture B (15 mg) | N/A |
| 1235274 | Enalaprilat (300 mg) | 84680-54-6 |
| 1235300 | Enalapril Maleate (200 mg) | 76095-16-4 |
| 1235398 | Enanthic Acid (100 mg) (Heptanoic Acid) | 111-14-8 |
| 1235503 | Endotoxin (10,000 USP Endotoxin Units) (COLD SHIPMENT REQUIRED) | N/A |
| 1235809 | Enflurane (1 mL) | 13838-16-9 |
| 1235820 | Enoxaparin Sodium (300 mg) | 679809-58-6 |
| 1235831 | Enoxaparin Sodium for Bioassays (COLD SHIPMENT REQUIRED) | 9041-08-1 |
| 1235853 | Enoxaparin Sodium Molecular Weight Calibrant A (8.0 mg) | N/A |
| 1235864 | Enoxaparin Sodium Molecular Weight Calibrant B (6.0 mg) | 9041-08-1 |
| 1235900 | Enrofloxacin (200 mg) | 93106-60-6 |
| 1235911 | Enrofloxacin Related Compound Mixture (50 mg) | N/A |
| 1235933 | Entacapone (150 mg) | 130929-57-6 |
| 1235944 | Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide) | 145195-63-7 |
| 1235966 | Entecavir Monohydrate (200 mg) | 209216-23-9 |
| 1235977 | Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine) | 649761-24-0 |
| 1235988 | Entecavir System Suitability Mixture (15 mg) (This is a mixture containing entecavir 1-epimer (0.2%), entecavir (99.6%), 8-hydroxy entecavir (0.1%), and 8-methoxy entecavir (0.1%)) | N/A |
| 1235999 | Ephedrine Hydrochloride (200 mg) (List Chemical) | 50-98-6 |
| 1236007 | Ephedrine Sulfate (200 mg) (List Chemical) | 134-72-5 |
| 1236506 | 4-Epianhydrotetracycline Hydrochloride (50 mg) | 4465-65-0 |
| 1236663 | Epicoprostanol (200 mg) | 516-92-7 |
| 1236700 | (-)-Epigallocatechin-3-O-gallate (20 mg) | 989-51-5 |
| 1236801 | Epilactose (200 mg) | 50468-56-9 |
| 1236833 | Lovastatin Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture) | N/A |
| 1236889 | Epinastine Hydrochloride (250 mg) | 108929-04-0 |
| 1236970 | Epinephrine (200 mg) | 51-43-4 |
| 1237000 | Epinephrine Bitartrate (200 mg) | 51-42-3 |
| 1237382 | Epirubicin Hydrochloride (200 mg) | 56390-09-1 |
| 1237509 | Epitetracycline Hydrochloride (250 mg) | 23313-80-6 |
| 1237553 | Eplerenone (250 mg) | 107724-20-9 |
| 1237600 | Epoprostenol Sodium (100 mg) (COLD SHIPMENT REQUIRED) | 61849-14-7 |
| 1237611 | Epoprostenol Related Compound A (15 mg) (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid) (COLD SHIPMENT REQUIRED) | 58962-34-8 |
| 1237622 | Epoprostenol Related Compound B (15 mg) (Sodium 5-(diphenylphosphinoyl)pentanoate) | N/A |
| 1237752 | Eprinomectin (300 mg) (COLD SHIPMENT REQUIRED) | 123997-26-2 |
| 1238002 | Equilin (25 mg) | 474-86-2 |
| 1238217 | Eprosartan Mesylate (50 mg) ((E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, monomethanesulfonate) | 144143-96-4 |
| 1238228 | Eprosartan Related Compound A (20 mg) ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid hydrochloride) | N/A |
| 1238239 | Eprosartan Related Compound B (15 mg) (3-(thiophen-2-yl)propanoic acid) | 5928-51-8 |
| 1238240 | Eprosartan Related Compound C (25 mg) (2-(thiophen-2-ylmethyl)malonic acid) | 4475-24-5 |
| 1238251 | Eprosartan Related Compound D (15 mg) (4-(bromomethyl)benzoic acid) | 6232-88-8 |
| 1238262 | Eprosartan Related Compound E (15 mg) (4-(hydroxymethyl)benzoic acid) | 3006-96-0 |
| 1239005 | Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) | 50-14-6 |
| 1239504 | Ergoloid Mesylates (300 mg) | 8067-24-1 |
| 1240004 | Ergonovine Maleate (150 mg) (List Chemical) | 129-51-1 |
| 1241007 | Ergosterol (50 mg) | 57-87-4 |
| 1241506 | Ergotamine Tartrate (150 mg) (List Chemical) | 379-79-3 |
| 1241550 | Ergotaminine (100 mg) | 639-81-6 |
| 1241823 | Erythorbic Acid (50 mg) | 89-65-6 |
| 1241903 | Erythritol (200 mg) | 149-32-6 |
| 1242000 | Erythromycin (250 mg) | 114-07-8 |
| 1242010 | Erythromycin B (100 mg) | 527-75-3 |
| 1242021 | Erythromycin C (50 mg) | N/A |
| 1242032 | Erythromycin Related Compound N (50 mg) (N-Demethylerythromycin A) | N/A |
| 1243002 | Erythromycin Estolate (200 mg) | 3521-62-8 |
| 1245008 | Erythromycin Ethylsuccinate (200 mg) | 1264-62-6 |
| 1246000 | Erythromycin Gluceptate (200 mg) | 23067-13-2 |
| 1247003 | Erythromycin Lactobionate (200 mg) | 3847-29-8 |
| 1248006 | Erythromycin Stearate (200 mg) | 643-22-1 |
| 1248200 | Erythropoietin for Bioassays | 113427-24-0 |
| 1248218 | Erythropoietin (100 ug) | 113427-24-0 |
| 1249202 | Escin (350 mg) | 11072-93-8 |
| 1249406 | Escitalopram Oxalate (200 mg) | 219861-08-2 |
| 1249417 | Escitalopram Related Compound A (10 mg) ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydroxymethylbenzonitrile hemi(+)-di-toluoyltartrate) | 128173-53-5 |
| 1249701 | Esmolol Hydrochloride (100 mg) | 81161-17-3 |
| 1249789 | Esomeprazole Magnesium (25 mg) | 217087-09-7 |
| 1249803 | Esomeprazole Strontium (20 mg) | 934714-36-0 |
| 1249905 | Estazolam CIV (100 mg) | 29975-16-4 |
| 1249916 | Estazolam Related Compound A (10 mg) (5-Chloro-2-(3-chloromethyl-4H-1,2,4-triazol-4-yl)-benzophenone) | 37945-06-5 |
| 1250008 | Estradiol (500 mg) | 35380-71-3 |
| 1250020 | Estradiol Related Compound B (10 mg) (1,3,5(10),6-estratetraen-3,17beta-diol) | 7291-41-0 |
| 1250041 | Estradiol Related Compound C (15 mg) (1,3,5(10)-estratrien-3,17beta-diol-6-one) | 571-92-6 |
| 1251000 | Estradiol Benzoate (250 mg) | 50-50-0 |
| 1252003 | Estradiol Cypionate (200 mg) | 313-06-4 |
| 1252193 | Estradiol Cypionate System Suitability Mixture (10 mg) | N/A |
| 1254009 | Estradiol Valerate (100 mg) | 979-32-8 |
| 1254031 | Estradiol Valerate Identification Mixture (15 mg) | N/A |
| 1254508 | Estriol (100 mg) | 50-27-1 |
| 1254519 | Estriol Related Compound A (25 mg) (Estra-1,3,5(10),9(11)-tetraene-3,16alpha,17Beta-triol) | 246021-20-5 |
| 1255001 | Estrone (200 mg) | 53-16-7 |
| 1255500 | Estropipate (500 mg) | 7280-37-7 |
| 1255850 | Eszopiclone CIV (100 mg) | 138729-47-2 |
| 1255861 | Eszopiclone Related Compound A (10 mg) (6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo [3,4,b] pyrazin-5-yl 4-methylpiperazine-1-carboxylate 4-oxide) | 43200-96-0 |
| 1256004 | Ethacrynic Acid (200 mg) | 58-54-8 |
| 1257007 | Ethambutol Hydrochloride (200 mg) | 1070-11-7 |
| 1257018 | Ethambutol Related Compound A (15 mg) ((2R,2’S)-2,2′-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) | 10054-06-5 |
| 1257029 | Ethambutol Related Compound B (15 mg) (((2R,2’R)-2,2′-[Ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) dihydrochloride) | 134566-79-3 |
| 1258305 | Ethchlorvynol CIV (0.7 mL) | 113-18-8 |
| 1260001 | Ethinyl Estradiol (150 mg) | 57-63-6 |
| 1260012 | Ethinyl Estradiol Related Compound A (20 mg) (6-Keto-ethinyl estradiol) | N/A |
| 1260023 | Ethinyl Estradiol Related Compound B (20 mg) (19-Nor-17alpha-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol monohydrate) | 1231-96-5 |
| 1261004 | Ethionamide (200 mg) | 536-33-4 |
| 1262801 | Ethopabate (125 mg) | 59-06-3 |
| 1262823 | Ethopabate Related Compound A (25 mg) (Methyl-4-acetamido-2-hydroxybenzoate) | N/A |
| 1264002 | Ethosuximide (500 mg) | 77-67-8 |
| 1264501 | Ethotoin (500 mg) | 86-35-1 |
| 1265300 | Ethyl 4-nitrobenzoate (40 mg) | 99-77-4 |
| 1265402 | Ethyl Acetate (1.2 mL/ampule; 3 ampules) | 141-78-6 |
| 1265424 | Ethyl Acrylate and Methyl Methacrylate Copolymer Dispersion (1.5 g) (Poly(ethyl acrylate-co-methyl methacrylate)) | N/A |
| 1265457 | Ethylbenzene (0.5 mL/ampule; 3 ampules) | 100-41-4 |
| 1265504 | Ethylcellulose (1 g) | 9004-57-3 |
| 1265515 | Ethylene Glycol (0.5 mL) | 107-21-1 |
| 1265526 | 2-Ethylhexan-1-ol (1.5 mL) | 104-76-7 |
| 1265537 | Ethylhexyl Triazone (200 mg) | 88122-99-0 |
| 1265548 | Ethylhexyl Triazone Related Compound A (20 mg) (2-ethylhexyl 4-aminobenzoate) | 26218-04-2 |
| 1265559 | Ethylhexyl Triazone Related Compound B (20 mg) (4-[(4,6-Bis[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) | N/A |
| 1265560 | Ethylhexyl Triazone Related Compound C (20 mg) (Bis(2-ethylhexyl) 4,4′-[(6-{[4-(ethoxycarbonyl)phenyl]amino}-1,3,5-triazine-2,4-diyl)bis(azanediyl)]dibenzoate) | N/A |
| 1265592 | Ethylene Glycol and Vinyl Alcohol Graft Copolymer (1 g) | 121786-16-1 |
| 1265606 | Ethyl Formate (1.2 mL/ampule; 3 ampules) | 109-94-4 |
| 1265739 | 1-Ethoxy-2-Methylpropane (3 x 0.2 mL) | 627-02-1 |
| 1265752 | Ethyl Laurate (500 mg) | 106-33-2 |
| 1265800 | Ethyl Lauroyl Arginate (200 mg) | 60372-77-2 |
| 1265843 | Ethyl Linoleate (1 mL) | 544-35-4 |
| 1266008 | Ethyl Maltol (1 g) | 4940-11-8 |
| 1266609 | Ethyl Oleate (1 mL) | 111-62-6 |
| 1266802 | N-Ethylpiperazine (0.5 mL) | 5308-25-8 |
| 1266868 | Ethyl Palmitate (500 mg) | 628-97-7 |
| 1267000 | Ethylparaben (200 mg) | 120-47-8 |
| 1267102 | Ethyl Stearate (100 mg) | 111-61-5 |
| 1267500 | Ethyl Vanillin (200 mg) | 121-32-4 |
| 1268003 | Ethynodiol Diacetate (200 mg) | 297-76-7 |
| 1268502 | Etidronate Disodium (200 mg) | 7414-83-7 |
| 1268513 | Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) | 13517-23-2 |
| 1268604 | Etidronic Acid Monohydrate (1 g) | 25211-86-3 |
| 1268706 | Etodolac (400 mg) | 41340-25-4 |
| 1268728 | Etodolac Related Compound A (25 mg) ((+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid) | 109518-50-5 |
| 1268750 | Etomidate (200 mg) | 33125-97-2 |
| 1268772 | Metomidate Hydrochloride (50 mg) (methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate hydrochloride) | 35944-74-2; |
| 36557-22-9 | ||
| 1268783 | Etonogestrel (100 mg) | 54048-10-1 |
| 1268794 | Etonogestrel Related Compound A (10 mg) (13Beta-Ethyl-11-methylenegon-4-ene-3,17-dione) | 54024-17-8 |
| 1268808 | Etoposide (300 mg) | 33419-42-0 |
| 1268852 | Etoposide Resolution Mixture (30 mg) | 33419-42-0 |
| 1268900 | Eucalyptol (200 mg) | 470-82-6 |
| 1268919 | Eucalyptus Oil (1 g) | 8000-48-4 |
| 1268965 | Eugenol (500 mg) | 97-53-0 |
| 1268998 | [Glu13]-Exenatide (1 mg) | N/A |
| 1269009 | [Met(O)14]-Exenatide (1 mg) | 1678417-38-3 |
| 1269017 | Evening Primrose Oil (1 g) | 308064-97-3 |
| 1269028 | Ezetimibe (250 mg) | 163222-33-1 |
| 1269039 | Ezetimibe System Suitability Mixture (20 mg) | Mixture |
| 1269045 | [N-Acetyl-His1]-Exenatide (1 mg) | N/A |
| 1269050 | Exemestane (150 mg) | 107868-30-4 |
| 1269061 | Exemestane Related Compound A (15 mg) (6-Methyleneandrosta-4-ene-3,17-dione) | 19457-55-7 |
| 1269072 | Exemestane Related Compound B (15 mg) (6-hydroxymethylandrostra-1,4-diene-3,17-dione) | 184972-09-6 |
| 1269083 | Exemestane Related Compound C CIII (15 mg) (androsta-1,4-diene-3,17-dione) | 897-06-3 |
| 1269094 | Exemestane System Suitability Mixture (25 mg) | N/A |
| 1269105 | Exenatide (2.73 mg) | 141758-74-9 |
| 1269119 | FAME Standard Mixture (100 mg) (A mixture of 25 Fatty Acid Methyl Esters) | 71076-49-8 |
| 1269130 | Famciclovir Related Compound E (25 mg) (2-aminopurine) | N/A |
| 1269141 | Famciclovir Related Compound F (25 mg) (2-Amino-6-chloropurine) | 10310-21-1 |
| 1269152 | Famciclovir (200 mg) | 104227-87-4 |
| 1269163 | Famciclovir System Suitability Mixture (20 mg) (Mixture of Famciclovir, Propionyl famciclovir and 6-Chloro famciclovir) | N/A |
| 1269174 | Famciclovir Related Compound A (20 mg) (2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride) | 246021-75-0; 104227-86-3 (base |
| 1269185 | Famciclovir Related Compound B (20 mg) [4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate] | 104227-88-5 |
| 1269196 | Famciclovir Related Compound C (20 mg) (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate) | 174155-70-5 |
| 1269200 | Famotidine (125 mg) | 76824-35-6 |
| 1269221 | Famotidine Related Compound B (25 mg) (3,5-bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphany]ethyl]-4H-1,2,4,6-thiatriazine1,1-dioxide) | 89268-62-2 |
| 1269232 | Famotidine Related Compound C (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide hydrochloride) | 76824-17-4 |
| 1269243 | Famotidine Related Compound D (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide) | 76824-16-3 |
| 1269254 | Famotidine Related Compound E (25 mg) (2,2′-[4,4′-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine) | 129083-44-9 |
| 1269265 | Famotidine Related Compound F (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid) | 107880-74-0 |
| 1269312 | Felbamate (250 mg) | 25451-15-4 |
| 1269323 | Felbamate Related Compound A (25 mg) (3-Hydroxy-2-phenylpropyl carbamate) | N/A |
| 1269334 | Felbamate Related Compound B (25 mg) (Phenethyl carbamate) | 6326-19-8 |
| 1269356 | Febantel (200 mg) | 58306-30-2 |
| 1269367 | Febantel Related Compound A (15 mg) (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate) | 92088-58-9 |
| 1269378 | Febantel Related Compound B (15 mg) (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) | 92114-71-1 |
| 1269389 | Felodipine (300 mg) | 72509-76-3 |
| 1269390 | Felodipine Related Compound A (15 mg) (ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | 96302-71-7 |
| 1269403 | Fenbendazole (100 mg) | 43210-67-9 |
| 1269414 | Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate) | 10605-21-7 |
| 1269425 | Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) | 20367-38-8 |
| 1269436 | Fenofibric Acid (250 mg) (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid) | 42017-89-0 |
| 1269447 | Fenofibrate (200 mg) | 49562-28-9 |
| 1269458 | Fenoldopam Mesylate (200 mg) | 67227-57-0 |
| 1269469 | Fenoldopam Related Compound A (20 mg) (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) | N/A |
| 1269470 | Fenoldopam Related Compound B (20 mg) (1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate) | N/A |
| 1269505 | Fenoprofen Calcium (500 mg) | 53746-45-5 |
| 1269550 | Fenoprofen Sodium (500 mg) | 66424-46-2 |
| 1269607 | Fenofibrate Related Compound A (25 mg) ((4-chlorophenyl)(4-hydroxyphenyl)methanone) | 42019-78-3 |
| 1269618 | Fenofibrate Related Compound B (25 mg) (2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid) | 42017-89-0 |
| 1269629 | Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate) | 217636-48-1 |
| 1269902 | Fentanyl CII (100 mg) | 437-38-7 |
| 1269913 | Fentanyl Related Compound A (100 mg) ((2-bromoethyl)benzene) | 103-63-9 |
| 1269924 | Fentanyl Related Compound B (10 mg) (4-Anilinopiperidine) | 23056-29-3 |
| 1269946 | Fentanyl Related Compound D (10 mg) (N-Phenyl-1-(phenylmethyl)-4-piperidinamine) | 1155-56-2 |
| 1269957 | Fentanyl Related Compound E CII (10 mg) (N-Phenyl-1-(2-phenylethyl)-4-piperidinamine) | 21409-26-7 |
| 1269979 | Fentanyl Related Compound G CI (10 mg) (Acetyl fentanyl; N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide) | 3258-84-2 |
| 1270005 | Fentanyl Citrate CII (100 mg) | 990-73-8 |
| 1270231 | Trigonella Foenum-graecum Seed Dry Extract (1 g) | N/A |
| 1270311 | Ferulic Acid (25 mg) ((E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid) | 537-98-4 |
| 1270355 | Ferrous Sulfate (2 x 1 g) | 7782-63-0 |
| 1270363 | Fexofenadine (200 mg) (2-(4-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid dihydrate) | 885946-90-7 |
| 1270377 | Fexofenadine Hydrochloride (200 mg) | 153439-40-8 |
| 1270388 | Fexofenadine Related Compound A (25 mg) (4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid) | 76811-98-8 |
| 1270399 | Fexofenadine Related Compound B (25 mg) (3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid hydrochloride monohydrate) | N/A |
| 1270402 | Finasteride (200 mg) | 98319-26-7 |
| 1270424 | Fish Oil (1 g) | 8016-13-5 |
| 1270435 | Filgrastim (0.98 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1270446 | Fexofenadine Related Compound C (15 mg) ((+/-)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene hydrochloride) | N/A |
| 1270457 | High Molecular Weight Filgrastim (0.7 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1270480 | Fingolimod Hydrochloride (300 mg) | 162359-56-0 |
| 1270526 | Fingolimod System Suitability Mixture (40 mg) | N/A |
| 1270548 | Fetal Bovine Serum (10 mL) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | N/A |
| 1270708 | Flavoxate Hydrochloride (200 mg) | 3717-88-2 |
| 1270719 | Flavoxate Related Compound A (25 mg) (3-methylflavone-8-carboxylic acid) | 3468-01-7 |
| 1270720 | Flavoxate Related Compound B (20 mg) (3-Methylflavone-8-carboxylic acid methyl ester) | 90101-87-4 |
| 1270731 | Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) | 35888-94-9 |
| 1270774 | Flax Seed Oil (1 g) | 8001-26-1 |
| 1270800 | Flecainide Acetate (200 mg) | 54143-56-5 |
| 1270821 | Flecainide Related Compound A (75 mg) (3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine hydrochloride) | N/A |
| 1271008 | Floxuridine (250 mg) | 50-91-9 |
| 1271700 | Fluconazole (200 mg) | 86386-73-4 |
| 1271711 | Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) | N/A |
| 1271722 | Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) | 81886-51-3 |
| 1271733 | Fluconazole Related Compound C (10 mg) (1,1′-(1,3-phenylene)di(1H-1,2,4-triazole)) | 514222-44-7 |
| 1272000 | Flucytosine (200 mg) | 2022-85-7 |
| 1272204 | Fludarabine Phosphate (300 mg) | 75607-67-9 |
| 1272907 | Fludeoxyglucose (100 mg) | 29702-43-0 |
| 1272918 | Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) | 23978-09-8 |
| 1272929 | Fludeoxyglucose Related Compound B (10 mg) (2-chloro-2-deoxy-D-glucose) | 14685-79-1 |
| 1273003 | Fludrocortisone Acetate (200 mg) | 514-36-3 |
| 1273808 | Flumazenil (200 mg) | 78755-81-4 |
| 1273819 | Flumazenil Related Compound A (20 mg) (8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylic acid) | N/A |
| 1273820 | Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylate) | N/A |
| 1273841 | Flumazenil Related Compound C (500 mg) (N,N-Dimethylformamide diethyl acetal) | 1188-33-6 |
| 1274006 | Flumethasone Pivalate (200 mg) | 2002-29-1 |
| 1274505 | Flunisolide (200 mg) | 77326-96-6 |
| 1274607 | Flunixin Meglumine (300 mg) | 42461-84-7 |
| 1274629 | Flunixin Related Compound A (15 mg) (2-Chloronicotinic acid) | 2942-59-8 |
| 1274630 | Flunixin Related Compound B (25 mg) (2-Methyl-3-(trifluoromethyl)aniline) | 54396-44-0 |
| 1274631 | Flunixin Related Compound C (50 mg) (Ethyl 2-chloronicotinate) | 1452-94-4 |
| 1275009 | Fluocinolone Acetonide (200 mg) | 67-73-2 |
| 1276001 | Fluocinonide (200 mg) | 356-12-7 |
| 1277004 | Fluorescein (200 mg) | 2321-07-5 |
| 1277037 | Fluorescein Related Compound C (25 mg) (2-(2,4-Dihydroxybenzoyl)benzoic acid) | 2513-33-9 |
| 1277252 | Fluoride Dentifrice: Sodium Fluoride/Silica (4.6 oz) | N/A |
| 1277274 | Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz) | N/A |
| 1277300 | Fluoride Dentifrice: Sodium Monofluorophosphate-Calcium Carbonate (4.6 oz) | N/A |
| 1277354 | Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate (4.6 oz) | N/A |
| 1277401 | Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica (5.25 oz) | N/A |
| 1277423 | Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica (5.25 oz) | N/A |
| 1277456 | Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) | N/A |
| 1278007 | Fluorometholone (200 mg) | 426-13-1 |
| 1278018 | Fluorometholone Related Compound A (15 mg) (11Beta,17alpha-Dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione) | 6870-94-6 |
| 1278109 | Fluorometholone Acetate (200 mg) | 3801-06-7 |
| 1278302 | Fluoroquinolonic Acid (150 mg) | 86393-33-1 |
| 1279000 | Fluorouracil (250 mg) | 51-21-8 |
| 1279019 | Fluorouracil Related Compound A (25 mg) (Pyrimidine-2,4,6(1H,3H,5H)-trione) | 67-52-7 |
| 1279021 | Fluorouracil Related Compound B (25 mg) (Dihydropyrimidine-2,4,5(3H)-trione) | 496-76-4 |
| 1279054 | Fluorouracil Related Compound E (25 mg) (5-Chloropyrimidine-2,4(1H,3H)-dione) | 1820-81-1 |
| 1279065 | Fluorouracil Related Compound F (25 mg) (2-Ethoxy-5-fluoropyrimidin-4(1H)-one) | 56177-80-1 |
| 1279804 | Fluoxetine Hydrochloride (200 mg) | 56296-78-7 |
| 1279815 | Fluoxetine Related Compound A (15 mg) (N-methyl-3-phenyl-3-[(alpha, alpha, alpha-trifluoro-m-tolyl)oxy]propylamine hydrochloride) | 79088-29-2 |
| 1279826 | Fluoxetine Related Compound B (5 mL of a 0.01N HCl Solution, approx. 2 mg/mL) (N-Methyl-3-phenylpropylamine) | 23580-89-4 |
| 1279837 | Fluoxetine Related Compound C (15 mg) (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid) | N/A |
| 1280009 | Fluoxymesterone CIII (200 mg) | 76-43-7 |
| 1280803 | Fluphenazine Decanoate Dihydrochloride (300 mg) | 2376-65-0 |
| 1281001 | Fluphenazine Enanthate Dihydrochloride (125 mg) | 3105-68-8 |
| 1282004 | Fluphenazine Hydrochloride (125 mg) | 146-56-5 |
| 1282591 | Foeniculin (4 x 50 mg) | 78259-41-3 |
| 1282707 | Fondaparinux Sodium for Assay (0.6 mL) (COLD SHIPMENT REQUIRED) | 114870-03-0 |
| 1282718 | Fondaparinux Sodium Identification (30 mg) | 114870-03-0 |
| 1282729 | Fondaparinux Sodium System Suitability Mixture A (2.5 mg) | N/A |
| 1282730 | Fondaparinux Sodium System Suitability Mixture B (2.5 mg) | N/A |
| 1283200 | Formic Acid (1.2 mL/ampule; 3 ampules) | 64-18-6 |
| 1283244 | Forskolin (40 mg) (7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one) | 66575-29-9 |
| 1283255 | Powdered Forskohlii Extract (500 mg) | N/A |
| 1283302 | Foscarnet Sodium (50 mg) | 34156-56-4 |
| 1283313 | Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosphanyl)formate) | N/A |
| 1283324 | Foscarnet Related Compound D (0.27 mL) (O,O-diethyl ethoxycarbonylphosphonate) | 1474-78-8 |
| 1283404 | Fosinopril Sodium (200 mg) | 88889-14-9 |
| 1283415 | Fosinopril Related Compound A (25 mg) ((4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline) | 95399-71-6 |
| 1283426 | Fosinopril Related Compound B (25 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) | N/A |
| 1283437 | Fosinopril Related Compound C (15 mg) ((4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline propionate (ester), sodium salt) | N/A |
| 1283448 | Fosinopril Related Compound D (15 mg) ((4R)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt) | N/A |
| 1283459 | Fosinopril Related Compound E (15 mg) ((4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl)phospinyl]acetyl-L-proline propionate (ester), sodium salt) | N/A |
| 1283460 | Fosinopril Related Compound F (15 mg) ((4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate(ester), sodium salt) | N/A |
| 1283470 | Fosinopril Related Compound G (15 mg) ((4-phenylbutyl)phosphinyl acetic acid, disodium salt) | N/A |
| 1283481 | Fosinopril Related Compound H (25 mg) (4-phenylbutyl phosphonic acid) | 46348-61-2 |
| 1284000 | Flurandrenolide (100 mg) | 1524-88-5 |
| 1285002 | Flurazepam Hydrochloride CIV (200 mg) | 1172-18-5 |
| 1285308 | Flurazepam Related Compound C (50 mg) (5-chloro-2-(2-diethylaminoethylamino)-2′-fluorobenzophenone hydrochloride) | N/A |
| 1285603 | Flurazepam Related Compound F (50 mg) (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one) | 2886-65-9 |
| 1285750 | Flurbiprofen (200 mg) | 5104-49-4 |
| 1285760 | Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)propionic Acid) | 6341-72-6 |
| 1285807 | Flurbiprofen Sodium (200 mg) | 56767-76-1 |
| 1285818 | Fluticasone Propionate Related Compound J (15 mg) (6alpha, 9alpha-difluoro-11beta,17alpha-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carboxylic acid) | 28416-82-2 |
| 1285829 | Fluticasone Propionate Related Compound D (15 mg) (S-methyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxyandrosta-1,4-diene-17beta-carbothioate) | 73205-13-7 |
| 1285840 | Fluticasone Propionate Related Compounds Mixture (25 mg) | N/A |
| 1285851 | Flutamide (200 mg) | 13311-84-7 |
| 1285862 | o-Flutamide (50 mg) | N/A |
| 1285873 | Fluticasone Propionate (100 mg) | 80474-14-2 |
| 1285884 | Fluticasone Propionate Resolution Mixture (25 mg) | N/A |
| 1285895 | Fluticasone Propionate System Suitability Mixture (25 mg) (Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D) | N/A |
| 1285909 | Fluvoxamine Maleate (200 mg) | 61718-82-9 |
| 1285910 | Fluticasone Propionate Nasal Spray Resolution Mixture (25 mg) | N/A |
| 1285931 | Fluvastatin Sodium (2 x 350 mg) | 93957-55-2 |
| 1285942 | Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) | N/A |
| 1285964 | Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) | 129332-29-2 |
| 1285986 | Flutamide Related Compound B (20 mg) (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide) | 393-12-4 |
| 1285997 | Flutamide Related Compound A (20 mg) (4-nitro-3-(trifluoromethyl)aniline) | 393-11-3 |
| 1286005 | Folic Acid (500 mg) (Vitamin M or Vitamin Bc) | 59-30-3 |
| 1286027 | Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) | 1492-18-8 |
| 1286060 | Formononetin (50 mg) | 485-72-3 |
| 1286107 | Formoterol Fumarate (200 mg) | 183814-30-4 |
| 1286118 | Formoterol Fumarate System Suitability Mixture CI (20 mg) | N/A |
| 1286129 | Formoterol Fumarate Resolution Mixture (20 mg) | N/A |
| 1286209 | Mafenide Related Compound A (50 mg) (4-Formylbenzenesulfonamide) | N/A |
| 1286300 | 10-Formylfolic Acid (25 mg) | 134-05-4 |
| 1286322 | Fosfomycin Tromethamine (800 mg) | 78964-85-9 |
| 1286366 | Fosphenytoin Sodium (350 mg) | 92134-98-0 |
| 1286402 | Frovatriptan Racemate (15 mg) | 147009-08-3 |
| 1286413 | Frovatriptan Succinate (200 mg) | 158930-17-7 |
| 1286424 | Frovatriptan Related Compound A (20 mg) ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide) | N/A |
| 1286504 | Fructose (125 mg) | 57-48-7 |
| 1286606 | L-Fucose (200 mg) | 2438-80-4 |
| 1286650 | Fulvestrant (200 mg) | 129453-61-8 |
| 1286661 | Fulvestrant System Suitability Mixture (30 mg) | N/A |
| 1286708 | Fumaric Acid (200 mg) | 110-17-8 |
| 1286800 | Furazolidone (200 mg) | 67-45-8 |
| 1287008 | Furosemide (200 mg) | 54-31-9 |
| 1287020 | Furosemide Related Compound A (50 mg) (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid) | N/A |
| 1287030 | Furosemide Related Compound B (100 mg) (4-Chloro-5-sulfamoylanthranilic Acid) | 3086-91-7 |
| 1287303 | Gabapentin (250 mg) | 60142-96-3 |
| 1287325 | Gabapentin Related Compound A (50 mg) (2-Azaspiro[4.5]decan-3-one) | 64744-50-9 |
| 1287347 | Gabapentin Related Compound B (30 mg) ((1-cyanocyclohexyl)acetic acid) (COLD SHIPMENT REQUIRED) | 133481-09-1 |
| 1287358 | Gabapentin Related Compound D (10 mg) ((1-(3-oxo-2-aza-spiro[4.5]dec-2-ylmethyl)-cyclohexyl)acetic acid) | N/A |
| 1287369 | Gabapentin Related Compound E (25 mg) (carboxymethyl-cyclohexanecarboxylic acid) | 67950-95-2 |
| 1287507 | Gadodiamide (500 mg) | 131410-48-5 |
| 1287518 | Gadodiamide Related Compound A (50 mg) (gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide) | N/A |
| 1287529 | Gadodiamide Related Compound B (50 mg) (gadolinium disodium diethylenetriamine pentaacetic acid) | N/A |
| 1287609 | Gadopentetate Monomeglumine (500 mg) | 92923-57-4 |
| 1287631 | Gadoteridol (500 mg) | 120066-54-8 |
| 1287642 | Gadoteridol Related Compound A (50 mg) (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) | 120041-08-9 |
| 1287653 | Gadoteridol Related Compound B (50 mg) (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt) | 112188-16-6 |
| 1287664 | Gadoteridol Related Compound C (50 mg) (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid) | 220182-19-4 |
| 1287675 | Gadoversetamide (200 mg) | 131069-91-5 |
| 1287686 | Gadoversetamide Related Compound A (200 mg) (Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(4-)]gadolinium) | N/A |
| 1287700 | Galactose (200 mg) | 59-23-4 |
| 1287711 | Galactitol (500 mg) | 608-66-2 |
| 1287722 | Galactosamine Hydrochloride (50 mg) | 1772-03-8 |
| 1287755 | Galantamine Hydrobromide (200 mg) | 1953-04-4; 69353-21-5 |
| 1287766 | Galantamine Hydrobromide Racemic (15 mg) | 193146-85-9 |
| 1287777 | Galantamine Hydrobromide Related Compounds Mixture (25 mg) | N/A |
| 1288000 | Gallamine Triethiodide (200 mg) | 65-29-2 |
| 1288306 | Ganciclovir (200 mg) | 82410-32-0 |
| 1288317 | Ganciclovir Related Compound A (15 mg) ((RS)-2-Amino-9-(2,3-dihydroxy-propoxymethyl)-1,9-dihydro-purin-6-one) | N/A |
| 1288339 | Ganciclovir Mono-N-methyl Valinate (10 mg) (2-(RS)-[(guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride) | N/A |
| 1288340 | Powdered Garcinia Hydroxycitrate Extract (500 mg) | N/A |
| 1288372 | Ganoderma lucidum Fruiting Body Dry Extract (1 g) | N/A |
| 1288383 | Ganoderic Acid A (50 mg) | 81907-62-2 |
| 1288408 | Gatifloxacin (300 mg) | 112811-59-3 |
| 1288419 | Gatifloxacin Related Compound A (15 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | 616205-76-6 |
| 1288441 | Gatifloxacin Related Compound D (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | 112811-57-1 |
| 1288452 | Gatifloxacin Related Compound E (15 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride) | 1219097-41-2 |
| 1288463 | Gemcitabine Hydrochloride (200 mg) | 122111-03-9 |
| 1288485 | Gelatin (500 mg) | 9000-70-8 |
| 1288500 | Gemfibrozil (200 mg) | 25812-30-0 |
| 1288510 | Gemfibrozil Related Compound A (20 mg) ((E,Z)-2,2-dimethyl-5-[2,5-dimethyl-4-(propene-1-yl)phenoxy]valeric acid) | N/A |
| 1288805 | Genistin (30 mg) | 529-59-9 |
| 1288816 | Genistein (15 mg) | 446-72-0 |
| 1289003 | Gentamicin Sulfate (200 mg) | 1405-41-0 |
| 1290002 | Gentian Violet (650 mg) | 548-62-9 |
| 1291005 | Gibberellic Acid (200 mg) | 77-06-5 |
| 1291446 | Ginger Constituent Mixture (0.2 mg) (6-gingerol and 6-shogaol) | N/A |
| 1291504 | Powdered Ginger (500 mg) | N/A |
| 1291548 | Ginkgolic Acids (20 mg) (Mixture of ginkgolic acid C13:0, ginkgolic acid C15:1 and ginkgolic acid C17:1) | N/A |
| 1291559 | Ginkgo Terpene Lactones (50 mg) | NA |
| 1291672 | Ginsenoside Rg1 (20 mg) | 22427-39-0 |
| 1291683 | Powdered American Ginseng Extract (1.5 g) | 90045-38-8 |
| 1291708 | Powdered Asian Ginseng Extract (1.5 g) | 50647-08-0 |
| 1291719 | Panax Notoginseng Root and Rhizome Dry Extract (1 g) | N/A |
| 1292303 | Glimepiride (200 mg) | 93479-97-1 |
| 1292314 | Glimepiride Related Compound A (20 mg) (glimepiride cis-isomer) | N/A |
| 1292325 | Glimepiride Related Compound B (20 mg) (glimepiride sulfonamide, or 3-Ethyl-4-methyl-2-oxo-N-(4-sulfamoylphenethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide) | 119018-29-0 |
| 1292336 | Glimepiride Related Compound C (20 mg) (glimepiride urethane, or methyl ((4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonyl)carbamate) | 119018-30-3 |
| 1292347 | Glimepiride Related Compound D (20 mg) (Glimepiride 3-isomer, or 1-[[m-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea) | N/A |
| 1292507 | Glipizide (125 mg) | 29094-61-9 |
| 1292609 | Glipizide Related Compound A (25 mg) (N-{2-[(4-aminosulfonyl)phenyl]ethyl}-5-methyl-pyrazinecarboxamide) | 33288-71-0 |
| 1292610 | Glipizide Related Compound B (15 mg) (6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide) | N/A |
| 1292631 | Glipizide Related Compound C (15 mg) (1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea) | 66375-96-0 |
| 1294036 | rGlucagon (2 x 2.94 mg) (recombinant Glucagon (Human)) (COLD SHIPMENT REQUIRED) | 16941-32-5 |
| 1294150 | Gluconolactone (100 mg) | 90-80-2 |
| 1294207 | Glucosamine Hydrochloride (200 mg) | 66-84-2 |
| 1294284 | N-Glycolylneuraminic Acid (200 mg) | 1113-83-3 |
| 1294319 | D-Glucuronic Acid (50 mg) | 6556-12-3 |
| 1294808 | Glutamine (100 mg) | 56-85-9 |
| 1294820 | Glutathione (300 mg) | 70-18-8 |
| 1294848 | Gamma-Glutamyl-(S)-allyl-L-cysteine (30 mg) | 91216-95-4 |
| 1294976 | Glutamic Acid (200 mg) | 56-86-0 |
| 1294987 | L-Glutamic Acid Hydrochloride (100 mg) | 138-15-8 |
| 1295505 | Glyburide (200 mg) | 10238-21-8 |
| 1295516 | Glyburide Related Compound A (25 mg) (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide) | 16673-34-0 |
| 1295527 | Glyburide Related Compound B (25 mg) (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS) | 21165-77-5 |
| 1295607 | Glycerin (2 mL) | 56-81-5 |
| 1295709 | Glyceryl Dibehenate (200 mg) (formerly known as Glyceryl Behenate) | N/A |
| 1295724 | Glyceryl Distearate (500 mg) | 1323-83-7 |
| 1295731 | Glyceryl Monolinoleate (500 mg) | 26545-74-4 |
| 1295742 | Glyceryl Monooleate 90% (250 mg) | 111-03-5 |
| 1295753 | Glyceryl Monooleate 40% (500 mg) | 25496-72-4 |
| 1295764 | Glyceryl Monocaprylate (Type II) (300 mg) | 26402-26-6 |
| 1295775 | Glyceryl Monocaprylocaprate (Type I) (300 mg) | 91744-32-0 |
| 1295797 | Glyceryl Tricaprylate (3 x 0.5 mL) | 538-23-8 |
| 1295800 | Glycine (200 mg) | 56-40-6 |
| 1295844 | Glycitein (15 mg) | 40957-83-3 |
| 1295855 | Glycitin (15 mg) | 40246-10-4 |
| 1295866 | Glycyl-L-Glutamine (200 mg) | 211446-46-7 |
| 1295877 | Glycyl-L-Tyrosine (200 mg) | 39630-46-1 |
| 1295888 | Glycyrrhizic Acid (25 mg) | 1405-86-3 |
| 1296009 | Glycopyrrolate (200 mg) | 51186-83-5 |
| 1296010 | Glycopyrrolate Erythro Isomer (25 mg) ((RS)-3-[(RS)-2-cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide) | N/A |
| 1296029 | Glycopyrrolate Related Compound A (50 mg) (5-Nitrobenzene-1,3-dicarboxylic acid) | 618-88-2 |
| 1296031 | Glycopyrrolate Related Compound B (50 mg) (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride) | 13118-10-0 |
| 1296042 | Glycopyrrolate Related Compound C (25 mg) (2-Cyclopentyl-2-hydroxy-2-phenylacetic acid) | 427-49-6 |
| 1296086 | Glycopyrrolate Related Compound I (15 mg) ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide) | N/A |
| 1296100 | Glycopyrrolate Related Compound L (50 mg) (Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate) | 19833-96-6 |
| 1296756 | Gonadorelin Acetate (50 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 52699-48-6 |
| 1296767 | Gonadorelin Acetate Related Compound A (10 mg) (gonadorelin free acid trifluoroacetate salt) (COLD SHIPMENT REQUIRED) | N/A |
| 1296803 | Gonadorelin Hydrochloride (6.53 mg) (COLD SHIPMENT REQUIRED) | 51952-41-1 |
| 1297001 | Human Chorionic Gonadotropin (1 vial, 5,760 USP Units per package) (COLD SHIPMENT REQUIRED) | 9002-61-3 |
| 1297205 | Goserelin Acetate (100 mg) (COLD SHIPMENT REQUIRED) | 145546-80-1 |
| 1297216 | Goserelin Related Compound A (2 mg) (4-D-Serine Goserelin) (COLD SHIPMENT REQUIRED) | N/A |
| 1297250 | Goserelin System Suitability Mixture (1.0 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1297770 | Powdered Centella Asiatica Extract (1 g) | N/A |
| 1298004 | Gramicidin (200 mg) | 1405-97-6 |
| 1298092 | Granisetron (100 mg) | 109889-09-0 |
| 1298106 | Granisetron Hydrochloride (150 mg) | 107007-99-8 |
| 1298117 | Granisetron Related Compound A (15 mg) (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide) | 127472-42-8 |
| 1298128 | Granisetron Related Compound B (15 mg) (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide) | 107007-95-4 |
| 1298139 | Granisetron Related Compound C (15 mg) (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride) | 141136-01-8 |
| 1298140 | Granisetron Related Compound D (15 mg) (1-methyl-1H-indazole-3-carboxylic acid) | 50890-83-0 |
| 1298150 | Granisetron Related Compound E (15 mg) ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate) | N/A |
| 1298208 | Grape Seeds Oligomeric Proanthocyanidins (500 mg) | 222838-60-0 |
| 1298219 | Purified Grape Seeds Oligomeric Proanthocyanidins (500 mg) | N/A |
| 1298401 | Powdered Decaffeinated Green Tea Extract (300 mg) | 84650-60-2 |
| 1299007 | Griseofulvin (200 mg) | 126-07-8 |
| 1299200 | Griseofulvin Permeability Diameter (2 g) | 126-07-8 |
| 1300004 | Guaiacol (1 g) (2-Methoxyphenol) | 90-05-1 |
| 1301007 | Guaifenesin (200 mg) | 93-14-1 |
| 1301404 | Guanabenz Acetate (200 mg) | 23256-50-0 |
| 1301801 | Guanethidine Monosulfate (200 mg) | 645-43-2 |
| 1302101 | Guanfacine Hydrochloride (125 mg) | 29110-48-3 |
| 1302156 | Guanine (100 mg) | 73-40-5 |
| 1302203 | Purified Guggul Extract (500 mg) | N/A |
| 1302214 | Guggulsterone Z (25 mg) | 39025-23-5 |
| 1302247 | Gymnemagenin (15 mg) | 22467-07-8 |
| 1302258 | Native Gymnema Extract (1 g) | 90045-47-9 |
Chuẩn USP từ H - N
Chuẩn dược điển USP từ H đến N
| Mã code | Tên chuẩn dược điển | Mã CAS# |
| 1302509 | Halcinonide (200 mg) | 3093-35-4 |
| 1302906 | Halobetasol Propionate (200 mg) | 66852-54-8 |
| 1303002 | Haloperidol (200 mg) | 52-86-8 |
| 1303013 | Haloperidol Related Compound A (10 mg) (4,4′-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophenone) | 67987-08-0 |
| 1303024 | Haloperidol Related Compound B (10 mg) (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one) | N/A |
| 1303057 | Haloperidol Decanoate (200 mg) | 74050-97-8 |
| 1303501 | Halothane (1 mL) | 151-67-7 |
| 1303750 | Hemoglobin Protease Substrate (100 g) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 9008-02-0 |
| 1304016 | Heparin Sodium for Assays (9.5 mg) (COLD SHIPMENT REQUIRED) | 9041-08-1 |
| 1304038 | Heparin Sodium Identification (50 mg) (COLD SHIPMENT REQUIRED) | 9041-08-1 |
| 1304049 | Heparin Sodium System Suitability (50 mg) | N/A |
| 1304050 | Heparin Sodium with Oversulfated Chondroitin Sulfate (8.8 mg) | N/A |
| 1304107 | Heparin Sodium Molecular Weight Calibrant (10.3 mg) | N/A |
| 1304118 | Low Molecular Weight Heparin for Bioassays (5 mg) | 9041-08-1 |
| 1304130 | Low Molecular Weight Heparin for Boron Analysis (300 mg) | 9041-08-1 |
| 1304209 | Heptane (1.2 mL/ampule; 3 ampules) | 142-82-5 |
| 1304377 | Hesperidin (200 mg) | 64726-90-5 |
| 1305008 | Hexachlorophene (500 mg) | 70-30-4 |
| 1305303 | Hexacosanol (100 mg) | 506-52-5 |
| 1305507 | 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) | 82240-09-3 |
| 1308200 | Hexylene Glycol (125 mg) | 107-41-5 |
| 1308307 | Hexylresorcinol (200 mg) | 136-77-6 |
| 1308505 | L-Histidine (200 mg) | 71-00-1 |
| 1308550 | L-Histidine Monohydrochloride Monohydrate (200 mg) | 5934-29-2 |
| 1309009 | Histamine Dihydrochloride (250 mg) | 56-92-8 |
| 1309911 | Powdered Holy Basil Extract (1 g) | 91845-35-1 |
| 1310008 | Homatropine Hydrobromide (200 mg) | 51-56-9 |
| 1311000 | Homatropine Methylbromide (250 mg) | 80-49-9 |
| 1311306 | Homopolymer Polypropylene (3 Strips) | 9003-07-0 |
| 1311408 | Homosalate (500 mg) | 118-56-9 |
| 1311500 | Coagulation Factor VIIa (2 x 1.15 mg) (Eptacog Alfa (Activated)) | 102786-61-8 |
| 1311518 | Coagulation Factor VIIa For Bioassay | 102786-61-8 |
| 1311714 | rHuman Interleukin 4 (51 micrograms) (recombinant interleukin 4, human) (COLD SHIPMENT REQUIRED) | N/A |
| 1313006 | Hydralazine Hydrochloride (200 mg) | 304-20-1 |
| 1313210 | Hydrastine (10 mg) | 118-08-1 |
| 1314009 | Hydrochlorothiazide (200 mg) | 58-93-5 |
| 1314960 | Hydrocodone CII (125 mg) | 125-29-1 |
| 1315001 | Hydrocodone Bitartrate CII (100 mg) | 34195-34-1 |
| 1315012 | Hydrocodone Related Compound A CII (70 mg) (4-hydroxy-3-methoxy-17-methylmorphinan-6-one) | 847-86-9 |
| 1316004 | Hydrocortisone (200 mg) | 50-23-7 |
| 1317007 | Hydrocortisone Acetate (200 mg) | 50-03-3 |
| 1317302 | Hydrocortisone Butyrate (200 mg) | 13609-67-1 |
| 1319002 | Hydrocortisone Hemisuccinate (200 mg) | 83784-20-7 |
| 1320001 | Hydrocortisone Phosphate Triethylamine (200 mg) | N/A |
| 1321004 | Hydrocortisone Valerate (200 mg) | 57524-89-7 |
| 1322007 | Hydroflumethiazide (200 mg) | 135-09-1 |
| 1323000 | Hydromorphone Hydrochloride CII (50 mg) | 71-68-1 |
| 1323019 | Hydromorphone N-Oxide Hydrochloride CII (15 mg) (4,5alpha-Epoxy-3-hydroxy-17-methylmorphinan-6-one N-oxide, hydrochloride) | 109648-80-8 (base) |
| 1323021 | Hydromorphone Related Compound A CII (10 mg) (7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methylmorphinan-6-one perchlorate) | 91265-67-7 |
| 1324002 | Hydroquinone (500 mg) | 123-31-9 |
| 1324308 | Hydroxocobalamin Acetate (150 mg) | 22465-48-1 |
| 1324319 | Hydroxocobalamin Chloride (3 x 150 mg) | 58288-50-9 |
| 1325005 | Hydroxyamphetamine Hydrobromide (200 mg) | 306-21-8 |
| 1327000 | Hydroxychloroquine Sulfate (200 mg) | 747-36-4 |
| 1327319 | 4-Hydroxyisoleucine (35 mg) | 781658-23-9 |
| 1327408 | 6-Hydroxynicotinic Acid (50 mg) | 5006-66-6 |
| 1329006 | Hydroxyprogesterone Caproate (200 mg) | 630-56-8 |
| 1329505 | Propantheline Bromide Related Compound A (50 mg) (9-Hydroxypropantheline Bromide) | N/A |
| 1329709 | Hydroxypropyl Betadex (200 mg) | 128446-35-5 |
| 1329800 | Hydroxypropyl Cellulose (500 mg) | 9004-64-2 |
| 1329822 | Low-substituted Hydroxypropyl Cellulose (100 mg) | 9004-64-2 |
| 1329913 | 5-Hydroxy-L-tryptophan (100 mg) | 4350-09-8 |
| 1330005 | Hypromellose (250 mg) (Hydroxypropyl Methylcellulose) | 9004-65-3 |
| 1331008 | 12-Hydroxystearic Acid (200 mg) | 106-14-9 |
| 1332000 | Hydroxyurea (200 mg) | 127-07-1 |
| 1333003 | Hydroxyzine Hydrochloride (500 mg) | 2192-20-3 |
| 1333058 | Hydroxyzine Related Compound A (25 mg) (1-[(4-Chlorophenyl)phenylmethyl]piperazine) | 303-26-4 |
| 1334006 | Hydroxyzine Pamoate (500 mg) | 10246-75-0 |
| 1335009 | Hyoscyamine Sulfate (125 mg) | 6835-16-1 |
| 1335010 | Hyoscyamine Related Compound A (10 mg) (Norhyoscyamine Sulfate) | 537-29-1 |
| 1335202 | Hyperoside (50 mg) | 482-36-0 |
| 1335279 | Hypromellose Acetate Succinate (100 mg) | 71138-97-1 |
| 1335304 | Hypromellose Phthalate (100 mg) | 9050-31-1 |
| 1335417 | Ibandronate Sodium (200 mg) | 138926-19-9 |
| 1335428 | Ibandronate Related Compound A (25 mg) (3-[Methyl(pentyl)amino]propanoic acid hydrochloride) | 625120-81-2 |
| 1335508 | Ibuprofen (750 mg) | 15687-27-1 |
| 1335541 | Ibuprofen Related Compound C (0.2 mL/ampule; 3 ampules) (4-isobutylacetophenone) | 38861-78-8 |
| 1335596 | Ibuprofen Related Compound J (25 mg) (2-(4-Isobutyrylphenyl)propanoic acid) | 65813-55-0 |
| 1335610 | Ibutilide Fumarate (100 mg) | 122647-32-9 |
| 1335621 | Ibutilide Related Compound A (20 mg) (N-Ethyl-N-heptyl-4-[4-(methylsulfonamido)phenyl]-4-oxobutanamide) | 100632-58-4 |
| 1335632 | Ibutilide Related Compound B (20 mg) (N-Ethyl-N-heptyl-4-hydroxy-4-[4-(methylsulfonamido)phenyl]butanamide) | 160087-98-9 |
| 1335701 | Idarubicin Hydrochloride (50 mg) | 57852-57-0 |
| 1336001 | Idoxuridine (250 mg) | 54-42-2 |
| 1336205 | Ifosfamide (500 mg) | 3778-73-2 |
| 1336249 | Iloperidone (200 mg) | 133454-47-4 |
| 1336250 | Iloperidone Related Compound A (20 mg) ([4′-(3-Chloropropoxy)-3′-methoxy]acetophenone) | 58113-30-7 |
| 1336500 | Imidazole (200 mg) | 288-32-4 |
| 1336806 | Imidurea (200 mg) | 39236-46-9 |
| 1337004 | Iminodibenzyl (25 mg) | 494-19-9 |
| 1337809 | Imipenem Monohydrate (100 mg) | 74431-23-5 |
| 1338007 | Imipramine Hydrochloride (200 mg) | 113-52-0 |
| 1338313 | Imiquimod (200 mg) | 99011-02-6 |
| 1338324 | Imiquimod Related Compound A (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline) | 99010-24-9 |
| 1338335 | Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide) | 99010-63-6 |
| 1338346 | Imiquimod Related Compound C (25 mg) (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline) | 99010-64-7 |
| 1338357 | Imiquimod Related Compound D (25 mg) (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine) | 853792-81-1 |
| 1338368 | Imiquimod Related Compound E (25 mg) (N4-Isobutylquinoline-3,4-diamine) | 99010-09-0 |
| 1338481 | Imipramine Pamoate (300 mg) | 10075-24-8 |
| 1338801 | Indapamide (500 mg) | 26807-65-8 |
| 1338812 | Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide) | 63968-75-2 |
| 1338845 | Indapamide Related Compound D | 85440-79-5 |
| 1339000 | Indigotindisulfonate Sodium (750 mg) | 860-22-0 |
| 1339178 | Indinavir (100 mg) | 180683-37-8 |
| 1339189 | Indinavir System Suitability (100 mg) | 180683-37-8 |
| 1340009 | Indocyanine Green (250 mg) | 3599-32-4 |
| 1340960 | Inositol (500 mg) | 87-89-8 |
| 1341001 | Indomethacin (200 mg) | 53-86-1 |
| 1342037 | Insulin Aspart (7.62 mg) (COLD SHIPMENT REQUIRED) | 116094-23-6 |
| 1342059 | Insulin Glargine (15.06 mg) (COLD SHIPMENT REQUIRED) | 160337-95-1 |
| 1342060 | Insulin Glargine for Peak Identification (3.2 mg) (Mixture of Insulin Glargine and 0A-Arg-Insulin Glargine) (COLD SHIPMENT REQUIRED) | N/A |
| 1342106 | Insulin Human (100 mg) (COLD SHIPMENT REQUIRED) | 11061-68-0 |
| 1342150 | High Molecular Weight Insulin Human (8.4 mg) (COLD SHIPMENT REQUIRED) | 11061-68-0 |
| 1342208 | Insulin (Beef) (50 mg) (COLD SHIPMENT REQUIRED) | 11070-73-8 |
| 1342300 | Insulin Pork (50 mg) (COLD SHIPMENT REQUIRED) | 12584-58-6 |
| 1342321 | Insulin Lispro (5.73 mg) (COLD SHIPMENT REQUIRED) | 133107-64-9 |
| 1342401 | Interferon Beta-1A | 145258-61-3 |
| 1342412 | Interferon Beta-1A for Bioidentity | 145258-61-3 |
| 1343007 | Iodipamide (200 mg) | 606-17-7 |
| 1343517 | Iodixanol (200 mg) | 92339-11-2 |
| 1343540 | Iodixanol Related Compound C (25 mg) (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N’-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | N/A |
| 1343550 | Iodixanol Related Compound D (50 mg) (5-[acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 89797-00-2 |
| 1343561 | Iodixanol Related Compound E (25 mg) (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) | 255376-57-9 |
| 1344305 | o-Iodohippuric Acid (100 mg) | 147-58-0 |
| 1344509 | Iodoquinol (100 mg) | 83-73-8 |
| 1344600 | Iohexol (200 mg) | 66108-95-0 |
| 1344622 | Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 31127-80-7 |
| 1344644 | Iohexol Related Compound B (50 mg) (5-amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) | 76801-93-9 |
| 1344666 | Iohexol Related Compound C (50 mg) (N,N’-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide) | N/A |
| 1344702 | Iopamidol (200 mg) | 60166-93-0 |
| 1344724 | Iopamidol Related Compound A (50 mg) (N,N’-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoiso-phthalamide) | 60166-98-5 |
| 1344735 | Iopamidol Related Compound B (50 mg) (5-Glycolamido-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide) | N/A |
| 1344746 | Iopamidol Related Compound C (40 mg) (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide) | N/A |
| 1344804 | Iopromide (400 mg) | 73334-07-3 |
| 1344826 | Iopromide Related Compound A (50 mg) (5-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) | N/A |
| 1344837 | Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) | N/A |
| 1345002 | Iothalamic Acid (200 mg) | 2276-90-6 |
| 1345104 | Ioversol (200 mg) | 87771-40-2 |
| 1345115 | Ioversol Related Compound A (50 mg) (5-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) | 76801-93-9 |
| 1345126 | Ioversol Related Compound B (50 mg) (N,N’-bis(2,3-dihydroxypropyl)-5-[(N-(2-hydroxyethyl)-carbamoyl)methoxy]-2,4,6-triiodoisophthalamide) | N/A |
| 1345159 | Ioxaglic Acid (100 mg) | 59017-64-0 |
| 1345206 | Ioxilan (400 mg) | 107793-72-6 |
| 1345228 | Ioxilan Related Compound A (100 mg) (5-amino-2,4,6-triiodo-3 N-(2-hydroxyethyl)carbamoyl benzoic acid) | 22871-58-5 |
| 1347507 | Ipratropium Bromide (200 mg) | 66985-17-9 |
| 1347518 | Ipratropium Bromide Related Compound A (10 mg) ((1R,3r,5S,8r)-3-Hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) | 58005-18-8 |
| 1347529 | Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) | 58073-59-9 |
| 1347530 | Ipratropium Bromide Related Compound C (15 mg) ((2-RS)-3-hydroxy-2-phenylpropanoic acid) | 552-63-6 |
| 1347609 | Irinotecan Hydrochloride (100 mg) | 136572-09-3 |
| 1347610 | Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 19685-09-7 |
| 1347631 | Irinotecan Related Compound B (10 mg) ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 86639-52-3 |
| 1347642 | Irinotecan Related Compound C (10 mg) (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-9-yl (1,4′-bipiperidine)- 1′-carboxylate hydrochloride) | N/A |
| 1347653 | Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate) | N/A |
| 1347664 | Irinotecan Related Compound E (15 mg) ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 78287-27-1 |
| 1347700 | Irbesartan (200 mg) | 138402-11-6 |
| 1347711 | Irbesartan Related Compound A (25 mg) (1-pentanoylamino-cyclopentanecarboxylic acid [2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) | 748812-53-5 |
| 1347755 | Amiloxate (Isoamyl Methoxycinnamate) (750 mg/ampule) | 71617-10-2 |
| 1347802 | Isobutyl acetate (1.2 mL/ampule; 3 ampules) | 110-19-0 |
| 1347813 | Isobutylidene Diurea (300 mg) (1,1′-(2-Methylpropane-1,1-diyl)diurea) | 6104-30-9 |
| 1347824 | Isobutyl Heptanoate (5 x 0.5 mL) | 7779-80-8 |
| 1347835 | Isobutyl Isobutyrate (5 x 0.5 mL) | 97-85-8 |
| 1347880 | Isobutyraldehyde (3 x 1.2 mL) | 78-84-2 |
| 1348000 | Isocarboxazid (200 mg) | 59-63-2 |
| 1348500 | Isoetharine Hydrochloride (250 mg) | 2576-92-3 |
| 1348601 | Red Clover Aerial Parts Isoflavone Aglycones Dry Extract | N/A |
| 1348907 | Isoflupredone Acetate (200 mg) | 338-98-7 |
| 1349003 | Isoflurane (1 mL) | 26675-46-7 |
| 1349014 | Isoflurane Related Compound A (0.1 mL) (1-chloro-2,2,2-trifluoroethyl chlorodifluoromethyl ether) | 32778-08-8 |
| 1349025 | Isoflurane Related Compound B (0.1 mL) (2,2,2-trifluoroethyldifluoromethyl ether) | 1885-48-9 |
| 1349502 | L-Isoleucine (200 mg) | 73-32-5 |
| 1349604 | Isomalathion (50 mg) | 3344-12-5 |
| 1349626 | Isomalt (200 mg) | 64519-82-0 |
| 1349637 | Isomaltulose (5 g) | 58024-13-8 |
| 1349659 | Isometheptene Mucate (200 mg) | 7492-31-1 |
| 1349670 | Isonaringin (30 mg) ((RS)-5-Hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | 108815-81-2 |
| 1349706 | Isoniazid (200 mg) | 54-85-3 |
| 1350002 | Isopropamide Iodide (200 mg) | 71-81-8 |
| 1350104 | Isopropyl Acetate (1.2 mL/ampule; 3 ampules) | 108-21-4 |
| 1350352 | Isopropyl Isostearate (3 x 1 mL) | 68171-33-5 |
| 1350400 | Isopropyl Myristate (5 x 100 mg) | 110-27-0 |
| 1350603 | Isopropyl Palmitate (500 mg) | 142-91-6 |
| 1351005 | Isoproterenol Hydrochloride (125 mg) | 51-30-9 |
| 1351107 | Isopteropodine (20 mg) | 5171-37-9 |
| 1351800 | Isorhamnetin (30 mg) | 480-19-3 |
| 1352008 | Isosorbide (75% solution, 1 g) | 652-67-5 |
| 1353000 | Diluted Isosorbide Dinitrate (500 mg of 25% mixture with lactose) | 87-33-2 |
| 1353102 | Diluted Isosorbide Mononitrate (750 mg) | 16051-77-7 |
| 1353113 | Diluted Isosorbide Mononitrate Related Compound A (150 mg) (1,4:3,6-Dianhydro-D-glucitol 2-nitrate in lactose) | 16106-20-0 |
| 1353157 | Isostearyl Isostearate (1 mL) | 41669-30-1 |
| 1353215 | Terbinafine Related Compound C (25 mg) ((2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride) | 877265-30-0 |
| 1353500 | Isotretinoin (200 mg) | 4759-48-2 |
| 1354003 | Isoxsuprine Hydrochloride (200 mg) | 579-56-6 |
| 1354207 | Isradipine (200 mg) | 75695-93-1 |
| 1354218 | Isradipine Related Compound A (15 mg) (Isopropyl methyl 4-(4-benzofurazanyl)-2,6-dimethyl-3,5-pyridinedicarboxylate) | N/A |
| 1354251 | Itraconazole (100 mg) | 84625-61-6 |
| 1354262 | Itraconazole System Suitability Mixture (25 mg) | N/A |
| 1354309 | Ivermectin (200 mg) | 70288-86-7 |
| 1354400 | Ixabepilone (100 mg) | 219989-84-1 |
| 1354411 | Ixabepilone System Suitability Mixture (10 mg) | N/A |
| 1354852 | KDN (100 mg) (3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid) | 22594-61-2 |
| 1354900 | Kaempferol (15 mg) | 520-18-3 |
| 1354954 | Kaempferol-3-O-Robinoside-7-O-Glucoside (100 mg) (7-Beta-D-Glucopyranosyloxy-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-Lmannopyranosyl)-Beta-D-galactopyranoside) | 114924-89-9 |
| 1355006 | Kanamycin Sulfate (200 mg) | 5965-95-7 |
| 1355709 | Powdered Kava Extract (1 g) | N/A |
| 1355753 | Kawain (200 mg) | 500-64-1 |
| 1356009 | Ketamine Hydrochloride CIII (250 mg) | 1867-66-9 |
| 1356020 | Ketamine Related Compound A (50 mg) (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol) | 6740-87-0 |
| 1356315 | Ketorolac Related Compound A (20 mg) (5-benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide) | 167105-80-8 |
| 1356326 | Ketorolac Related Compound B (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol) | 154476-25-2 |
| 1356337 | Ketorolac Related Compound C (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one) | 113502-52-6 |
| 1356348 | Ketorolac Related Compound D (20 mg) (5-benzoyl-2,3-dihydro-1H-pyrrolizine) | 113502-55-9 |
| 1356508 | Ketoconazole (200 mg) | 65277-42-1 |
| 1356552 | Ketoprofen Related Compound C (20 mg) (2-(3-carboxyphenyl)propionic acid) | 68432-95-1 |
| 1356563 | Ketoprofen Related Compound D (20 mg) (3-acetylbenzophenone) | 66067-44-5 |
| 1356585 | Ketoprofen Related Compound F (20 mg) (3-(1-Cyanoethyl)benzophenone) | 42872-30-0 |
| 1356599 | Krill Oil (2 g) | 8016-13-5 |
| 1356632 | Ketoprofen (200 mg) | 22071-15-4 |
| 1356643 | Ketoprofen Related Compound A (25 mg) (alpha-methyl-3-(4-methylbenzoyl) benzeneacetic acid) | 107257-20-5 |
| 1356654 | Labetalol Hydrochloride (200 mg) | 32780-64-6 |
| 1356665 | Ketorolac Tromethamine (200 mg) | 74103-07-4 |
| 1356676 | Anhydrous Lactose (100 mg) (Mixture of alpha and beta anomers) | 63-42-3 |
| 1356687 | Lactitol (500 mg) | 81025-04-9 |
| 1356698 | Lactase (200 mg) (COLD SHIPMENT REQUIRED) | 9031-11-2 |
| 1356701 | Lactose Monohydrate (500 mg) | 10039-26-6 |
| 1356734 | Lactic Acid (1.5 mL/ampule; 3 ampules) | 50-21-5 |
| 1356756 | Lamotrigine (150 mg) | 84057-84-1 |
| 1356778 | Lamotrigine Related Compound B (20 mg) (2,3-dichlorobenzoic acid) | 50-45-3 |
| 1356789 | Lamotrigine Related Compound C (10 mg) (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one) | 252186-78-0 |
| 1356790 | Lamotrigine Related Compound D (10 mg) (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide) | 252186-79-1 |
| 1356803 | Lactulose (1 g) | 4618-18-2 |
| 1356825 | Lactobionic Acid (200 mg) | 96-82-2 (acid form); |
| 5965-65- | ||
| 1356836 | Lamivudine (200 mg) | 134678-17-4 |
| 1356847 | Lamivudine Resolution Mixture A (10 mg) | N/A |
| 1356858 | Lamivudine Resolution Mixture B (10 mg) | N/A |
| 1356869 | Lamivudine Resolution Mixture C (0.8 mg) | N/A |
| 1356871 | Hydrogenated Lanolin (200 mg) | N/A |
| 1356880 | Lanolin (20 g) | 8006-54-0 |
| 1356891 | Lauryl Alcohol (125 mg) | 112-53-8 |
| 1356905 | Lanolin Alcohols (5 g) | 8027-33-6 |
| 1356916 | Lansoprazole (150 mg) | 103577-45-3 |
| 1356927 | Lansoprazole Related Compound A (25 mg) (2-({[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfonyl)benzimidazole) | 131926-99-3 |
| 1356931 | Lansoprazole Related Compound B (25 mg) (2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate) | 1288338-69-1 |
| 1356945 | Lauroyl Arginine (100 mg) (dodecanoylarginine hydrochloride) | N/A |
| 1356949 | Lauric Acid (500 mg) | 143-07-7 |
| 1356950 | Lauroyl Polyoxylglycerides (500 mg) | N/A |
| 1356960 | Leflunomide (200 mg) | 75706-12-6 |
| 1356971 | Letrozole (200 mg) | 112809-51-5 |
| 1356982 | Letrozole Related Compound A (25 mg) (4,4′-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile) | N/A |
| 1357001 | L-Leucine (200 mg) | 61-90-5 |
| 1357045 | Leflunomide Related Compound A (100 mg) (4-(trifluoromethyl)aniline) | 455-14-1 |
| 1357056 | Leflunomide Related Compound B (20 mg) (2-Cyano-3-hydroxy-N-(4′-trifluoromethylphenyl)-crotone amide) | 108605-62-5 |
| 1357067 | Leflunomide Related Compound C (10 mg) (N-(3′-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide) | 61643-23-0 |
| 1357227 | Lamivudine Related Compound A (25 mg) ((2RS,5R)-5-(Cytosine-1-yl)-1,3-oxathiolane-2-carboxylic acid) | N/A |
| 1357475 | Latanoprost (50 mg) | 130209-82-4 |
| 1357486 | Latanoprost Related Compound A (50 mg) (Isopropyl (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) | 913258-34-1 |
| 1357497 | Latanoprost Related Compound B (25 mg) (Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoate) | 145773-22-4 |
| 1357522 | Latanoprost Related Compound D (25 mg) (Isopropyl (Z)-7-{(1R,2R,3R,5S)-2-[(R)-5-phenyl-3-(triethylsilyloxy)pentyl]-3,5-bis(triethylsilyloxy)cyclopentyl}hept-5-enoate) | 477884-78-9 |
| 1357533 | Latanoprost Related Compound E (25 mg) ((Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}-5-heptenoic acid) | 41639-83-2 |
| 1358004 | Leucovorin Calcium (500 mg) | 1492-18-8 |
| 1358503 | Leuprolide Acetate (200 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 74381-53-6 |
| 1358784 | Levalbuterol Hydrochloride (200 mg) | 50293-90-8 |
| 1358795 | Levalbuterol Related Compound A (30 mg) (4-(2-tert-butylamino-ethyl)-2-hydroxymethyl-phenol) | N/A |
| 1358809 | Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) | 18910-68-4 |
| 1358810 | Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) | 18910-70-8 |
| 1358820 | Levalbuterol Related Compound D (30 mg) (5-[2-{(1,1-dimethylethyl)amino}-1-hydroxyethyl]-2-hydroxy-benzaldehyde sulfate (2:1)) | 156339-88-7 |
| (freebase) | ||
| 1358831 | Levalbuterol Related Compound E (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-3-(ethoxy-methyl)-4-hydroxy-benzenemethanol) | 754926-25-5 |
| 1358842 | Levalbuterol Related Compound F (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl}-4-(phenylmethoxy)-1,3-benzenedimethanol) | 174607-68-2 |
| 1358864 | Levalbuterol Related Compound H (10 mg) (4-[2-(tert-butylamino)-1-methoxyethyl]-2-(hydroxymethyl)phenol acetate) | N/A |
| 1359302 | Levamisole Hydrochloride (125 mg) | 16595-80-5 |
| 1359404 | Levetiracetam (200 mg) | 102767-28-2 |
| 1359415 | Levetiracetam Racemic Mixture (15 mg) (1:1 mixture of levetiracetam S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide) | 33996-58-6 |
| 1359426 | Levetiracetam Related Compound A (20 mg) ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide) | 102767-31-7 |
| 1359437 | Levetiracetam Related Compound B (20 mg) ((S)-2-aminobutanamide hydrochloride) | 7682-20-4 |
| 1359506 | Levmetamfetamine CII (75 mg) | 33817-09-3 |
| 1359801 | Levobunolol Hydrochloride (200 mg) | 27912-14-7 |
| 1359856 | Levocabastine Hydrochloride (50 mg) | 79547-78-7 |
| 1359867 | Levocabastine Related Compound A (50 mg) (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride) | 80139-91-9 |
| 1359903 | Levocarnitine (400 mg) | 541-15-1 |
| 1359925 | Levocarnitine Related Compound A (100 mg) (2-propen-1-aminium, 3-carboxy-N,N,N-trimethyl-, chloride) | 6538-82-5 |
| 1359958 | Levocetirizine Amide (75 mg) | 909779-33-5 |
| 1359969 | Levocetirizine Dihydrochloride (200 mg) | 130018-87-0 |
| 1361009 | Levodopa (200 mg) | 59-92-7 |
| 1361010 | Levodopa Related Compound A (50 mg) ((3-(2,4,5-Trihydroxyphenyl)-L-alanine) or (3-(3,4,6-Trihydroxyphenyl)alanine)) | 27244-64-0 |
| 1362103 | Levofloxacin (200 mg) | 138199-71-0 |
| 1362114 | Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | 117707-40-1 |
| 1362125 | Levofloxacin Related Compound B (35 mg) ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | 100986-89-8 |
| 1362136 | Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate) | 177472-30-9 |
| 1362158 | Levofloxacin Related Compound E (25 mg) ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride) | 1346603-62-0 |
| 1362169 | Levofloxacin Related Compound F (25 mg) ((S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | 117620-85-6 |
| 1362307 | Levomenol (100 mg) | 23089-26-1 |
| 1362359 | Levomethorphan Solution (3 x 1.2 mL) (0.1 mg/mL 3-Methoxy-17-methylmorphinan in methanol) | 125-70-2 |
| 1362500 | Levonordefrin (200 mg) | 829-74-3 |
| 1362602 | Levonorgestrel (125 mg) | 797-63-7 |
| 1364007 | Levorphanol Tartrate CII (500 mg) | 5985-38-6 |
| 1365000 | Levothyroxine (500 mg) | 51-48-9 |
| 1365021 | Levothyroxine for Peak Identification (15 mg) (levothyroxine sodium spiked with liothyronine, triiodothyroacetic acid, tetraiodothyroacetic acid) | N/A |
| 1365065 | Levothyroxine Sodium (50 mg) | 25416-65-3 (hydrate) |
| 1366002 | Lidocaine (250 mg) | 137-58-6 |
| 1366013 | Lidocaine Hydrochloride (150 mg) | 6108-05-0 |
| 1366080 | Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) | 1131-01-7 |
| 1367005 | Lincomycin Hydrochloride (200 mg) | 7179-49-9 |
| 1367504 | Lindane (200 mg) | 58-89-9 |
| 1367561 | Linezolid (200 mg) | 165800-03-3 |
| 1367570 | Linezolid Related Compound A (20 mg) ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | N/A |
| 1367581 | Linezolid Related Compound B (20 mg) ((S)-N-{[3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide) | 216868-57-4 |
| 1367592 | Linezolid Related Compound C (20 mg) ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | 168828-90-8 |
| 1367606 | Linezolid Related Compound D (20 mg) ((R)-[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl methanesulfonate) | N/A |
| 1367639 | Linezolid R-Isomer (20 mg) (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide) | N/A |
| 1367647 | Linoleyl Alcohol (5 X 30 mg) | 506-43-4 |
| 1367676 | Conjugated Linoleic Acids – Free Fatty Acid (3 x 100 mg) | N/A |
| 1367699 | Linolenyl Alcohol (5 x 30 mg) | 506-44-5 |
| 1367708 | Linoleoyl Polyoxylglycerides (100 mg) | N/A |
| 1368008 | Liothyronine (250 mg) | 6893-02-3 |
| 1368201 | Alpha Lipoic Acid (500 mg) | 1077-28-7 |
| 1368609 | Lisinopril (300 mg) | 83915-83-7 |
| 1368610 | Lisinopril Related Compound A (250 mg) ((S)-2-{(3S,8aS)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-alpha]pyrazin-2(1H)-yl}-4-phenylbutanoic acid) | 328385-86-0 |
| 1369000 | Lithium Carbonate (300 mg) | 554-13-2 |
| 1369055 | Lithol Rubine BK (100 mg) (2-Naphthalenecarboxylic acid, 3-hydroxy-4-[(E)-2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1)) | 5281-04-9 |
| 1369419 | Lomustine (200 mg) | 13010-47-4 |
| 1369431 | Lomustine Related Compound B (25 mg) (1-(2-Chloroethyl)-3-cyclohexylurea) | 08-11-7 |
| 1369442 | Lomustine Related Compound C (25 mg) (1,3-Dicyclohexylurea) | 2387-23-7 |
| 1369453 | Lomustine Related Compound D (25 mg) (3-(2-Chloroethyl)-1-cyclohexyl-1-nitrosourea) | 54749-91-6 |
| 1369689 | Lonicera Japonica Flower Dry Extract (500 mg) | N/A |
| 1369703 | Lonicera Macranthoides Flower Dry Extract (500 mg) (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B) | N/A |
| 1370000 | Loperamide Hydrochloride (200 mg) | 34552-83-5 |
| 1370065 | Loperamide Related Compound F (25 mg) (1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine 1-oxide hydrate) | 106900-12-3 |
| 1370101 | Lopinavir (350 mg) | 192725-17-0 |
| 1370156 | Lopinavir System Suitability Mixture (10 mg) | N/A |
| 1370203 | Loracarbef (200 mg) | 121961-22-6 |
| 1370225 | Loracarbef L-Isomer (25 mg) | N/A |
| 1370269 | Loratadine Related Compound C (15 mg) (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one) | 31251-41-9 |
| 1370270 | Loratadine (200 mg) | 79794-75-5 |
| 1370280 | Loratadine Related Compound A (15 mg) (8-chloro-6,11-dihydro-11(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b] pyridine) | 100643-71-8 |
| 1370291 | Loratadine Related Compound B (15 mg) (8-Chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine) | N/A |
| 1370305 | Lorazepam CIV (200 mg) | 846-49-1 |
| 1370327 | Lorazepam Related Compound A (25 mg) (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one) | 2848-96-6 |
| 1370338 | Lorazepam Related Compound B (25 mg) (2-Amino-2′,5-dichlorobenzophenone) | 2958-36-3 |
| 1370349 | Lorazepam Related Compound C (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxaldehyde) | 93955-15-8 |
| 1370350 | Lorazepam Related Compound D (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid) | 54643-79-7 |
| 1370360 | Lorazepam Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol) | N/A |
| 1370462 | Losartan Potassium (150 mg) | 124750-99-8 |
| 1370473 | Losartan Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) | 83857-96-9 |
| 1370484 | Losartan Related Compound B (20 mg) (2-Butyl-4-chloro-(1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate) | 1006062-27-6 |
| 1370495 | Losartan Related Compound C (20 mg) (2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde) | 114798-36-6 |
| 1370509 | Losartan Related Compound D (20 mg) (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | N/A |
| 1370510 | Losartan Related Compound E (20 mg) (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt) | N/A |
| 1370600 | Lovastatin (125 mg) | 75330-75-5 |
| 1370611 | Lovastatin Related Compound A (20 mg) (4,4a-Dihydrolovastatin) | N/A |
| 1370655 | Lovastatin Impurity Identification Mixture (30 mg) | N/A |
| 1370702 | Loxapine Succinate (125 mg) | 27833-64-3 |
| 1370713 | Loxapine Related Compound A (20 mg) (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) | 3454-96-4 |
| 1370724 | Lufenuron Related Compound B (15 mg) (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) | N/A |
| 1370735 | Lufenuron Related Compound C (15 mg) (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) | N/A |
| 1370746 | Lumefantrine (100 mg) | 82186-77-4 |
| 1370757 | Lumefantrine Related Compound A (25 mg) ((RS, Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol) | N/A |
| 1370779 | Lufenuron (200 mg) | 103055-07-8 |
| 1370780 | Lufenuron Related Compound G (15 mg) (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate) | N/A |
| 1370804 | Lutein (3 X 50 mg) | 127-40-2 |
| 1370837 | Luteolin 7-O-Glucoside (30 mg) (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside) | 5373-11-5 |
| 1370860 | Lycopene (500 mg) | N/A |
| 1370906 | Lynestrenol (20 mg) | 52-76-6 |
| 1371501 | L-Lysine monoacetate (200 mg) | 57282-49-2 |
| 1372005 | L-Lysine Hydrochloride (200 mg) | 657-27-2 |
| 1372050 | Lysophosphatidylcholine (250 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 9008-30-4 |
| 1372061 | Lysophosphatidylcholine (Soy) (40 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 9008-30-4 |
| 1372333 | Polyallylamine Hydrochloride (200 mg) (2-propen-1-amine hydrochloride, homopolymer) | 71550-12-4 |
| 1372344 | Polyamide 6 (1 g) | 25038-54-4 |
| 1372402 | Polyoxyl Lauryl Ether (500 mg) | 9002-92-0 |
| 1372424 | Polyoxyl 4 Lauryl Ether (1 mL) | 5274-68-0 |
| 1372468 | Polyoxyl 23 Lauryl Ether (0.5 g) | 9002-92-0 |
| 1372504 | Polyoxyl Oleate (500 mg) | 9004-96-0 |
| 1372606 | Polyoxyl 10 Stearyl Ether (1 g) | 9005-00-9 |
| 1373008 | Mafenide Acetate (200 mg) | 13009-99-9 |
| 1374000 | Magaldrate (200 mg) | 74978-16-8 |
| 1374226 | Magnesium Carbonate (2 g) (AS) | 546-93-0 |
| 1374248 | Magnesium Chloride (1 g) (AS) | 7791-18-6 |
| 1374260 | Magnesium Hydroxide (1 g) (AS) | 1309-42-8 |
| 1374292 | Magnesium Phosphate (2 g) (AS) | 7757-87-1 |
| 1374306 | Magnesium Salicylate (200 mg) | 18917-95-8 |
| 1374340 | Magnesium Stearate (5 g) (Mixture of magnesium stearate and magnesium palmitate) | N/A |
| 1374361 | Magnesium Sulfate (1 g) (Magnesium Sulfate (1:1) heptahydrate) | 10034-99-8 |
| 1374383 | Powdered Malabar-Nut-Tree, Leaf Extract (1 g) | N/A |
| 1374408 | Malathion (500 mg) | 121-75-5 |
| 1374500 | Maleic Acid (300 mg) | 110-16-7 |
| 1374601 | Malic Acid (500 mg) | 6915-15-7 |
| 1374907 | Maltitol (200 mg) | 585-88-6 |
| 1375003 | Maltol (500 mg) | 118-71-8 |
| 1375025 | Maltose Monohydrate (500 mg) | 6363-53-7 |
| 1375047 | Maltotriose (500 mg) | 113158-51-3 |
| 1375058 | Mandelic Acid (500 mg) | 90-64-2 |
| 1375069 | Mangafodipir Trisodium (300 mg) | 140678-14-4 |
| 1375070 | Mangafodipir Related Compound A (15 mg) (manganese (II) dipyridoxyl monophosphate sodium salt) | N/A |
| 1375080 | Mangafodipir Related Compound B (15 mg) (manganese (II) dipyridoxyl diphosphate mono-overalkylated sodium salt) | N/A |
| 1375091 | Mangafodipir Related Compound C (15 mg) (manganese (III) dipyridoxyl diphosphate sodium salt) | N/A |
| 1375105 | Mannitol (1.5 g) | 69-65-8 |
| 1375127 | Manganese Chloride (2 g) (RS) | 13446-34-9 |
| 1375149 | Manganese Sulfate (1 g) (AS) | 10034-96-5 |
| 1375160 | Mannosamine Hydrochloride (300 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1375182 | Mannose (500 mg) | 3458-28-4 |
| 1375207 | Maprotiline Hydrochloride (200 mg) | 10347-81-6 |
| 1375241 | Maprotiline Related Compound D (15 mg) (3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2-en-1-amine, hydrochloride) | 38849-14-8 |
| 1375309 | Mazindol CIV (350 mg) | 22232-71-9 |
| 1375502 | Mebendazole (200 mg) | 31431-39-7 |
| 1375524 | Mebendazole Related Compound D (15 mg) (Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate) | 132119-11-0 |
| 1375706 | Mebrofenin (100 mg) | 78266-06-5 |
| 1376006 | Mecamylamine Hydrochloride (200 mg) | 826-39-1 |
| 1376017 | Mecamylamine Related Compound A (10 mg) (N,1,7,7-tetramethyl bicyclo [2.2.1] heptan-2-amine hydrochloride) | 22321-23-9 |
| 1376505 | Mechlorethamine Hydrochloride (100 mg) (International Restricted Sales Item) | 55-86-7 |
| 1377009 | Meclizine Hydrochloride (500 mg) | 31884-77-2 |
| 1377010 | Meclizine Related Compound A (15 mg) (4-chlorobenzhydrol) | N/A |
| 1377029 | Meclizine Related Compound B (15 mg) (1-[(4-Chlorophenyl)(phenyl)methyl]-4-(2-methylbenzyl)piperazine dihydrochloride monohydrate) | 31884-77-2 |
| 1377508 | Meclocycline Sulfosalicylate (300 mg) | 73816-42-9 |
| 1377803 | Meclofenamate Sodium (500 mg) | 6385-02-0 |
| 1378001 | Medroxyprogesterone Acetate (200 mg) | 71-58-9 |
| 1378012 | Medroxyprogesterone Acetate Related Compound A (25 mg) (6alpha-Methyl-3,20-dioxopregnan-17-yl acetate) | N/A |
| 1378023 | Medroxyprogesterone Acetate Related Compound B (25 mg) (17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione) | 520-85-4 |
| 1379059 | Mefloquine Hydrochloride (100 mg) | 51773-92-3 |
| 1379060 | Mefloquine Related Compound A (20 mg) (threo-mefloquine) | N/A |
| 1379081 | Calcium D,L-5-Methyltetrahydrofolate (300 mg) | 26560-38-3 |
| 1379106 | Megestrol Acetate (250 mg) | 595-33-5 |
| 1379128 | Megestrol Acetate Related Compound C (20 mg) (6,17a-beta-Dimethyl-3,17-dioxo-17a-homoandrosta-4,6-diene-17a-alpha-yl acetate) | 74910-22-8 |
| 1379139 | Megestrol Acetate Related Compound D (20 mg) (6-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | 32634-95-0 |
| 1379140 | Meglumine (500 mg) (AS) | 6284-40-8 |
| 1379172 | Megestrol Acetate Related Compound H (20 mg) | 907193-65-1 |
| 1379183 | Melamine (250 mg) (2,4,6-Triamino-1,3,5-triazine) | 108-78-1 |
| 1379254 | Melengestrol Acetate (125 mg) | 2919-66-6 |
| 1379265 | Melengestrol Acetate Related Compound A (25 mg) (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | 6815-51-6 |
| 1379276 | Melengestrol Acetate Related Compound B (25 mg) (6,16-dimethylene-17-hydroxypregna-4-ene-3,20-dione) | 80097-73-0 |
| 1379300 | Melphalan Hydrochloride (300 mg) | 1465-26-5 |
| 1379401 | Meloxicam (400 mg) | 71125-38-7 |
| 1379412 | Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide) | 24683-26-9 |
| 1379423 | Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine) | 7305-71-7 |
| 1379434 | Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide) | N/A |
| 1379445 | 4-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) | N/A |
| 1379456 | (Z)-N’-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide) | 1145656-36-5 |
| 1379605 | Mefenamic Acid (200 mg) | 61-68-7 |
| 1380105 | Melatonin (150 mg) | 73-31-4 |
| 1380116 | Melatonin Related Compound A (15 mg) (2-(5-methoxy-1H-indol-3-yl)ethanamine) | 608-07-1 |
| 1380502 | Memantine Hydrochloride (150 mg) | 41100-52-1 |
| 1380513 | Memantine Related Compound A (50 mg) (1,3-Dimethyladamantane) | 702-79-4 |
| 1380524 | Memantine Related Compound B (15 mg) (3,5-Dimethyladamantane-1-ol) | 707-37-9 |
| 1380535 | Memantine Related Compound C (50 mg) (1-Chloro-3,5-dimethyladamantane) | 707-36-8 |
| 1380546 | Memantine Related Compound D (50 mg) (1-Bromo-3,5-dimethyladamantane) | 941-37-7 |
| 1380557 | Memantine Related Compound E (15 mg) (N-3,5-Dimethyladamantan-1-yl formamide) | 351329-88-9 |
| 1381006 | Menadione (200 mg) (Vitamin K3) | 58-27-5 |
| 1381083 | Menaquinone-4 (50 mg) (2-Methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthalene-1,4-dione) (COLD SHIPMENT REQUIRED) | 863-61-6 |
| 1381119 | Menaquinone-7 (3 x 50 mg) (Vitamin K2) | 2124-57-4 |
| 1381200 | Menhaden Oil (2 mL) (COLD SHIPMENT REQUIRED) | 8002-50-4 |
| 1381709 | Menthol (250 mg) | 2216-51-5 |
| 1381742 | Meradimate (500 mg/ampule) (Menthyl Anthranilate) | 134-09-8 |
| 1383001 | Meperidine Hydrochloride CII (200 mg) | 50-13-5 |
| 1385007 | Mephenytoin (250 mg) | 50-12-4 |
| 1386000 | Mephobarbital CIV (250 mg) | 115-38-8 |
| 1387002 | Mepivacaine Hydrochloride (200 mg) | 1722-62-9 |
| 1388005 | Meprednisone (200 mg) | 1247-42-3 |
| 1389008 | Meprobamate CIV (200 mg) | 57-53-4 |
| 1391000 | 3-Mercapto-2-methylpropanoic Acid 1,2-Diphenylethylamine Salt (75 mg) | N/A |
| 1392002 | Mercaptopurine (500 mg) | 6112-76-1 |
| 1392454 | Meropenem (300 mg) | 119478-56-7 |
| 1392705 | Mesalamine (200 mg) | 89-57-6 |
| 1392807 | Mesna (200 mg) | 19767-45-4 |
| 1392818 | Mesna Related Compound A (50 mg) (2-(Acetylsulfanyl)ethanesulfonic acid) | 69536-71-6 |
| 1392829 | Mesna Related Compound B (50 mg) (2,2-(Disulfanediyl)bis(ethanesulfonic acid)) | 45127-11-5 |
| 1393005 | Mesoridazine Besylate (250 mg) | 32672-69-8 |
| 1394008 | Mestranol (200 mg) | 72-33-3 |
| 1395204 | Metacresol (1 mL) | 108-39-4 |
| 1395500 | Metaproterenol Sulfate (200 mg) | 5874-97-5 |
| 1396003 | Metaraminol Bitartrate (200 mg) | 33402-03-8 |
| 1396149 | Metaxalone (200 mg) | 1665-48-1 |
| 1396150 | Metaxalone Related Compound A (10 mg) (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one) | N/A |
| 1396168 | Metaxalone Related Compound B (25 mg) (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol) | 66766-07-2 |
| 1396171 | Metaxalone Related Compound C (25 mg) (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine) | 805972-34-3 |
| 1396309 | Metformin Hydrochloride (200 mg) | 1115-70-4 |
| 1396310 | Metformin Related Compound A (30 mg) (1-Cyanoguanidine) | 461-58-5 |
| 1396331 | Metformin Related Compound B (25 mg) (1-Methylbiguanide hydrochloride) | 1674-62-0 |
| 1396342 | Metformin Related Compound C (25 mg) (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine) | 1985-46-2 |
| 1396364 | Methacholine Chloride (5 x 150 mg) | 62-51-1 |
| 1396400 | Methacrylic Acid and Methyl Methacrylate Copolymer (1:1) (200 mg) (Methacrylic Acid Copolymer Type A) | 25086-15-1 |
| 1396502 | Methacrylic Acid Copolymer Type B (200 mg) | N/A |
| 1396604 | Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) (Methacrylic Acid Copolymer Type C) (200 mg) | 25212-88-8 |
| 1396659 | Partially-Neutralized Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) (1 g) | 25212-88-8 |
| 1397006 | Methacycline Hydrochloride (200 mg) | 3963-95-9 |
| 1398009 | Methadone Hydrochloride CII (200 mg) | 1095-90-5 |
| 1399001 | Methamphetamine Hydrochloride CII (125 mg) | 51-57-0 |
| 1406005 | Methazolamide (500 mg) | 554-57-4 |
| 1408000 | Methdilazine Hydrochloride (200 mg) | 1229-35-2 |
| 1409003 | Methenamine (500 mg) | 100-97-0 |
| 1409502 | Methenamine Hippurate (200 mg) | 5714-73-8 |
| 1409604 | Methenamine Mandelate (200 mg) | 587-23-5 |
| 1410002 | Methicillin Sodium (500 mg) (AS) | 7246-14-2 |
| 1411005 | Methimazole (200 mg) | 60-56-0 |
| 1411016 | Methimazole Related Compound A (3 x 50 mg) (2,2-Dimethoxy-N-methylethanamine) | 122-07-6 |
| 1411038 | Methimazole Related Compound C (3 x 50 mg) (1-Methyl-2-(methylthio)-1H-imidazole) | 14486-52-3 |
| 1411504 | L-Methionine (200 mg) | 63-68-3 |
| 1412008 | Methocarbamol (200 mg) | 532-03-6 |
| 1413000 | Methohexital CIV (500 mg) | 18652-93-2 |
| 1413988 | R-Methotrexate (5 mg) ((R)-2-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzamido)pentanedioic acid) | 59-05-2 |
| 1413999 | Methotrexate System Suitability Mixture (5 mg) | N/A |
| 1414003 | Methotrexate (500 mg) | 59-05-2 |
| 1414025 | Methotrexate Related Compound B (75 mg) ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid) | 54-62-6 |
| 1414036 | Methotrexate Related Compound C (50 mg) ((S)-2-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl](methyl)amino}benzamido) pentanedioic acid) | 2410-93-7 |
| 1414058 | Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride) | 70844-48-3 |
| 1415006 | Methotrimeprazine (200 mg) | 60-99-1 |
| 1417001 | Methoxsalen (200 mg) | 298-81-7 |
| 1417113 | Indomethacin Related Compound A (25 mg) (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid) | 2882-15-7 |
| 1418004 | Methoxyflurane (0.5 mL) | 76-38-0 |
| 1418650 | Methoxymethylguanine (20 mg) | N/A |
| 1420006 | Levodopa Related Compound B (50 mg) (3-methoxytyrosine) | N/A |
| 1421009 | Methscopolamine Bromide (200 mg) | 155-41-9 |
| 1422001 | Methsuximide (500 mg) | 77-41-8 |
| 1424007 | Methyclothiazide (200 mg) | 135-07-9 |
| 1424018 | Methyclothiazide Related Compound A (50 mg) (4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide) | N/A |
| 1424051 | Methyl Acetate (1.2 mL/ampule; 3 ampules) | 79-20-9 |
| 1424084 | 9-Methylacridine (25 mg) | 611-64-3 |
| 1424109 | Methyl Alcohol (3 x 1.5 mL) | 67-56-1 |
| 1424153 | 3-Methyl-1-butanol (1.2 mL/ampule; 3 ampules) | 123-51-3 |
| 1424209 | Methylbenzhydrol (50 mg) | 7111-76-4 |
| 1424211 | Methylbenzethonium Chloride (200 mg) | 25155-18-4 |
| 1424222 | Methyl Benzylidene Camphor (200 mg) | 36861-47-9 |
| 1424233 | Methyl Caprate (3 x 100 mg) | 110-42-9 |
| 1424244 | Methyl Caproate (3 x 100 mg) | 106-70-7 |
| 1424255 | Methyl Caprylate (300 mg) | 111-11-5 |
| 1424506 | Methylcellulose (1 g) (AS) | 9004-67-5 |
| 1424550 | Methylcobalamin (2 x 150 mg) | 13422-55-4 |
| 1424608 | Terbinafine Related Compound A (25 mg) (N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride) | 65473-13-4 |
| 1425000 | 4-Methyl-2,5-dimethoxyamphetamine Hydrochloride CI (25 mg) (AS) (STP) | 15589-00-1 |
| 1426002 | Methyldopa (500 mg) | 41372-08-1 |
| 1427005 | Methyldopate Hydrochloride (200 mg) | 2508-79-4 |
| 1427027 | Methyldopa Related Compound B (10 mg) ((S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride) | 35026-10-9 |
| 1427038 | Methyldopa Related Compound C (20 mg) ((S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride monohydrate) | N/A |
| 1428008 | Methylene Blue (750 mg) | 122965-43-9 |
| 1428229 | Methylene Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate) | 1449248-72-9 |
| 1429113 | Methylenediurea (300 mg) (1,1′-Methylenediurea) | 13547-17-6 |
| 1430000 | Methylergonovine Maleate (50 mg) | 57432-61-8 |
| 1430101 | Methyl Ethyl Ketone (1.2 mL/ampule; 3 ampules) | 78-93-3 |
| 1430203 | Methyl Isobutyl Ketone (1.2 mL/ampule; 3 ampules) | 108-10-1 |
| 1430305 | Methyl Laurate (5 x 100 mg) | 111-82-0 |
| 1430327 | Methyl Linoleate (5 x 50 mg) | 112-63-0 |
| 1430349 | Methyl Linolenate (5 x 50 mg) (COLD SHIPMENT REQUIRED) | 301-00-8 |
| 1430509 | 3-O-Methylmethyldopa (50 mg) | N/A |
| 1430724 | Methylnaltrexone Peak Identification Mixture CII (10 mg) (Methylnaltrexone Bromide containing about 0.1% methylnaltrexone related compound A) | N/A |
| 1430735 | Methylnaltrexone Bromide (100 mg) | 73232-52-7 |
| 1430815 | 6-Methylnicotinic Acid (50 mg) | 3222-47-7 |
| 1430917 | Methyl 12-Hydroxystearate (200 mg) | 141-23-1 |
| 1431501 | Methyl Myristate (3 x 100 mg) | 124-10-7 |
| 1431556 | Methyl Oleate (5 x 100 mg) | 112-62-9 |
| 1431603 | Methyl Palmitate (3 x 100 mg) | 112-39-0 |
| 1431625 | Methyl Palmitoleate (3 x 100 mg) | 1120-25-8 |
| 1432005 | Methylparaben (125 mg) | 99-76-3 |
| 1433008 | Methylphenidate Hydrochloride CII (125 mg) | 23655-65-4 |
| 1434011 | Methylphenidate Hydrochloride Erythro Isomer Solution CII (0.5 mL) | N/A |
| 1434022 | Methylphenidate Related Compound A (50 mg) (alpha-Phenyl-2-piperidineacetic Acid Hydrochloride) | N/A |
| 1435003 | Methylprednisolone (200 mg) | 83-43-2 |
| 1435014 | Methylprednisolone Related Compound A (25 mg) (17,21-Dihydroxy-6alpha-methylpregna-1,4-diene-3,11,20-trione) | 91523-05-6 |
| 1435036 | Methylprednisolone Related Compound C (25 mg) (11beta-Hydroxy-6alpha-methylandrosta-1,4-diene-3,17-dione) | 61919-52-6 |
| 1436006 | Methylprednisolone Acetate (200 mg) | 53-36-1 |
| 1437009 | Methylprednisolone Hemisuccinate (250 mg) | 2921-57-5 |
| 1437053 | 2-Methyl-1-propanol (1.2 mL/ampule; 3 ampules) | 78-83-1 |
| 1437202 | Methylpyrrolidone (2 g) | 872-50-4 |
| 1437392 | Methyl Ricinoleate (100 mg) | 141-24-2 |
| 1437450 | Methyl Salicylate (2 mL) | 119-36-8 |
| 1437461 | Methyl Salicylate Related Compound A (50 mg) (Dimethyl 4-hydroxyisophthalate) | 5985-24-0 |
| 1437508 | Methyl Stearate (300 mg) | 112-61-8 |
| 1437600 | Methylsulfonylmethane (200 mg) | 67-71-0 |
| 1437701 | Terbinafine Related Compound D (25 mg) ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en-4-yn-1-amine hydrochloride) | 877265-33-3 |
| 1438001 | Methyltestosterone CIII (250 mg) | 58-18-4 |
| 1438205 | Methyl Tricosanoate (200 mg) (Tricosanoic acid, methyl ester) | 2433-97-8 |
| 1440003 | Methysergide Maleate (350 mg) | 129-49-7 |
| 1440808 | Metoclopramide Hydrochloride (500 mg) | 54143-57-6 |
| 1440819 | Metoclopramide Related Compound A (15 mg) (4-acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide) | 5608-13-9 |
| 1440820 | Metoclopramide Related Compound B (15 mg) (methyl 4-acetamido-5-chloro-2-methoxybenzoate) | 4093-31-6 |
| 1440841 | Metoclopramide Related Compound D (15 mg) (methyl 4-acetamido-2-methoxybenzoate) | 4093-29-2 |
| 1441200 | Metolazone (200 mg) | 17560-51-9 |
| 1441232 | Metoprolol Related Compound A (20 mg) ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol) | N/A |
| 1441243 | Metoprolol Related Compound B (100 mg) ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane) | N/A |
| 1441254 | Metoprolol Related Compound C (15 mg) ((+/-)4-[2-Hydroxy-3-(1-methylethyl)aminopropoxy]benzaldehyde hydrochloride) | N/A |
| 1441265 | Metoprolol Related Compound D (50 mg) ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride) | 1486464-40-7 |
| 1441287 | Metoprolol Fumarate (200 mg) | 119637-66-0 |
| 1441298 | Metoprolol Succinate (200 mg) | 98418-47-4 |
| 1441301 | Metoprolol Tartrate (200 mg) | 56392-17-7 |
| 1442009 | Metronidazole (100 mg) | 443-48-1 |
| 1442100 | Metronidazole Benzoate (100 mg) | 13182-89-3 |
| 1443001 | Metyrapone (200 mg) | 54-36-4 |
| 1443205 | Metyrosine (200 mg) | 672-87-7 |
| 1443250 | Mexiletine Hydrochloride (200 mg) | 5370-01-4 |
| 1443307 | Mezlocillin Sodium (350 mg) | 42057-22-7 |
| 1443362 | Mibolerone CIII (200 mg) | 3704-09-4 |
| 1443409 | Miconazole (200 mg) | 22916-47-8 |
| 1443431 | Miconazole Related Compound C (50 mg) (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride) | N/A |
| 1443464 | Miconazole Related Compound F (50 mg) (1-{2-[(3,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole) | 47447-55-2 |
| 1443497 | Miconazole Related Compound I (50 mg) (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate) | 24169-00-4 |
| 1443500 | Miconazole Nitrate (200 mg) | 22832-87-7 |
| 1443599 | Midazolam CIV (300 mg) | 59467-70-8 |
| 1443602 | Midazolam Hydrochloride CIV (200 mg) | 59467-96-8 |
| 1443657 | Milnacipran Hydrochloride (250 mg) | 101152-94-7 |
| 1443668 | Milnacipran Related Compound A (25 mg) (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride) | 871100-19-5 (free base) |
| 1443679 | Milnacipran Related Compound B (25 mg) (1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one) | 153275-06-0 |
| 1443680 | Milnacipran Related Compound C (25 mg) ((1RS ,2SR)-2-[(1,3-Dioxoisoindolin-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide) | 105310-75-6 |
| 1443704 | Midodrine Hydrochloride (200 mg) | 3092-17-9 |
| 1443715 | Midodrine Related Compound A (40 mg) (2-amino-1-(2,5-dimethoxyphenyl)ethanol) | 3600-87-1 |
| 1443759 | Mifepristone (200 mg) | 84371-65-3 |
| 1443806 | Milbemycin Oxime (200 mg) | 129496-10-2 |
| 1443825 | Skim Milk Powder (20 g) | N/A |
| 1443847 | Skim Milk Powder with Melamine – Level A (20 g) | N/A |
| 1443850 | Powdered Milk Thistle Extract (250 mg) | 84604-20-6 |
| 1443872 | Skim Milk Powder with Melamine – Level C (20 g) | N/A |
| 1443883 | Skim Milk Powder with Melamine – Level D (20 g) | N/A |
| 1443894 | Skim Milk Powder with Melamine – Level E (20 g) | N/A |
| 1443908 | Milrinone (500 mg) | 78415-72-2 |
| 1443919 | Milrinone Related Compound A (50 mg) (1,6-Dihydro-2-methyl-6-oxo(3,4′-bipyridine)-5-carboxamide) | 80047-24-1 |
| 1443952 | Mineral Oil (1.5 mL) | 8042-47-5 |
| 1444004 | Minocycline Hydrochloride (350 mg) | 13614-98-7 |
| 1444208 | Minoxidil (125 mg) | 38304-91-5 |
| 1444220 | Minoxidil Related Compound E (25 mg) (6-(Piperidin-1-yl)pyrimidine-2,4-diamine) | 24867-26-3 |
| 1444235 | Mirtazapine Related Compound B (25 mg) (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate) | 155172-12-6 |
| 1444241 | Mirtazapine Related Compound C (50 mg) (2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one) | 191546-96-0 |
| 1444252 | Mirtazapine Related Compound D (50 mg) (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one) | 191546-97-1 |
| 1444279 | Mirtazapine (350 mg) | 85650-52-8 |
| 1444285 | Mirtazapine Related Compound A (15 mg) (1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine) | 61337-68-6 |
| 1444296 | Mirtazapine Resolution Mixture (25 mg) | N/A |
| 1444300 | Misoprostol (100 mg) | 59122-46-2 |
| 1444707 | Mitomycin (50 mg) | 50-07-7 |
| 1445007 | Mitotane (500 mg) | 53-19-0 |
| 1445200 | Mitoxantrone Hydrochloride (400 mg) | 70476-82-3 |
| 1445211 | Mitoxantrone System Suitability Mixture (0.3 mg) | N/A |
| 1445346 | Modafinil Related Compound A (20 mg) (2-[(diphenylmethyl)sulfinyl]acetic acid) | 63547-24-0 |
| 1445357 | Modafinil Related Compound B (20 mg) (2-[(diphenylmethyl)sulfonyl]acetamide) | 118779-53-6 |
| 1445368 | Modafinil Related Compound C (20 mg) (2-[(diphenylmethyl)sulfenyl]acetamide) | 68524-30-1 |
| 1445379 | Modafinil Related Compound D (20 mg) (Bis(diphenylmethyl)ether) | 574-42-5 |
| 1445380 | Modafinil Related Compound E (20 mg) (Bis(diphenylmethyl)disulfide) | 1726-02-9 |
| 1445404 | Modafinil CIV (200 mg) | 68693-11-8 |
| 1445426 | Moexipril Hydrochloride (100 mg) | 82586-52-5 |
| 1445448 | Mogroside V (100 mg) | 88901-36-4 |
| 1445459 | Molindone Hydrochloride (500 mg) | 15622-65-8 |
| 1445470 | Mometasone Furoate (200 mg) | 83919-23-7 |
| 1445481 | Monensin Sodium (200 mg) | 22373-78-0 |
| 1445492 | Monk Fruit Extract (500 mg) | N/A |
| 1445506 | Monobenzone (200 mg) | 103-16-2 |
| 1445550 | Monoclonal IgG System Suitability (2 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1445608 | Moexipril Related Compound A (20 mg) ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid) | 103775-14-0 |
| 1445619 | Moexipril Related Compound B (20 mg) ((S)-ethyl 2-{(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino[1,2-b]isoquinolin-2(6H,11H,11aH)-yl}-4-phenylbutanoate) | 103733-51-3 |
| 1445620 | Moexipril Related Compound C (20 mg) ((S)-tert-butyl 2-{(S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, maleate) | 103733-40-0 |
| 1445631 | Moexipril Related Compound D (20 mg) ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride) | N/A |
| 1445642 | Moexipril Related Compound E (20 mg) ((S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) | 82586-62-7 |
| 1445653 | Moexipril Related Compound F (20 mg) ((S)-2-[(S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino]propanoic acid) | 82717-96-2 |
| 1445664 | Moexipril Related Compound G (20 mg) ((S)-6,7-dimethoxy-2-{(S)-2-[(S)-1-methoxy-1-oxo-4-phenylbutan-2-ylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride) | N/A |
| 1445925 | Monoethanolamine (1 mL) | 141-43-5 |
| 1446000 | Monoglycerides (125 mg) | 68990-53-4 |
| 1446600 | Monosodium Glutamate (500 mg) (Monosodium L-glutamate, monohydrate) | 6106-04-3 |
| 1446804 | Monostearyl Maleate (100 mg) | 2424-62-6 |
| 1446815 | Montelukast Dicyclohexylamine (150 mg) | 577953-88-9 |
| 1446837 | Montelukast for Peak Identification (20 mg) | N/A |
| 1446848 | Montelukast Racemate (20 mg) | 577953-88-9 |
| 1446859 | Montelukast Sodium (50 mg) | 151767-02-1 |
| 1446906 | Morantel Tartrate (100 mg) | 26155-31-7 |
| 1446950 | Moricizine Hydrochloride (250 mg) | 29560-58-5 |
| 1447002 | Morphine Monohydrate CII (50 mg) (AS) | 6009-81-0 |
| 1448005 | Morphine Sulfate CII (500 mg) | 6211-15-0 |
| 1448016 | Morphine Related Compound A CI (20 mg) (Morphine N-Oxide) | 639-46-3 |
| 1448027 | Morphine Related Compound B CII (20 mg) (Pseudomorphine) | 125-24-6 |
| 1448559 | Moxidectin (200 mg) | 113507-06-5 |
| 1448560 | Moxidectin System Suitability Mixture (50 mg) | N/A |
| 1448606 | Moxifloxacin Hydrochloride (200 mg) | 192927-63-2 |
| 1448617 | Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) | 151213-15-9 |
| 1448628 | Moxifloxacin Related Compound B (25 mg) (1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | N/A |
| 1448639 | Moxifloxacin Related Compound C (25 mg) (1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate) | N/A |
| 1448640 | Moxifloxacin Related Compound D (15 mg) (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid) | 1029364-77-9 |
| 1448655 | Moxifloxacin Related Compound E (25 mg) (1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride) | N/A |
| 1448661 | Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | 1179992-99-4 |
| 1448672 | Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride) | 1394029-14-1 |
| 1448854 | Low Molecular Weight Heparin Molecular Weight Calibrant (10.6 mg) | 9041-08-1 |
| 1448901 | Mupirocin (50 mg) | 12650-69-0 |
| 1448912 | Mupirocin Calcium (200 mg) | 115074-43-6 |
| 1448923 | Mupirocin Lithium (100 mg) | 73346-79-9 |
| 1448956 | Mycophenolate Mofetil (200 mg) | 128794-94-5 |
| 1448967 | Mycophenolate Mofetil Related Compound A (15 mg) (2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate) | N/A |
| 1448978 | Mycophenolate Mofetil Related Compound B (15 mg) [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] | 26675-76-3 |
| 1448989 | Mycophenolate Sodium (200 mg) | 37415-62-6 |
| 1448990 | Myristic Acid (200 mg) | 544-63-8 |
| 1449008 | Myristyl Alcohol (5 x 100 mg) | 112-72-1 |
| 1449518 | Nabumetone (200 mg) | 42924-53-8 |
| 1449530 | Nabumetone Related Compound A (15 mg) (1-(6-methoxy-2-naphthyl)-but-1-en-3-one) | 127053-22-9 |
| 1449700 | Nadolol (200 mg) | 42200-33-9 |
| 1450007 | Nafcillin Sodium (200 mg) | 7177-50-6 |
| 1450404 | Naftifine Hydrochloride (200 mg) | 65473-14-5 |
| 1451000 | Nalidixic Acid (200 mg) | 389-08-2 |
| 1452002 | Nalorphine Hydrochloride CIII (250 mg) | 57-29-4 |
| 1453005 | Naloxone (200 mg) | 465-65-6 |
| 1453504 | Naltrexone (200 mg) | 16590-41-3 |
| 1453526 | Naltrexone Related Compound A CII (30 mg) (N-(3-butenyl)-noroxymorphone Hydrochloride) | N/A |
| 1454008 | Nandrolone CIII (50 mg) | 434-22-0 |
| 1455000 | Nandrolone Decanoate CIII (250 mg) (COLD SHIPMENT REQUIRED) | 360-70-3 |
| 1457006 | Naphazoline Hydrochloride (200 mg) | 550-99-2 |
| 1457017 | Naphazoline Related Compound A (30 mg) (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide) | 36321-43-4 |
| 1457083 | Naphthalene (200 mg) | 91-20-3 |
| 1457301 | Naproxen (200 mg) | 22204-53-1 |
| 1457312 | Naproxen Related Compound A (20 mg) (6-methoxy-2-naphthoic acid) | 2471-70-7 |
| 1457403 | Naproxen Sodium (200 mg) | 26159-34-2 |
| 1457414 | Naproxen Related Compound K (50 mg) (1-(6-Methoxynaphthalen-2-yl)ethanol) | 77301-42-9 |
| 1457425 | Naproxen Related Compound L (15 mg) (1-(6-methoxynaphthalen-2-yl)ethanone) | 3900-45-6 |
| 1457436 | Naproxen Related Compound G (50 mg) ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid) | 23979-41-1 |
| 1457458 | Narasin (125 mg) | 55134-13-9 |
| 1457469 | Naratriptan Hydrochloride (125 mg) | 143388-64-1 |
| 1457491 | Naratriptan Resolution Mixture (20 mg) | N/A |
| 1457505 | Natamycin (200 mg) | 7681-93-8 |
| 1457607 | Nateglinide (200 mg) | 105816-04-4 |
| 1457618 | Nateglinide Related Compound A (10 mg) (trans-4-isopropylcyclohexanecarboxylic acid) | 7077-05-6 |
| 1457629 | Nateglinide Related Compound B (10 mg) (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine) | 105816-05-5 |
| 1457630 | Nateglinide Related Compound C (5 mg) (N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine) | 105816-06-6 |
| 1457833 | Nebivolol Hydrochloride (150 mg) | 152520-56-4 |
| 1457844 | Near IR System Suitability (1 unit) (Dysprosium (Dy2O3), Erbium (Er2O3), Holmium (Ho2O3), talc [Mg3Si4O10(OH)2] (1:1:1:1 w/w)) | N/A |
| 1457855 | Nebivolol Related Compound A (30 mg) (See USP Certificate for full Chemical Name) | N/A |
| 1457866 | Nebivolol Related Compound B (30 mg) (See USP Certificate for full Chemical Name) | N/A |
| 1457877 | Nebivolol Related Compound C (100 mg) (COLD SHIPMENT REQUIRED) ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) | 876514-31-7 |
| 1457888 | Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) | 793669-26-8 |
| 1457899 | Nebivolol Related Compound E (30 mg) (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) | N/A |
| 1457902 | Nefazodone Hydrochloride (200 mg) | 82752-99-6 |
| 1457913 | Nefazodone Related Compound A (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) | 57059-62-8 |
| 1457924 | Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) | N/A |
| 1457979 | Nelfinavir Related Compound A (15 mg) ((3S,4aS,8aS)-N-tert-Butyl-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylsulfinyl)butyl]decahydroisoquinoline-3-carboxamide) | 1041389-28-9 |
| 1458009 | Neomycin Sulfate (200 mg) | 1405-10-3 |
| 1458042 | Neohesperidin (30 mg) ((S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) | 13241-33-3 |
| 1458053 | Neohesperidine Dihydrochalcone (100 mg) | 20702-77-6 |
| 1459001 | Neostigmine Bromide (200 mg) | 114-80-7 |
| 1460000 | Neostigmine Methylsulfate (200 mg) | 51-60-5 |
| 1460204 | Neotame (200 mg) | 243116-62-3 |
| 1460215 | Neotame Related Compound A (15 mg) (N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine) | 190910-14-6 |
| 1460500 | Netilmicin Sulfate (500 mg) | 56391-57-2 |
| 1460703 | Nevirapine Anhydrous (100 mg) | 129618-40-2 |
| 1460714 | Nevirapine Hemihydrate (100 mg) | N/A |
| 1460725 | Nevirapine Related Compound A (15 mg) (5,11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one) | 133627-17-5 |
| 1460736 | Nevirapine Related Compound B (10 mg) (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one) | N/A |
| 1460747 | Nevirapine Related Compound C (15 mg) (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one) | N/A |
| 1461003 | Niacin (200 mg) | 59-67-6 |
| 1462006 | Niacinamide (500 mg) | 98-92-0 |
| 1463224 | Nicardipine Hydrochloride (200 mg) | 54527-84-3 |
| 1463304 | Nicotine Bitartrate Dihydrate (400 mg) | 6019-06-3 |
| 1463326 | Nicotine Related Compound A (20 mg) (1,2,3,6-tetrahydro-2,3′-bipyridine) | 2743-90-0 |
| 1463337 | Nicotine Related Compound B (20 mg) (3-(1-methyl-1H-pyrrol-2-yl)pyridine) | 487-19-4 |
| 1463348 | Nicotine Related Compound C (20 mg) ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one) | 486-56-6 |
| 1463359 | Nicotine Related Compound D (20 mg) (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate) | N/A |
| 1463360 | Nicotine Related Compound E (20 mg) ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate) | N/A |
| 1463371 | Nicotine Related Compound F (20 mg) (3-(pyrrolidin-2-yl)pyridine) | 5746-86-1 |
| 1463382 | Nicotine Related Compound G (20 mg) ((S)-3-(piperidin-2-yl)pyridine) | 494-52-0 |
| 1463472 | Nilutamide (200 mg) | 63612-50-0 |
| 1463508 | Nifedipine (125 mg) | 21829-25-4 |
| 1463600 | Nifedipine Nitrophenylpyridine Analog (25 mg) | N/A |
| 1463701 | Nifedipine Nitrosophenylpyridine Analog (25 mg) (Dimethyl 4-(2-nitrosophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) | N/A |
| 1463858 | Nimodipine (125 mg) | 66085-59-4 |
| 1463869 | Nimodipine Related Compound B (50 mg) (bis(2-methoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) | 70172-96-2 |
| 1463870 | Nimodipine Related Compound A (50 mg) (2-methoxyethyl-1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate) | 85677-93-6 |
| 1463950 | Nitrilotriacetic Acid (50 mg) | 139-13-9 |
| 1463960 | Nitazoxanide (200 mg) | 55981-09-4 |
| 1463971 | Nitazoxanide Related Compound A (25 mg) (5-Nitrothiazole-2-amine) | 121-66-4 |
| 1464001 | Nitrofurantoin (500 mg) | 67-20-9 |
| 1465004 | Nitrofurazone (200 mg) | 59-87-0 |
| 1465503 | Nitrofurfural Diacetate (100 mg) | 92-55-7 |
| 1466007 | Nitrofurazone Related Compound A (500 mg) (5-Nitro-2-furfuraldazine) | 112537-96-9 |
| 1466506 | Diluted Nitroglycerin (5 ampules, approx. 200 mg of a 0.974% solution in propylene glycol each) (COLD SHIPMENT REQUIRED) | 55-63-0 |
| 1466572 | 4-Nitrobenzoic Acid (50 mg) | 62-23-7 |
| 1467804 | Nizatidine (200 mg) | 76963-41-2 |
| 1467837 | PS NMR System Suitability (1 mg) | N/A |
| 1467848 | Nobiletin (100 mg) (2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-chromen-4-one) | 478-01-3 |
| 1467950 | Nonoxynol 9 (0.5 mL) | 68412-54-4 |
| 1468400 | Nordazepam CIV (50 mg) (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one) | 1088-11-5 |
| 1468454 | Norelgestromin (200 mg) | 53016-31-2 |
| 1468465 | Norelgestromin Related Compound A (15 mg) (13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-5(6)-en-20-yn-3-one oxime) | N/A |
| 1468501 | Norepinephrine Bitartrate (125 mg) | 108341-18-0 |
| 1469005 | Norethindrone (200 mg) | 68-22-4 |
| 1470004 | Norethindrone Acetate (100 mg) | 51-98-9 |
| 1470026 | Norethindrone Related Compound B CIII (30 mg) (Estr-4-ene-3,17-dione) | 734-32-7 |
| 1471506 | Norfloxacin (200 mg) | 70458-96-7 |
| 1471517 | Norfloxacin Related Compound A (15 mg) (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | 68077-26-9 |
| 1471550 | Norfloxacin Related Compound E (15 mg) (7-Chloro-1-ethyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | 75001-78-4 |
| 1471583 | Norfloxacin Related Compound H (15 mg) (7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) | 105440-01-5 |
| 1471619 | Norfloxacin Related Compound K (15 mg) (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | 70459-07-3 |
| 1471914 | Norgestimate (200 mg) | 35189-28-7 |
| 1471925 | Norgestimate Related Compound A (25 mg) (Levonorgestrel Acetate) | 13732-69-9 |
| 1471958 | Deacetylnorgestimate (25 mg) ((E)- and (Z)-17-deacetyl norgestimate mixture) | 53016-31-2 |
| 1472000 | Norgestrel (125 mg) | 6533-00-2 |
| 1472043 | Norgestrel Related Compound L (25 mg) (13-Ethylgon-4-ene-3,17-dione) | 21800-83-9 |
| 1473002 | Noroxymorphone Hydrochloride CII (50 mg) | N/A |
| 1473206 | Norphenylephrine Hydrochloride (25 mg) | 4779-94-6 |
| 1473400 | Norscopolamine (20 mg) ((1R ,2R ,4S ,5S ,7s )-3-Oxa-9-azatricyclo[3.3.1.0^2,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate) | 4684-28-0 |
| 1474005 | Nortriptyline Hydrochloride (200 mg) | 894-71-3 |
| 1474504 | Noscapine (100 mg) | 128-62-1 |
| 1475008 | Novobiocin (200 mg) | 56677-21-5 |
| 1477003 | Nystatin (200 mg) (COLD SHIPMENT REQUIRED) | 1400-61-9 |
Chuẩn USP từ O - R
Chuẩn dược điển USP từ O đến R
| Mã code | Tên chuẩn dược điển | Mã CAS# |
| 1477411 | Octocrylene (500 mg) | 6197-30-4 |
| 1477502 | Octoxynol 9 (200 mg) | 9002-93-1 |
| 1477604 | Octreotide Acetate (4.37 mg) (COLD SHIPMENT REQUIRED) | 79517-01-4 |
| 1477615 | Octreotide Non-Cyclic System Suitability Marker (20 mg) (COLD SHIPMENT REQUIRED) | 774239-80-4 |
| 1477808 | Octyldodecanol (3 x 100 mg) | 5333-42-6 |
| 1477900 | Octinoxate (500 mg) (Octyl Methoxycinnamate) | 5466-77-3 |
| 1477943 | Octisalate (400 mg) (Octyl Salicylate) | 118-60-5 |
| 1478083 | R-Ofloxacin (25 mg) ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) | 100986-86-5 |
| 1478108 | Ofloxacin (200 mg) | 82419-36-1 |
| 1478119 | Ofloxacin Related Compound A (25 mg) (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid) | 82419-52-1 |
| 1478130 | Oleic Acid (1 g) | 112-80-1 |
| 1478141 | Oleanolic Acid (15 mg) ((3beta)-3-hydroxyolean-12-en-28-oic acid) | 508-02-1 |
| 1478152 | Oleoyl Polyoxylglycerides (100 mg) | N/A |
| 1478163 | Oleuropein (25 mg) | 32619-42-4 |
| 1478185 | Oleyl Alcohol (5 x 50 mg) | 143-28-2 |
| 1478200 | Oleyl Oleate (0.5 mL) | 3687-45-4 |
| 1478210 | Oligosaccharide System Suitability Mixture A (20 ug) | N/A |
| 1478221 | Oligosaccharide System Suitability Mixture B (20 ug) | N/A |
| 1478232 | Oligosaccharide System Suitability Mixture C (20 ug) | N/A |
| 1478243 | Oligosaccharide System Suitability Mixture D (20 ug) | N/A |
| 1478254 | Olive Oil (200 mg) | 8001-25-0 |
| 1478265 | Olive Leaf Dry Extract (500 mg) | 8001-25-0 |
| 1478301 | Olanzapine (200 mg) | 132539-06-1 |
| 1478312 | Olanzapine Related Compound A (15 mg) (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile) | 138564-59-7 |
| 1478323 | Olanzapine Related Compound B (15 mg) (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one) | 221176-49-4 |
| 1478334 | Olanzapine Related Compound C (5 mg) (2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4′-N-oxide) (COLD SHIPMENT REQUIRED) | 174794-02-6 |
| 1478367 | Olmesartan Medoxomil (100 mg) | 144689-63-4 |
| 1478378 | Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2′-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one) | 849206-43-5 |
| 1478403 | Olopatadine Hydrochloride (150 mg) | 140462-76-6 |
| 1478425 | Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide) | 173174-07-7 |
| 1478436 | Olopatadine Related Compound C (35 mg) ((11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid) | 55453-87-7 |
| 1478479 | R-Omeprazole (15 mg) (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt) | 161796-77-6 |
| 1478480 | Omeprazole Related Compound B (15 mg) (5-Methoxy-1H-benzimidazol-2-thiol) | 37052-78-1 |
| 1478491 | Omeprazole Related Compound F and G Mixture (25 mg) | N/A |
| 1478505 | Omeprazole (200 mg) | 73590-58-6 |
| 1478516 | Omeprazole Related Compound A (15 mg) (5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole) | 88546-55-8 |
| 1478527 | Omeprazole Related Compound E (15 mg) (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide) | 176219-04-8 |
| 1478549 | Omeprazole Magnesium (10 mg) | 95382-33-5 |
| 1478561 | Omeprazole Related Compound I (15 mg) (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) | 158812-85-2 |
| 1478571 | Ondansetron (300 mg) | 99614-02-5 |
| 1478582 | Ondansetron Hydrochloride (300 mg) | 103639-04-9 |
| 1478593 | Ondansetron Related Compound A (50 mg) (3[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride) | 119812-29-2 |
| 1478618 | Ondansetron Related Compound C (30 mg) (1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one) | 27397-31-1 |
| 1478629 | Ondansetron Related Compound D (30 mg) (9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one) | N/A |
| 1478630 | Ondansetron Resolution Mixture (50 mg) | N/A |
| 1478651 | Ononin (50 mg) (3-(4-Methoxyphenyl)-4-oxo-4H-chromen7-yl beta-D-glucopyranoside) | 486-62-4 |
| 1478673 | Orbifloxacin (350 mg) | 113617-63-3 |
| 1478800 | Orlistat (200 mg) (COLD SHIPMENT REQUIRED) | 96829-58-2 |
| 1478811 | Orlistat Related Compound A (25 mg) ((3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone) | 104872-06-2 |
| 1478822 | Orlistat Related Compound B (20 mg) (diisopropyl hydrazine-1,2-dicarboxylate) | 19740-72-8 |
| 1478833 | Orlistat Related Compound C (25 mg) (Triphenylphosphine oxide) | 791-28-6 |
| 1478844 | Orlistat Related Compound D (10 mg) (N-formyl-L-leucine (3S,4R,6S)-3-hexyl-2-oxo-6-undecyltetrahydro-2H-pyran-4-yl ester) | 130793-27-0 |
| 1478855 | Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) | N/A |
| 1479009 | Orphenadrine Citrate (200 mg) | 4682-36-4 |
| 1479010 | Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) | N/A |
| 1479020 | Orphenadrine Related Compound B (20 mg) (N-ethyl-N,N-dimethyl [2-(2-methylbenzhydryloxy)ethyl]ammonium chloride) | N/A |
| 1479031 | Orphenadrine Related Compound C (20 mg) (N-methyl-[2-(2-methylbenzhydryloxy)ethyl]amine hydrochloride) | 10488-36-5 |
| 1479053 | Orphenadrine Related Compound E (50 mg) (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine) | 21945-86-8 |
| 1479064 | Orphenadrine Related Compound F (50 mg) (N,N-Dimethyl-2-[phenyl(p-tolyl)methoxy]ethanamine citrate) | 19804-27-4 |
| 1479304 | Oseltamivir Phosphate (200 mg) | 204255-11-8 |
| 1479315 | Oseltamivir Related Compound A (10 mg) ((3S,4R,5S)-ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate) | N/A |
| 1481000 | Oxacillin Sodium (200 mg) | 7240-38-2 |
| 1481044 | Oxacillin Related Compound C (15 mg) (5-Methyl-3-phenylisoxazole-4-carboxylic acid) | 1136-45-4 |
| 1481204 | Oxaliplatin (125 mg) | 61825-94-3 |
| 1481215 | Oxaliplatin Related Compound A (100 mg) (Ethanedioic acid, dihydrate) | 6153-56-6 |
| 1481226 | Oxaliplatin Related Compound B (15 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) dinitratoplatinum(II)) | 66900-68-3 |
| 1481237 | Oxaliplatin Related Compound C (20 mg) ([1R-trans-(1,2-cyclohexanediamine-N,N’)]-trans-dihydroxido-[oxalato(2-)-O,O’]platinum(IV)) | N/A |
| 1481248 | Oxaliplatin Related Compound D (10 mg) (cis-[(1S,2S)-1,2-cyclohexanediamine-N,N’][oxalato(2-)-O,O’]platinum) | 61758-77-8 |
| 1481260 | Oxaliplatin Related Compound F (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) diiodidoplatinum(II)) | 66845-32-7 |
| 1481306 | Oxaliplatin System Suitability (25 mg) ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N’) dichloridoplatinum(II)) | 61848-66-6 |
| 1482003 | Oxandrolone CIII (50 mg) | 53-39-4 |
| 1482014 | Oxandrolone Related Compound A CIII (20 mg) (17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androst-7-en-3-one) | N/A |
| 1482025 | Oxandrolone Related Compound B CIII (20 mg) (17 beta-hydroxy-17 alpha-methyl-4-oxa-5 alpha-androsta-3-one) | 4424-45-7 |
| 1482036 | Oxandrolone Related Compound C CIII (20 mg) (17,17-dimethyl-18-nor-2-oxa-5alpha-androst-13-en-3-one) | N/A |
| 1482207 | Oxaprozin (200 mg) | 21256-18-8 |
| 1483006 | Oxazepam CIV (200 mg) | 604-75-1 |
| 1483017 | Oxazepam Related Compound A (15 mg) (7-chloro-5-phenyl-4,5-dihydro-1H-benzodiazepine-2,3-dione) | 19554-95-1 |
| 1483028 | Oxazepam Related Compound B (15 mg) (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate) | 1824-74-4 |
| 1483039 | Oxazepam Related Compound C (15 mg) (6-chloro-4-phenylquinazoline-2-carbaldehyde) | 5958-05-4 |
| 1483152 | Oxcarbazepine (100 mg) | 28721-07-5 |
| 1483163 | Oxcarbazepine Related Compound A (10 mg) (N-Formyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | N/A |
| 1483174 | Oxcarbazepine Related Compound B (10 mg) (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide) | N/A |
| 1483185 | Oxcarbazepine Related Compound C (10 mg) (Acridin-9(10H)-one) | 578-95-0 |
| 1483196 | Oxcarbazepine Related Compound D (10 mg) (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide) | N/A |
| 1483200 | Oxcarbazepine Related Compound E (10 mg) (10(11H)-Oxo-5H-dibenz[b,f]azepine) | 21737-58-6 |
| 1483301 | Oxfendazole (200 mg) | 53716-50-0 |
| 1483425 | Oxiconazole Nitrate (200 mg) | 64211-46-7 |
| 1483436 | Oxiconazole Related Compound A (20 mg) (2′,4′-Dichloro-2-imidazol-1-ylacetophenone (E)-[O-(2,4-dichlorobenzyl)oxime]) | 76472-50-9 |
| 1483447 | Oxiconazole Related Compound B (20 mg) ((Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime) | 64211-06-9 |
| 1483458 | Oxiconazole Related Compound C (20 mg) (1-(2,4-Dichlorophenyl)-2-(1H -imidazol-1-yl)ethan-1-one hydrochloride) | 98164-08-0 |
| 1483469 | Oxiconazole Related Compound D (50 mg) ((2,4-Dichlorophenyl)methanol) | 1777-82-8 |
| 1483470 | Oxiconazole Related Compound E (100 mg) (2,4-Dichlorobenzyl chloride) | 94-99-5 |
| 1483505 | Oxprenolol Hydrochloride (200 mg) | 6452-73-9 |
| 1484009 | Oxtriphylline (500 mg) | 4499-40-5 |
| 1485001 | Oxybenzone (150 mg) | 131-57-7 |
| 1485103 | Oxybutynin Chloride (200 mg) | 1508-65-2 |
| 1485114 | Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) | 4335-77-7 |
| 1485125 | Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) | 10399-13-0 |
| 1485136 | Oxybutynin Related Compound C (20 mg) (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride) | N/A |
| 1485191 | Oxycodone CII (200 mg) | 76-42-6 |
| 1485205 | Oxycodone Hydrochloride CII (1 g) | 124-90-3 |
| 1485216 | Oxycodone Related Compound A CII (10 mg) (14-hydroxycodeinone) (COLD SHIPMENT REQUIRED) | 508-54-3 |
| 1485227 | Oxycodone Related Compound B CII (15 mg) (oxycodone N-oxide) | 71539-52-1 |
| 1485238 | Oxycodone Related Compound C CII (15 mg) (codeinone) | 467-13-0 |
| 1486004 | Oxymetazoline Hydrochloride (200 mg) | 2315-02-8 |
| 1486015 | Oxymetazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) | 1391053-50-1 |
| 1487007 | Oxymetholone CIII (200 mg) | 434-07-1 |
| 1488000 | Oxymorphone CII (300 mg) | 76-41-5 |
| 1488019 | Oxymorphone Related Compound A CII (25 mg) (4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one N-oxide) | 71360-37-7 |
| 1490103 | Oxyquinoline Sulfate (200 mg) | 134-31-6 |
| 1491004 | Oxytetracycline (200 mg) | 6153-64-6 |
| 1491015 | Oxytetracycline Hydrochloride (200 mg) | 2058-46-0 |
| 1491296 | Oxytocin Identification (15 mg) (COLD SHIPMENT REQUIRED) | 6233-83-6 |
| 1491300 | Oxytocin (1.81 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 50-56-6 |
| 1491332 | Paclitaxel (200 mg) | 33069-62-4 |
| 1491343 | Paclitaxel Related Compound A (20 mg) (Cephalomannine) | 71610-00-9 |
| 1491354 | Paclitaxel Related Compound B (20 mg) (10-deacetyl-7-epipaclitaxel) | N/A |
| 1491365 | Paclitaxel Impurity Mixture (10 mg) | N/A |
| 1491503 | Padimate O (300 mg) | 21245-02-3 |
| 1491795 | Paliperidone Resolution Mixture (20 mg) | N/A |
| 1491809 | Paliperidone (200 mg) | 144598-75-4 |
| 1491818 | Paliperidone Related Compound A (20 mg) (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one) | 849903-79-3 |
| 1491820 | Paliperidone Related Compound B (20 mg) (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride) | 84163-13-3 |
| 1491831 | Paliperidone Related Compound C (20 mg) (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-alpha]pyrimidin-4-one) | 130049-82-0 |
| 1491842 | Paliperidone Related Compound D (20 mg) (3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl) piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one N-oxide) | 761460-08-6 |
| 1492007 | Palmitic Acid (500 mg) | 57-10-3 |
| 1492040 | Palm Oil (1 g) | 8002-75-3 |
| 1492200 | Palonosetron Hydrochloride (100 mg) | 135729-62-3 |
| 1492211 | Palonosetron Enantiomer (15 mg) ((3aR)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 135729-75-8 |
| 1492222 | Palonosetron Related Compound A (15 mg) ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide) | 813425-83-1 |
| 1492233 | Palonosetron Related Compound B (15 mg) ((3S)-3-(1-Oxo-5,6-dihydro-1H-benzo[de]isoquinolin-2(4H)-yl)quinuclidine 1-oxide) | 1021456-82-5 |
| 1492244 | Palonosetron Related Compound C (15 mg) ((3aS)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 135729-76-9 |
| 1492255 | Palonosetron Related Compound D (15 mg) ((3aR)-2-[(3S)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 135755-51-0 |
| 1492266 | Palonosetron Related Compound E (15 mg) (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride) | 135729-55-4 |
| 1492700 | Pamabrom Related Compound A (30 mg) (8-Chlorotheophylline) | 85-18-7 |
| 1492801 | Pamidronate Disodium (100 mg) | 109552-15-0 |
| 1493000 | Pamoic Acid (250 mg) | 130-85-8 |
| 1494057 | Pancreatin Amylase and Protease (2 g) (COLD SHIPMENT REQUIRED) | 8049-47-6 |
| 1494079 | Pancreatin Lipase (2 g) (COLD SHIPMENT REQUIRED) | 8049-47-6 |
| 1494217 | Pancuronium Bromide (500 mg) | 15500-66-0 |
| 1494228 | Pancuronium Bromide Related Compound A (15 mg) (1,1′-(3alpha,17beta-dihydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | 15500-65-9 |
| 1494239 | Pancuronium Bromide Related Compound B (15 mg) (1,1′-(17beta-Acetoxy-3alpha-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | 41261-71-6 |
| 1494240 | Pancuronium Bromide Related Compound C (15 mg) (1,1′-(3alpha-acetoxy-17beta-hydroxy-5alpha-androstan-2beta,16beta-ylene) bis(1-methylpiperidinium) dibromide) | 27115-86-2 |
| 1494501 | Panthenol, Racemic (200 mg) | 16485-10-2 |
| 1494807 | Pantolactone (500 mg) | 599-04-2 |
| 1494895 | Pantoprazole Sodium (250 mg) | 164579-32-2 |
| 1494909 | Pantoprazole Related Compound A (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-1H-benzimidazole) | 127780-16-9 |
| 1494910 | Pantoprazole Related Compound B (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole) | 102625-64-9 |
| 1494920 | Pantoprazole Related Compound C (20 mg) (5-(difluoromethoxy)-1H-benzimidazole-2-thiol) | 97963-62-7 |
| 1494931 | Pantoprazole Related Compounds D and F Mixture (20 mg) | 624742-53-6 |
| 1494942 | Pantoprazole Related Compound E (20 mg) (6,6′-bis(difluoromethoxy)-2,2′-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1’H-5,5′-bibenzimidazolyl) | 2115779-15-0 |
| 1495005 | Papain (1 g) (COLD SHIPMENT REQUIRED) | 9001-73-4 |
| 1496008 | Papaverine Hydrochloride (200 mg) | 61-25-6 |
| 1496802 | Parachlorophenol (500 mg) | 106-48-9 |
| 1496904 | Paraffin (1 g) | 8002-74-2 |
| 1496959 | Paraldehyde (3 x 1.5 mL) | 123-63-7 |
| 1498706 | Parbendazole (200 mg) | 14255-87-9 |
| 1499403 | Paricalcitol (10 mg) (COLD SHIPMENT REQUIRED) | 131918-61-1 |
| 1499414 | Paricalcitol Solution (3 mL) (COLD SHIPMENT REQUIRED) | N/A |
| 1500003 | Paromomycin Sulfate (125 mg) | 1263-89-4 |
| 1500218 | Paroxetine Hydrochloride (350 mg) | 110429-35-1 |
| 1500230 | Paroxetine Related Compound B (15 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride) | N/A |
| 1500240 | Paroxetine Related Compound C (30 mg) ((+)-trans-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4″-fluorophenyl-4′-phenyl)piperidine hydrochloride) | 130855-30-0 |
| 1500251 | Paroxetine Related Compound D (10 mg) (cis-Paroxetine hydrochloride) (AS) | N/A |
| 1500262 | Paroxetine Related Compound E Mixture (25 mg) (1-Methyl-4-(p-fluorophenyl)-1,2,3,6-tetrahydropyridine in Paroxetine Hydrochloride Matrix) | N/A |
| 1500273 | Paroxetine Related Compound F (25 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine) | N/A |
| 1500284 | Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4”-fluorophenyl-4′-phenyl)piperidine hydrochloride) | N/A |
| 1500353 | Paroxetine System Suitability Mixture A (50 mg) | N/A |
| 1500400 | Parthenolide (25 mg) | 20554-84-1 |
| 1500502 | Particle Count Set (2 blanks and 2 suspensions) | N/A |
| 1500557 | Peanut Oil (1 g) | 8002-03-7 |
| 1500626 | Pegfilgrastim for Bioassay (COLD SHIPMENT REQUIRED) | 208265-92-3 |
| 1500659 | Pemetrexed Disodium (100 mg) (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate) | 357166-29-1 |
| 1500808 | Penbutolol Sulfate (200 mg) | 38363-32-5 |
| 1501006 | Penicillamine (200 mg) | 52-67-5 |
| 1501108 | Penicillamine Disulfide (200 mg) | 20902-45-8 |
| 1502009 | Penicillin G Benzathine (200 mg) | 41372-02-5 |
| 1502508 | Penicillin G Potassium (200 mg) | 113-98-4 |
| 1502552 | Penicillin G Procaine (200 mg) | 6130-64-9 |
| 1502701 | Penicillin G Sodium (150 mg) | 69-57-8 |
| 1504489 | Penicillin V (200 mg) | 87-08-1 |
| 1504503 | Penicillin V Potassium (200 mg) | 132-98-9 |
| 1504900 | Pentamidine Isethionate (200 mg) | 140-64-7 |
| 1504933 | Pentane (1.2 mL/ampule; 3 ampules) | 109-66-0 |
| 1504955 | 1-Pentanol (1.2 mL/ampule; 3 ampules) | 71-41-0 |
| 1505007 | Pentazocine CIV (500 mg) | 359-83-1 |
| 1505506 | Pentetic Acid (100 mg) | 67-43-6 |
| 1507002 | Pentobarbital CII (200 mg) | 76-74-4 |
| 1508901 | Pentoxifylline (200 mg) | 6493-05-6 |
| 1509019 | Powdered Black Pepper Extract (1 g) | 84929-41-9 |
| 1510051 | Pepsin for Assay (5 x 1 g) (COLD SHIPMENT REQUIRED) | 9001-75-6 |
| 1510801 | Perflubron (0.5 mL) | 423-55-2 |
| 1510845 | Pergolide Mesylate (200 mg) | 66104-23-2 |
| 1510867 | Pergolide Sulfoxide (50 mg) | 72822-01-6 |
| 1510889 | Perindopril Erbumine (100 mg) | 107133-36-8 |
| 1510890 | Perindopril Related Compound A (20 mg) ((2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid) | 80875-98-5 |
| 1510903 | Perindopril Related Compound B (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-carboxybutylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid) | 95153-31-4 |
| 1510914 | Perindopril Related Compound C (20 mg) ((S)-2-[(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]pentanoic acid) | 129970-99-6 |
| 1510925 | Perindopril Related Compound D (25 mg) ((S)-2-{(3S,5aS,9aS,10aR)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoic acid) | 130061-28-8 |
| 1510936 | Perindopril Related Compound E (10 mg) ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine) | N/A |
| 1510947 | Perindopril Related Compound F (10 mg) ((S)-ethyl 2-{(3S,5aS,9aS,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl}pentanoate) | 129970-98-5 |
| 1510999 | Perindopril Related Compound K (10 mg) ((3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione) | 2012-01-07 |
| 1511000 | Perphenazine (200 mg) | 58-39-9 |
| 1511021 | Perphenazine Related Compound B (15 mg) (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol) | 3533-97-9 |
| 1511203 | Perphenazine Sulfoxide (100 mg) | 10078-25-8 |
| 1513005 | Phenacetin (500 mg) | 62-44-2 |
| 1514008 | Phenacetin Melting Point Standard (1 g) (Approximately 135 degrees) | 62-44-2 |
| 1515000 | Phenazopyridine Hydrochloride (200 mg) | 136-40-3 |
| 1516003 | Phencyclidine Hydrochloride CII (25 mg) (AS) | 956-90-1 |
| 1516502 | Phendimetrazine Tartrate CIII (350 mg) | 50-58-8 |
| 1517006 | Phenelzine Sulfate (200 mg) | 156-51-4 |
| 1522301 | Pheniramine Maleate (150 mg) | 132-20-7 |
| 1524001 | Phenobarbital CIV (200 mg) | 50-06-6 |
| 1524806 | Phenol (500 mg) | 108-95-2 |
| 1525707 | Phenothiazine (500 mg) | 92-84-2 |
| 1526007 | Phenoxybenzamine Hydrochloride (250 mg) | 63-92-3 |
| 1526200 | Phenoxyethanol (500 mg) (2-Phenoxyethanol) | 122-99-6 |
| 1528002 | Phensuximide (500 mg) | 86-34-0 |
| 1528501 | Phentermine Hydrochloride CIV (200 mg) | 1197-21-3 |
| 1530004 | Phentolamine Mesylate (200 mg) | 65-28-1 |
| 1530503 | L-Phenylalanine (200 mg) | 63-91-2 |
| 1530809 | Ensulizole (200 mg) (2-phenylbenzimidazole-5-sulfonic acid) | 27503-81-7 |
| 1531007 | Phenylbutazone (250 mg) | 50-33-9 |
| 1532950 | Phenylephrine Bitartrate (25 mg) | 17162-39-9 |
| 1533002 | Phenylephrine Hydrochloride (200 mg) | 61-76-7 |
| 1533024 | Phenylephrine Related Compound C (30 mg) (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride) | 94240-17-2 |
| 1533035 | Phenylephrine Related Compound D (30 mg) ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol) | 1367567-95-0 |
| 1533046 | Phenylephrine Related Compound E (30 mg) (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride) | 71786-67-9 |
| 1533250 | Phenylethyl Alcohol (1 mL) | 60-12-8 |
| 1533261 | Phenylephrine Related Compound F (30 mg) ((R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate) | 1007885-60-0 |
| 1533272 | Phenylephrine Related Compound G (30 mg) ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine) | 1094089-46-9 |
| 1533308 | 5-Phenylhydantoin (100 mg) | 89-24-7 |
| 1533851 | Phenylpropanediol (100 mg) | N/A |
| 1533909 | Phenylpropanolamine Bitartrate (100 mg) (List Chemical) | 67244-90-0 |
| 1534005 | Phenylpropanolamine Hydrochloride (250 mg) (List Chemical) | 154-41-6 |
| 1534209 | Phenyl Salicylate Melting Point Standard (1 g) (COLD SHIPMENT REQUIRED) (Approximately 41 degrees) | 118-55-8 |
| 1534402 | Phenyltoloxamine Citrate (100 mg) | 1176-08-5 |
| 1534413 | Phenyltoloxamine Related Compound A (50 mg) (2-(2-benzylphenoxy)ethylmethylamine hydrochloride) | N/A |
| 1535008 | Phenytoin (200 mg) | 57-41-0 |
| 1535019 | Phenytoin Related Compound A (50 mg) (2,2-Diphenylglycine) | 3060-50-2 |
| 1535020 | Phenytoin Related Compound B (50 mg) (2,2-Diphenyl-2-ureidoacetic acid) | 6802-95-5 |
| 1535507 | Phenytoin Sodium (200 mg) | 630-93-3 |
| 1535700 | Phosphated Riboflavin (100 mg) | 6184-17-4 |
| 1535722 | Phosphatidic Acid (Soy) Monosodium (50 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | N/A |
| 1535733 | Phosphatidylcholine (250 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 97281-44-2 |
| 1535744 | Phosphatidylethanolamine (100 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 39382-08-6 |
| 1535755 | Phosphatidylcholine (Soy) (50 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 97281-47-5 |
| 1535766 | Phosphatidylethanolamine (Soy) (50 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 97281-51-1 |
| 1535788 | Phosphatidylinositol (Soy) Sodium (20 mg) (Phosphatidylinositol from soybean lecithin) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 383907-36-6 |
| 1535802 | Phosphoric Acid (1.5 mL/ampule; 3 ampules) | 7664-38-2 |
| 1535813 | Scaffold Human Dermis Reference Photomicrographs (CD) | N/A |
| 1535824 | Bovine Acellular Dermal Matrix Reference Photomicrographs (CD) | N/A |
| 1535835 | Cultured Rat Pheochromocytoma Reference Photomicrographs (CD) | N/A |
| 1535846 | Graftskin Reference Photomicrographs (CD) | N/A |
| 1535857 | Human Fibroblast-Derived Skin Substitute Reference Photomicrographs (CD) | N/A |
| 1535868 | Cryopreserved Human Fibroblast-Derived Dermal Substitute Reference Photomicrographs (CD) | N/A |
| 1535899 | Phthalic Acid (50 mg) | 88-99-3 |
| 1535959 | Phthalazine (20 mg) | 253-52-1 |
| 1536509 | Phyllanthin (15 mg) | 10351-88-9 |
| 1536510 | Powdered Phyllanthus Amarus Extract (1 g) | N/A |
| 1537003 | Physostigmine Salicylate (200 mg) | 57-64-7 |
| 1537910 | Phytic Acid Solution (5 mL) | 83-86-3 |
| 1538006 | Phytonadione (100 mg x 5 ampules) (Vitamin K1) | 84-80-0 |
| 1538505 | Pilocarpine (300 mg) | 92-13-7 |
| 1538902 | Pilocarpine Hydrochloride (200 mg) | 54-71-7 |
| 1539009 | Pilocarpine Nitrate (200 mg) | 148-72-1 |
| 1539508 | Pimozide (200 mg) | 2062-78-4 |
| 1539701 | Pindolol (200 mg) | 13523-86-9 |
| 1539803 | Maritime Pine Extract (2 g) | 90082-75-0 |
| 1539905 | Pioglitazone Hydrochloride (100 mg) | 112529-15-4 |
| 1541500 | Piperacillin (350 mg) | 66258-76-2 |
| 1541529 | Piperacillin Related Compound E (25 mg) (1-ethylpiperazine-2,3-dione) | 59702-31-7 |
| 1541601 | Piperazine (200 mg) | 110-85-0 |
| 1541703 | Piperazine Adipate (200 mg) | 142-88-1 |
| 1541805 | Piperazine Citrate (200 mg) | 144-29-6 |
| 1541907 | Piperazine Dihydrochloride (200 mg) | 142-64-3 |
| 1542003 | Piperazine Phosphate (200 mg) | 14538-56-8 |
| 1543200 | Piperine (20 mg) | 94-62-2 |
| 1544304 | Pirbuterol Acetate (200 mg) (AS) | 65652-44-0 |
| 1544406 | Piroctone Olamine (200 mg) | 68890-66-4 |
| 1544417 | Piroctone Related Compound A (15 mg) ((2-[5-methyl-3-(2,4,4-trimethylpentyl)-4,5-dihydroisoxazol-5-yl]acetic acid) 2-aminoethanol salt) | N/A |
| 1544428 | Piroctone Related Compound B (25 mg) (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one) | 50650-75-4 |
| 1544508 | Piroxicam (125 mg) | 36322-90-4 |
| 1544858 | Plant Stanol Esters (10 x 100 mg) | 194673-84-2 |
| 1544916 | Polyvinyl Chloride, Plasticized (3 Strips, 2” x 2 1/2” each) | 9002-86-2 |
| 1544927 | Plastic Additive 1 (100 mg) (Ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl] butanoate]) | 32509-66-3 |
| 1544938 | Plastic Additive 2 (200 mg) (pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]) | 6683-19-8 |
| 1544949 | Plastic Additive 3 (200 mg) (2,2′,2”,6,6′,6”-hexa-tert-butyl-4,4′,4”-[(2,4,6-trimethyl-1,3,5-benzenetriyl)trismethylene]triphenol) | 1709-70-2 |
| 1544950 | Plastic Additive 4 (200 mg) (Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate) | 2082-79-3 |
| 1544964 | Plastic Additive 5 (200 mg) (Tris(2,4-di-tert-butylphenyl) phosphite) | 31570-04-4 |
| 1544971 | Plastic Additive 6 (200 mg) (1,3,5-Tris(3,5-di-tert-butyl-4-hydroxybenzyl)-s-triazine-2,4,6(1H,3H,5H)-trione) | 27676-62-6 |
| 1544993 | Plastic Additive 8 (100 mg) (Dioctadecyl disulfide) | 2500-88-1 |
| 1545001 | Plastic Additive 9 (100 mg) (Didodecyl 3,3′-thiodipropionate) | 123-28-4 |
| 1545012 | Plastic Additive 10 (100 mg) (dioctadecyl 3,3′-thiodipropionate) | 693-36-7 |
| 1545023 | Plastic Additive 11 (100 mg) (Copolymer of Dimethyl Succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol)) | 65447-77-0 |
| 1545034 | Plastic Additive 12 (100 mg) (Oleamide) | 301-02-0 |
| 1545045 | Plastic Additive 13 (100 mg) (Erucamide) | 112-84-5 |
| 1545056 | Plastic Additive 14 (100 mg) (Di(2-ethylhexyl) phthalate) | 117-81-7 |
| 1545067 | Plastic Additive 15 (100 mg) (Epoxidized Soya Oil) | 8013-07-8 |
| 1545078 | Plastic Additive 16 (100 mg) (Epoxidized Linseed Oil) | 8016-11-3 |
| 1545090 | Plastic Additive 18 (5 x 25 mg) | 64685-81-0 |
| 1545409 | Polacrilex Resin (100 mg) | N/A |
| 1545500 | Polacrilin Potassium (200 mg) | 65405-55-2 |
| 1546106 | Poloxalene (500 mg) | 9003-11-6 |
| 1546150 | Poloxamer Liquid (1 mL) | 9003-11-6 |
| 1546161 | Poloxamer Solid (1 g) | 9003-11-6 |
| 1546183 | Polycarbonate (3 Strips, 2” x 2 1/2” each) | 25766-59-0 |
| 1546194 | Polydatin (20 mg) (3-Hydroxy-5-[(E)-2-(4-hydroxyphenyl)vinyl]phenyl Beta-D-glucopyranoside) | 27208-80-6 |
| 1546285 | Polydextrose (200 mg) | 68424-04-4 |
| 1546300 | Polydimethylsiloxane (500 mg) | 9016-00-6 |
| 1546401 | Polyethylene Glycol 200 (1 g) | 25322-68-3 |
| 1546423 | Polyethylene Glycol 300 (1 g) | 25322-68-3 |
| 1546445 | Polyethylene Glycol 400 (1 g) | 25322-68-3 |
| 1546467 | Polyethylene Glycol 600 (1 g) | 25322-68-3 |
| 1546489 | Polyethylene Glycol 1000 (1 g) | 25322-68-3 |
| 1546503 | Polyethylene Glycol 1500 (1 g) | 25322-68-3 |
| 1546525 | Polyethylene Glycol 3000 (1 g) | 25322-68-3 |
| 1546547 | Polyethylene Glycol 3350 (1 g) | 25322-68-3 |
| 1546569 | Polyethylene Glycol 4000 (1 g) (alpha-hydro-omega-hydroxypoly(oxy-1,2-ethanediyl)) | 25322-68-3 |
| 1546580 | Polyethylene Glycol 6000 (1 g) | 25322-68-3 |
| 1546605 | Polyethylene Glycol 8000 (1 g) | 25322-68-3 |
| 1546707 | High Density Polyethylene (3 strips) | 9002-88-4 |
| 1546809 | Low-Density Polyethylene (3 strips) | 9002-88-4 |
| 1546853 | Polyethylene Oxide (100 mg) | 25322-68-3 |
| 1546900 | Polyethylene Terephthalate (3 Strips 2” x 2 1/2”) | 25038-59-9 |
| 1546922 | Polyethylene Terephthalate G (PETG) (3 Strips) | 25640-14-6 |
| 1546933 | Polyglyceryl 3 Dioleate (1 g) | 79665-94-4 |
| 1546944 | Polyglyceryl 3 Diisostearate (1 mL) | 63705-03-3 |
| 1546955 | Polyglyceryl 6 Dioleate (1 g) | 76009-37-5 |
| 1546966 | Polyisobutylene (1 g) | 9003-27-4 |
| 1547007 | Polymyxin B Sulfate (200 mg) (COLD SHIPMENT REQUIRED) | 1405-20-5 |
| 1547153 | Polygonum multiflorum Root Dry Extract (200 mg) | N/A |
| 1547200 | Polyoxyl 35 Castor Oil (1 g) | 61791-12-6 |
| 1547255 | Polyoxyl 15 Hydroxystearate (500 mg) | 70142-34-6 |
| 1547302 | Polyoxyl 10 Oleyl Ether (1 mL) | 9004-98-2 |
| 1547346 | Polyoxyl 2 Stearyl Ether (1 g) | 9005-00-9 |
| 1547368 | Polyoxyl 20 Stearyl Ether (1 g) | 9005-00-9 |
| 1547379 | Polyoxyl 6 Stearate (200 mg) | N/A |
| 1547380 | Polyoxyl 8 Stearate (200 mg) | N/A |
| 1547391 | Polyoxyl 32 Stearate (200 mg) | N/A |
| 1547459 | Polyoxyl 75 Stearate (200 mg) | N/A |
| 1547550 | Polyoxyl 100 Stearate (200 mg) | N/A |
| 1547801 | Polyoxyl 20 Cetostearyl Ether (100 mg) | 68439-49-6 |
| 1547903 | Polyoxyl 40 Stearate (200 mg) | 9004-99-3 |
| 1547925 | Polysorbate 20 (2 g) | 9005-64-5 |
| 1547936 | Polysorbate 40 (2 g) | 9005-66-7 |
| 1547947 | Polysorbate 60 (2 g) | 9005-67-8 |
| 1547969 | Polysorbate 80 (4 x 0.5 g) | 9005-65-6 |
| 1548010 | Poly(ethylene-vinyl acetate) (1 g) | 24937-78-8 |
| 1548032 | Polyvinyl Acetate (1 g) | 9003-20-7 |
| 1548043 | Polyvinyl Acetate Dispersion (1 g) | 9003-20-7 |
| 1548065 | Polyvinyl Alcohol (100 mg) | 9002-89-5 |
| 1548076 | Polyvinyl Chloride (100 mg) | 9002-86-2 |
| 1548098 | Pomegranate Juice Concentrate (5 x 1 mL) | N/A |
| 1548101 | Potassium Benzoate (1 g) | 582-25-2 |
| 1548134 | Potassium Bicarbonate (1 g) | 298-14-6 |
| 1548167 | Potassium Carbonate (1 g) (AS) | 584-08-7 |
| 1548190 | Potassium Chloride (1 g) | 7447-40-7 |
| 1548225 | Potassium Citrate (1 g) (AS) | 6100-05-6 |
| 1548280 | Potassium Iodide (1 g) | 7681-11-0 |
| 1548349 | Potassium Nitrate (5 g) (AS) | 7757-79-1 |
| 1548407 | Potassium Sorbate (1 g) | 24634-61-5 |
| 1549807 | Potassium Acetate (500 mg) (AS) | 127-08-2 |
| 1549840 | Potassium Bitartrate (3 g) (AS) | 868-14-4 |
| 1550001 | Potassium Gluconate (200 mg) | 299-27-4 |
| 1551004 | Potassium Guaiacolsulfonate (500 mg) | 78247-49-1 |
| 1551128 | Dibasic Potassium Phosphate (5 g) (AS) | 7758-11-4 |
| 1551139 | Monobasic Potassium Phosphate (5 g) | 7778-77-0 |
| 1551140 | Potassium Sodium Tartrate (2 g) (AS) | 6381-59-5 |
| 1551150 | Potassium Sucrose Octasulfate (300 mg) | 76578-81-9 (heptahydrate) 7326 |
| 1551300 | Potassium Trichloroammineplatinate (25 mg) | 13820-91-2 |
| 1551503 | Povidone (100 mg) | 9003-39-8 |
| 1553000 | Pralidoxime Chloride (200 mg) | 14018-50-9 |
| 1553768 | Pramipexole Related Compound A (15 mg) ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine) | 106092-09-5 |
| 1553815 | Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride) | 104632-27-1 |
| 1553859 | Pramipexole Dihydrochloride Monohydrate (200 mg) | 191217-81-9 |
| 1554002 | Pramoxine Hydrochloride (400 mg) | 637-58-1 |
| 1554104 | Prasugrel Hydrochloride (150 mg) (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride) | 389574-19-0 |
| 1554192 | Pravastatin 1,1,3,3-Tetramethylbutylamine (200 mg) | 151006-14-3 |
| 1554206 | Pravastatin Sodium (50 mg) | 81131-70-6 |
| 1554217 | Pravastatin Related Compound A (10 mg) (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate) | N/A |
| 1554228 | Pravastatin Related Compound B (20 mg) (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate) | 81176-41-2 |
| 1554501 | Prazepam CIV (500 mg) | 2955-38-6 |
| 1554603 | Praziquantel (200 mg) | 55268-74-1 |
| 1554658 | Praziquantel Related Compound A (20 mg) (2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) | N/A |
| 1554669 | Praziquantel Related Compound B (50 mg) (2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-a]isoquinolin-4-one) | 125273-86-1 |
| 1554670 | Praziquantel Related Compound C (50 mg) (2-(N-formylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one) | N/A |
| 1554705 | Prazosin Hydrochloride (350 mg) | 19237-84-4 |
| 1554909 | Prednicarbate (200 mg) | 73771-04-7 |
| 1554910 | Prednicarbate Related Compound A (20 mg) (1,2-dihydroprednicarbate) | 671225-26-6 |
| 1554920 | Prednicarbate Related Compound B (20 mg) (prednisolone-17-ethylcarbonate) | 104286-02-4 |
| 1554931 | Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) | 5740-62-5 |
| 1555005 | Prednisolone (200 mg) | 50-24-8 |
| 1556008 | Prednisolone Acetate (200 mg) | 52-21-1 |
| 1556507 | Prednisolone Hemisuccinate (125 mg) | 2920-86-7 |
| 1557000 | Prednisolone Sodium Phosphate (500 mg) | 125-02-0 |
| 1558003 | Prednisolone Tebutate (200 mg) | 7681-14-3 |
| 1559006 | Prednisone (250 mg) | 53-03-2 |
| 1559505 | Prednisone Tablets (30 tablets) | 53-03-3 |
| 1559618 | Pregabalin CV (200 mg) | 148553-50-8 |
| 1559629 | Pregabalin Related Compound A (25 mg) ((R)-3-(Aminomethyl)-5-methylhexanoic acid) | 148553-51-9 |
| 1559647 | Pregabalin Related Compound C (25 mg) (4-Isobutylpyrrolidin-2-one) | 61312-87-6 |
| 1559709 | Prekallikrein Activator (22.5 IU) | N/A |
| 1560990 | Prilocaine (200 mg) | 721-50-6 |
| 1561008 | Prilocaine Hydrochloride (200 mg) | 1786-81-8 |
| 1561019 | Prilocaine Related Compound A (100 mg) (o-toluidine hydrochloride) | 636-21-5 |
| 1561020 | Prilocaine Related Compound B (50 mg) ((RS)-N-(4-methylphenyl)-2-(propylamino)propanamide) | N/A |
| 1561507 | Primaquine Phosphate (200 mg) | 63-45-6 |
| 1561518 | Primaquine Related Compound A (15 mg) (8-[(4-Aminopentyl)amino]-6-methoxyquinoline) | 525-61-1 |
| 1562000 | Primidone (200 mg) | 125-33-7 |
| 1562011 | Primidone Related Compound A (20 mg) (2-ethyl-2-phenylmalonamide) | 7206-76-0 |
| 1562033 | Primidone Related Compound C (20 mg) (2-phenyl butyramide) | 90-26-6 |
| 1563003 | Probenecid (200 mg) | 57-66-9 |
| 1563309 | Probucol (200 mg) | 23288-49-5 |
| 1563320 | Probucol Related Compound A (25 mg) (2,2′,6,6′-tetra-tert-butyldiphenoquinone) | 2455-14-3 |
| 1563331 | Probucol Related Compound B (25 mg) (4,4′-dithio-bis(2,6-di-tert-butylphenol)) | N/A |
| 1563342 | Probucol Related Compound C (25 mg) (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) | 1391054-68-4 |
| 1563502 | Procainamide Hydrochloride (200 mg) | 614-39-1 |
| 1564006 | Procaine Hydrochloride (200 mg) | 51-05-8 |
| 1565009 | Procarbazine Hydrochloride (200 mg) | 366-70-1 |
| 1566001 | Prochlorperazine Maleate (200 mg) | 84-02-6 |
| 1566045 | Prochlorperazine Related Compound A (10 mg) (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride) | N/A |
| 1567004 | Procyclidine Hydrochloride (200 mg) | 1508-76-5 |
| 1567999 | Progesterone System Suitability Mixture (40 mg) (Mixture contains 20-alpha-Progerol, 20-Beta-Progerol, 17alpha-Progesterone, 20-alpha-Progerol acetate, 20-Beta-Progerol acetate and Cyclohexylidene progesterone in Progesterone) | N/A |
| 1568007 | Progesterone (200 mg) | 57-83-0 |
| 1568018 | Progesterone Related Compound H (25 mg) (Pregna-4,6-diene-3,20-dione) | 1162-56-7 |
| 1568028 | Proguanil Related Compound A (25 mg) (1-cyano-3-isopropylguanidine) | 44830-55-9 |
| 1568040 | Proguanil Hydrochloride (200 mg) | 637-32-1 |
| 1568051 | Proguanil Related Compound C (25 mg) (1,5-bis(4-chlorophenyl)biguanide hydrochloride) | 13590-98-2 |
| 1568062 | Proguanil Related Compound D (25 mg) (1,5-bis(1-methylethyl)biguanide hydrochloride) | 35708-82-8 |
| 1568073 | Proguanil Related Compound E (25 mg) (1-(4-chlorophenyl)-3-cyanoguanidine) | 1482-62-8 |
| 1568084 | Proguanil Related Compound F (25 mg) (1-(3,4-dichlorophenyl)-5-isopropylbiguanide hydrochloride) | 6001-93-0 |
| 1568095 | Proguanil Related Compound G (25 mg) (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride) | 1071546-52-5 |
| 1568506 | L-Proline (200 mg) | 147-85-3 |
| 1569000 | Promazine Hydrochloride (200 mg) | 53-60-1 |
| 1569315 | Pimobendan (100 mg) | 74150-27-9 |
| 1569326 | Pimobendan Related Compound A (15 mg) (4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic acid) | N/A |
| 1569337 | Pimobendan Related Compound B (15 mg) (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide) | 74149-74-9 |
| 1570009 | Promethazine Hydrochloride (500 mg) | 58-33-3 |
| 1570029 | Promethazine Related Compound B (25 mg) (N,N-Dimethyl-2-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride) | 5568-90-1 |
| 1570304 | Propafenone Hydrochloride (200 mg) | 34183-22-7 |
| 1570315 | Propafenone Related Compound A (20 mg) (N-{2-Hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]propyl}-N-propylformamide) | N/A |
| 1570326 | Propafenone Related Compound B (50 mg) ((2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one) | 88308-22-9 |
| 1570406 | 1-Propanol (1.2 mL/ampule; 3 ampules) | 71-23-8 |
| 1570428 | 2-Propanol (1.2 mL/ampule; 3 ampules) | 67-63-0 |
| 1570439 | 2-Propanol System Suitability (3 x 1 mL) | N/A |
| 1570450 | Propanolamine (100 mg) (3-aminopropan-1-ol) | 156-87-6 |
| 1570483 | 1,3-Propanediol (1 mL) | 504-63-2 |
| 1570508 | Propantheline Bromide (200 mg) | 50-34-0 |
| 1571001 | Proparacaine Hydrochloride (200 mg) | 5875-06-9 |
| 1572208 | Propionic Acid (1.5 mL/ampule; 3 ampules) (AS) | 79-09-4 |
| 1572503 | Propofol (500 mg) | 2078-54-8 |
| 1572525 | Propofol Resolution Mixture (100 mg) (Propofol, 2,6-diisopropylphenyl isopropylether, and 2-isopropyl-6-n-propylphenol) | N/A |
| 1572536 | Propofol Related Compound A (25 mg) (3,3′-5,5′-tetraisopropyldiphenol) | 2416-95-7 |
| 1572547 | Propofol Related Compound B (30 mg) (2,6-diisopropylbenzoquinone) | N/A |
| 1572558 | Propofol Related Compound C (25 mg) (2,6-diisopropylphenyl isopropyl ether) | N/A |
| 1573007 | Propoxycaine Hydrochloride (200 mg) | 550-83-4 |
| 1575206 | Propoxyphene Related Compound A (50 mg) (alpha-d-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol hydrochloride) | N/A |
| 1576005 | Propranolol Hydrochloride (200 mg) | 318-98-9 |
| 1576402 | Propyl Acetate (1.2 mL/ampule; 3 ampules) | 109-60-4 |
| 1576504 | Propylene Carbonate (200 mg) | 108-32-7 |
| 1576661 | Propylene Glycol Monocaprylate Type I (1 g) | 31565-12-5; 85883-73-4 |
| 1576672 | Propylene Glycol Monocaprylate Type II (1 g) | 31565-12-5; 85883-73-4 |
| 1576683 | Propylene Glycol Dicaprylate/Dicaprate (1 mL) | 68583-51-7 |
| 1576708 | Propylene Glycol (5 x 1 mL) | 57-55-6 |
| 1576763 | Propylene Glycol Dilaurate (500 mg) | 22788-19-8 |
| 1576785 | Propylene Glycol Monolaurate Type I (500 mg) | 27194-74-7; 142-55-2 |
| 1576796 | Propylene Glycol Monolaurate Type II (500 mg) | 37321-62-3 |
| 1576800 | Propyl Gallate (200 mg) | 121-79-9 |
| 1576945 | Propylene Oxide (5 x 0.1 mL) | 75-56-9 |
| 1577008 | Propylparaben (200 mg) | 94-13-3 |
| 1578000 | Propylthiouracil (200 mg) | 51-52-5 |
| 1578500 | Prostaglandin A1 (25 mg) | 14152-28-4 |
| 1578554 | Prostaglandin B1 (25 mg) ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic Acid) | 13345-51-2 |
| 1578612 | Protamine Sulfate (2.85 mg) | 9009-65-8 |
| 1578805 | Protein A (250 uL/ampule; 2 ampules) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | N/A |
| 1578816 | rProtein A (250 uL/ampule; 2 ampules) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | N/A |
| 1578827 | rProtein A, C-Cys (250 uL/ampule; 2 ampules) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | N/A |
| 1579310 | Protocatechuic Acid (25 mg) (3,4-dihydroxybenzoic acid) | 99-50-3 |
| 1580002 | Protriptyline Hydrochloride (200 mg) | 1225-55-4 |
| 1581005 | Pseudoephedrine Hydrochloride (125 mg) (List Chemical) | 345-78-8 |
| 1581504 | Pseudoephedrine Sulfate (200 mg) (List Chemical) | 7460-12-0 |
| 1583805 | Pygeum Extract (150 mg) | 94279-95-5 |
| 1584003 | Pyrantel Pamoate (500 mg) | 22204-24-6 |
| 1584014 | Pyrantel Related Compound A (25 mg) ((Z)-1-Methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine Pamoate) | N/A |
| 1584105 | Pyrantel Tartrate (200 mg) | 33401-94-4 |
| 1585006 | Pyrazinamide (200 mg) | 98-96-4 |
| 1585505 | Pyrethrum Extract (100 mg) | N/A |
| 1586009 | Pyridostigmine Bromide (200 mg) | 101-26-8 |
| 1586020 | Pyridostigmine Related Compound A (50 mg) (Pyridin-3-yl dimethylcarbamate) | 51581-32-9 |
| 1586031 | Pyridostigmine Related Compound B (10 mg) (3-Hydroxy-1-methylpyridin-1-ium bromide) | N/A |
| 1587001 | Pyridoxine Hydrochloride (200 mg) | 58-56-0 |
| 1588004 | Pyrilamine Maleate (200 mg) | 59-33-6 |
| 1589007 | Pyrimethamine (200 mg) | 58-14-0 |
| 1589029 | Pyroglutamic Acid (30 mg) ((S)-5-Oxopyrrolidine-2-carboxylic acid) | 98-79-3 |
| 1592001 | Pyrvinium Pamoate (500 mg) | 3546-41-6 |
| 1592205 | Quazepam CIV (200 mg) | 36735-22-5 |
| 1592227 | Quazepam Related Compound A (30 mg) (7-Chloro-1-(2,2,2-trifluoroethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) | 49606-44-2 |
| 1592409 | Quercetin (500 mg) | 6151-25-3 |
| 1592704 | Quetiapine Fumarate (200 mg) | 111974-72-2 |
| 1592715 | Quetiapine System Suitability (25 mg) (Mixture contains Quetiapine Fumarate and about 1% each of Quetiapine Related Compound B, Quetiapine Related Compound G and Quetiapine Desethoxy) | N/A |
| 1592737 | Quetiapine Related Compound B (15 mg) (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride) | 111974-74-4 |
| 1592781 | Quetiapine Related Compound G (15 mg) (Dibenzo[b,f][1,4]thiazepin-11(10H)-one) | 3159-07-7 |
| 1592792 | Quetiapine Related Compound H (15 mg) (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide) | 1076199-40-0 |
| 1593401 | Quinapril Hydrochloride (400 mg) | 82586-55-8 |
| 1593412 | Quinapril Related Compound A (50 mg) (Ethyl[3S-[2(R*),3a,11a beta]]-1,3,4,6,11,11a-hexahydro-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetate) | 103733-49-9 |
| 1593423 | Quinapril Related Compound B (50 mg) (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]]-) | 82768-85-2 |
| 1594506 | Quinic Acid (200 mg) | 77-95-2 |
| 1595000 | Quinidine Gluconate (200 mg) | 7054-25-3 |
| 1595509 | Quinidine Sulfate (500 mg) | 6591-63-5 |
| 1596807 | Quinine Hydrochloride Dihydrate (1 g) | 6119-47-7 |
| 1597005 | Quinine Sulfate (500 mg) | 207671-44-1 |
| 1597504 | Quininone (50 mg) | 84-31-1 |
| 1598019 | Rabeprazole Sodium (200 mg) (Sodium 2-[(R)-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]benzimidazol-1-ide hydrate) | N/A |
| 1598020 | Rabeprazole Related Compound A (25 mg) (1-(1H-Benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate, sodium salt) | N/A |
| 1598031 | Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) | 924663-38-7 |
| 1598042 | Rabeprazole Related Compound C (25 mg) (1H-Benzimidazole-2-thiol) | 583-39-1 |
| 1598053 | Rabeprazole Related Compound D (25 mg) (2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfonyl]benzimidazole) | 117976-47-3 |
| 1598064 | Rabeprazole Related Compound E (25 mg) (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole) | 117977-21-6 |
| 1598075 | Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) | 168167-42-8 |
| 1598097 | Racepinephrine Hydrochloride (30 mg) ((RS)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol hydrochloride) | 329-63-5 |
| 1598100 | Ractopamine Hydrochloride (200 mg) | 90274-24-1 |
| 1598201 | Raloxifene Hydrochloride (200 mg) | 82640-04-8 |
| 1598234 | Raloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate) | 195454-31-0 |
| 1598267 | Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide) | 1193687-87-4 |
| 1598278 | Raltegravir Potassium (200 mg) | 871038-72-1 |
| 1598303 | Ramipril (125 mg) | 87333-19-5 |
| 1598314 | Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) | 91224-69-0 |
| 1598323 | Ramipril Related Compound B (20 mg) (Ramipril Isopropylester) | 295328-72-2 |
| 1598338 | Ramipril Related Compound C (20 mg) (Hexahydroramipril Hydrochloride) | N/A |
| 1598347 | Ramipril Related Compound D (20 mg) (Ramipril Diketopiperazine) | N/A |
| 1598405 | Ranitidine Hydrochloride (200 mg) | 66357-59-3 |
| 1598450 | Ranitidine Resolution Mixture (20 mg) | N/A |
| 1598507 | Ranitidine Related Compound A (50 mg) (5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine, hemifumarate salt) | 91224-69-0 |
| 1598609 | Ranitidine Related Compound B (50 mg) (N,N’-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine) | 72126-78-4 |
| 1598700 | Ranitidine Related Compound C (50 mg) (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine) | 73851-70-4 |
| 1598744 | Ranolazine (100 mg) | 95635-55-5 |
| 1598755 | Ranolazine Related Compound A (50 mg) ((+/-)-2-[(2-methoxyphenoxy)methyl]oxirane) | 2210-74-4 |
| 1598766 | Ranolazine Related Compound B (50 mg) (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate) | N/A |
| 1598777 | Ranolazine Related Compound C (50 mg) (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide) | 5294-61-1 |
| 1598788 | Ranolazine Related Compound D (50 mg) (2,2′-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide]) | 380204-72-8 |
| 1598802 | Raspberry Alcohol (50 mg) (4-(3-Hydroxybutyl)phenol) | 69617-84-1 |
| 1598813 | Raspberry Ketone (100 mg) (4-(4-hydroxyphenyl)-2-butanone) | 5471-51-2 |
| 1599000 | Rauwolfia Serpentina (15 g) | 8063-17-0 |
| 1599500 | Powdered Red Clover Extract (500 mg) | N/A |
| 1600121 | Rebaudioside A (500 mg) | 58543-16-1 |
| 1600132 | Rebaudioside B (100 mg) | 58543-17-2 |
| 1600154 | Rebaudioside D (100 mg) | 63279-13-0 |
| 1600303 | Refined Bleached Shellac (1 g) | 9000-59-3 |
| 1600314 | Regular Bleached Shellac (100 mg) | 9000-59-3 |
| 1600813 | Repaglinide (200 mg) | 135062-02-1 |
| 1600824 | Repaglinide Related Compound A (10 mg) ((S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate salt) | N/A |
| 1600835 | Repaglinide Related Compound B (50 mg) (3-Ethoxy-4-ethoxycarbonylphenylacetic acid) | 99469-99-5 |
| 1600846 | Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid) | N/A |
| 1600868 | Repaglinide Related Compound E (20 mg) ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid) | 147852-26-4 |
| 1601000 | Reserpine (200 mg) | 50-55-5 |
| 1601102 | Residual Solvents Mixture – Class 1 (1.2 mL/ampule; 3 ampules) (Ozone Depleting Substance) | N/A |
| 1601146 | Residual Solvent Class 1 – Benzene (1.2 mL/ampule; 3 ampules) | 71-43-2 |
| 1601168 | Residual Solvent Class 1 – Carbon Tetrachloride (1.2 mL/ampule; 3 ampules) (Ozone Depleting Substance) | N/A |
| 1601180 | Residual Solvent Class 1 – 1,2-Dichloroethane (1.2 mL/ampule; 3 ampules) | 107-06-2 |
| 1601204 | Residual Solvent Class 1 – 1,1-Dichloroethene (1.2 mL/ampule; 3 ampules) | 75-35-4 |
| 1601226 | Residual Solvent Class 1 – 1,1,1-Trichloroethane (1.2 mL/ampule; 3 ampules) (Ozone Depleting Substance) | N/A |
| 1601281 | Residual Solvents Class 2 – Mixture A (1.2 mL/ampule; 3 ampules) | N/A |
| 1601292 | Residual Solvents Class 2 – Mixture B (1.2 mL/ampule; 3 ampules) | N/A |
| 1601306 | Residual Solvent Class 2 – Mixture C (1.2 mL/ampule; 3 ampules) | N/A |
| 1601340 | Residual Solvent Class 2 – Acetonitrile (1.2 mL/ampule; 3 ampules) | 75-0508 |
| 1601361 | Residual Solvent Class 2 – Chlorobenzene (1.2 mL/ampule; 3 ampules) | N/A |
| 1601383 | Residual Solvent Class 2 – Chloroform (1.2 mL/ampule; 3 ampules) | N/A |
| 1601394 | Residual Solvent Class 2 – Cumene (1.2 mL/ampule; 3 ampules) | N/A |
| 1601408 | Residual Solvent Class 2 – Cyclohexane (1.2 mL/ampule; 3 ampules) | 110-82-7 |
| 1601420 | Residual Solvent Class 2 – 1,2-Dichloroethene (1.2 mL/ampule; 3 ampules) | N/A |
| 1601441 | Residual Solvent Class 2 – Methylene Chloride (1.2 mL/ampule; 3 ampules) | N/A |
| 1601452 | Residual Solvent Class 2 – Methylisobutylketone (3 x 1.2 mL) | 108-10-1 |
| 1601463 | Residual Solvent Class 2 – 1,2-Dimethoxyethane (1.2 mL/ampule; 3 ampules) | N/A |
| 1601485 | Residual Solvent Class 2 – N,N-Dimethylacetamide (1.2 mL/ampule; 3 ampules) | N/A |
| 1601500 | Residual Solvent Class 2 – N,N-Dimethylformamide (1.2 mL/ampule; 3 ampules) | N/A |
| 1601521 | Residual Solvent Class 2 – 1,4-Dioxane (1.2 mL/ampule; 3 ampules) | 123-91-1 |
| 1601543 | Residual Solvent Class 2 – 2-Ethoxyethanol (1.2 mL/ampule; 3 ampules) | N/A |
| 1601565 | Residual Solvent Class 2 – Ethylene Glycol (1.2 mL/ampule; 3 ampules) | N/A |
| 1601587 | Residual Solvent Class 2 – Formamide (1.2 mL/ampule; 3 ampules) | N/A |
| 1601601 | Residual Solvent Class 2 – Hexane (1.2 mL/ampule; 3 ampules) | N/A |
| 1601623 | Residual Solvent Class 2 – Methanol (1.2 mL/ampule; 3 ampules) | N/A |
| 1601645 | Residual Solvent Class 2 – 2-Methoxyethanol (1.2 mL/ampule; 3 ampules) | N/A |
| 1601667 | Residual Solvent Class 2 – Methylbutylketone (1.2 mL/ampule; 3 ampules) | N/A |
| 1601689 | Residual Solvent Class 2 – Methylcyclohexane (1.2 mL/ampule; 3 ampules) | N/A |
| 1601703 | Residual Solvent Class 2 – N-Methylpyrrolidone (1.2 mL/ampule; 3 ampules) | N/A |
| 1601725 | Residual Solvent Class 2 – Nitromethane (1.2 mL/ampule; 3 ampules) | N/A |
| 1601747 | Residual Solvent Class 2 – Pyridine (1.2 mL/ampule; 3 ampules) | N/A |
| 1601769 | Residual Solvent Class 2 – Sulfolane (1.2 mL/ampule; 3 ampules) | N/A |
| 1601770 | Residual Solvent Class 2 – Tetrahydrofuran (1.2 mL/ampule; 3 ampules) | N/A |
| 1601780 | Residual Solvent Class 2 – Tetralin (1.2 mL/ampule; 3 ampules) | N/A |
| 1601805 | Residual Solvent Class 2 – Toluene (1.2 mL/ampule; 3 ampules) | N/A |
| 1601827 | Residual Solvent Class 2 – Trichloroethylene (1.2 mL/ampule; 3 ampules) | N/A |
| 1601849 | Residual Solvent Class 2 – Xylenes (1.2 mL/ampule; 3 ampules) | N/A |
| 1602003 | Resorcinol (200 mg) | 108-46-3 |
| 1602105 | trans-Resveratrol (100 mg) | 501-36-0 |
| 1602502 | Retinyl Palmitate (4 x 50 mg) | 79-81-2 |
| 1602580 | Rhodiola Rosea Root and Rhizome Dry Extract (1 g) | N/A |
| 1602706 | Ribavirin (200 mg) | 36791-04-5 |
| 1602717 | Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) | 39925-19-4 |
| 1602740 | Ribavirin Related Compound D (15 mg) (1H-1,2,4-triazole-3-carboxamide) | 3641-08-5 |
| 1603006 | Riboflavin (500 mg) | 83-88-5 |
| 1603108 | Ribose (300 mg) | 50-69-1 |
| 1603800 | Rifabutin (50 mg) | 72559-06-9 |
| 1604009 | Rifampin (300 mg) | 13292-46-1 |
| 1604202 | Rifampin Quinone (25 mg) | 13983-13-6 |
| 1604337 | Riluzole (200 mg) | 1744-22-5 |
| 1604348 | Riluzole Related Compound A (25 mg) (4-trifluoromethoxyaniline) | 461-82-5 |
| 1604508 | Rimantadine Hydrochloride (300 mg) | 1501-84-4 |
| 1604600 | Rimexolone (100 mg) | 49697-38-3 |
| 1604610 | Risedronate Sodium (350 mg) | 329003-65-8 |
| 1604621 | Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate) | 105462-23-5 |
| 1604632 | Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt) | N/A |
| 1604643 | Risedronate Related Compound C (20 mg) ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)) | 75755-10-1 |
| 1604654 | Risperidone (100 mg) | 106266-06-2 |
| 1604665 | Risperidone System Suitability Mixture (10 mg) | N/A |
| 1604676 | Risperidone Related Compounds Mixture (25 mg) | N/A |
| 1604701 | Ritodrine Hydrochloride (200 mg) | 23239-51-2 |
| 1604756 | Risperidone Related Compound G (25 mg) (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride) | 152542-00-2 |
| 1604803 | Ritonavir (200 mg) | 155213-67-5 |
| 1604811 | Rivastigmine Related Compound C (15 mg) ((S)-3-[1-(Dimethylamino)ethyl]phenol) | 139306-10-8 |
| 1604814 | Ritonavir Related Compounds Mixture (50 mg) | 155213-67-5 |
| 1604825 | Rivastigmine Related Compound D (50 mg) (3-Acetylphenyl ethyl(methyl)carbamate) | 855300-09-3 |
| 1604836 | Rivastigmine (0.1 mL) | 123441-03-2 |
| 1604847 | Rivastigmine Tartrate R-Isomer (20 mg) ((R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate) | 415973-05-6 |
| 1604858 | Rivastigmine Tartrate (200 mg) | 129101-54-8 |
| 1604869 | Rivastigmine Related Compound A (15 mg) ((+)-Di-(p-toluoyl)-D-tartaric acid) | 32634-68-7 |
| 1604870 | Rivastigmine Related Compound B (15 mg) ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate) | 25081-93-0 |
| 1604880 | Rizatriptan Benzoate (200 mg) | 145202-66-0 |
| 1604891 | Rizatriptan Benzoate System Suitability Mixture (15 mg) | N/A |
| 1604905 | Rocuronium Bromide (250 mg) (COLD SHIPMENT REQUIRED) | 119302-91-9 |
| 1604916 | Rocuronium Peak Identification Mixture (25 mg) (rocuronium bromide spiked with rocuronium related compounds A, B, C, D, E, F, G, and H) | N/A |
| 1604950 | Rivastigmine Related Compound E (15 mg) ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride) | N/A |
| 1604961 | Rivastigmine Related Compound F (25 mg) (3-Vinylphenyl ethyl(methyl)carbamate) | N/A |
| 1605205 | Ropinirole Hydrochloride (200 mg) | 91374-20-8 |
| 1605216 | Ropinirole Related Compound A (50 mg) (4-(2-hydroxyethyl)indolin-2-one) | 139122-19-3 |
| 1605227 | Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) | 221264-21-7 |
| 1605497 | Ropivacaine (200 mg) | 84057-95-4 |
| 1605500 | Ropivacaine Hydrochloride (200 mg) | 132112-35-7 |
| 1605512 | Ropivacaine Related Compound A (25 mg) (2,6-dimethylaniline hydrochloride) | 21436-98-6 |
| 1605523 | Ropivacaine Related Compound B (50 mg) ((R)-(+)-1-Propylpiperidine-2-carboxylic acid (2,6-dimethylphenyl)-amide hydrochloride monohydrate) | 112773-90-7 |
| 1605588 | Rosavin (25 mg) ((2E)-3-Phenylprop-2-en-1-yl 6-O-alpha-l-arabinopyranosyl-Beta-D-glucopyranoside) | 84954-92-7 |
| 1605668 | Powdered Rosemary Extract (1 g) | 84604-14-8 |
| 1605680 | Powdered Rosemary Hydrophilic Extract (1 g) | 84604-14-8 |
| 1605817 | Rosiglitazone Maleate (200 mg) | 122320-73-4 |
| 1605828 | Rosiglitazone Related Compound A (25 mg) ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) | 160596-25-8 |
| 1605952 | Rosmarinic Acid (25 mg) | 20283-92-5 |
| 1606015 | Rosuvastatin Calcium (300 mg) | 147098-20-2 |
| 1606026 | Rosuvastatin Related Compound A (25 mg) (Calcium (3R,5S,E)-7-{4-(4-fluorophenyl)-2-[(2-hydroxy-N,2-dimethylpropyl)sulfonamido]-6-isopropylpyrimidin-5-yl}-3,5-dihydroxyhept-6-enoate salt (1:2)) | 1714147-47-3 |
| 1606037 | Rosuvastatin Related Compound B (25 mg) | N/A |
| 1606048 | Rosuvastatin Related Compound C (25 mg) (tert-Butyl2-[(4R,6S)-6-{(E)-2-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]vinyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate) | 289042-12-2 |
| 1606059 | Rosuvastatin Enantiomer (25 mg) (Calcium (3S,5R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate salt (1:2)) | N/A |
| 1606208 | Roxarsone (200 mg) | 121-19-7 |
| 1606274 | Rubusoside (100 mg) | 64849-39-4 |
| 1606401 | Rufinamide (200 mg) | 106308-44-5 |
| 1606412 | Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide) | 106308-41-2 |
| 1606423 | Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) | 217448-86-7 |
| 1606503 | Rutin (100 mg) | 153-18-4 |
Chuẩn USP từ S - Z
Chuẩn dược điển USP từ S đến Z
| Mã code | Tên chuẩn dược điển | Mã CAS# |
| 1607007 | Saccharin (200 mg) | 81-07-2 |
| 1607029 | Saccharin Calcium (100 mg) | 6381-91-5 |
| 1607040 | Saccharin Sodium (100 mg) | 128-44-9 |
| 1607200 | Safflower Oil (1 g) | 8001-23-8 |
| 1607299 | Safrole (4 x 50 mg) (List Chemical) (5-allylbenzo-1,3-dioxole) | 94-59-7 |
| 1607506 | Powdered St. John’s Wort Extract (600 mg) | 84082-80-4 |
| 1607903 | D-Salicin (150 mg) | 138-52-3 |
| 1608000 | Salicylamide (200 mg) | 65-45-2 |
| 1609002 | Salicylic Acid (125 mg) | 69-72-7 |
| 1609013 | Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid) | 99-96-7 |
| 1609024 | Salicylic Acid Related Compound B (100 mg) (4-hydroxyisophthalic acid) | 636-46-4 |
| 1609534 | Salidroside (25 mg) (2-(4-Hydroxyphenyl)ethyl-Beta-D-glucopyranoside) | 10338-51-9 |
| 1609589 | Salmeterol Resolution Check (15 mg) | N/A |
| 1609590 | Salmeterol System Suitability (15 mg) | N/A |
| 1609603 | Salmeterol Xinafoate (150 mg) | 94749-08-3 |
| 1609614 | Salmeterol Related Compound A (20 mg) (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol) | 1798014-51-3 |
| 1609625 | Salmeterol Related Compound B (3 x 1.3 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- | 108928-81-0 |
| 1609680 | Salmeterol Related Compound H (30 mg) (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) | N/A |
| 1609807 | Salsalate (150 mg) | 552-94-3 |
| 1609818 | Salvianolic Acid B (25 mg) | 121521-90-2 |
| 1609829 | Saquinavir Mesylate (200 mg) | 149845-06-7 |
| 1609831 | Saquinavir Related Compound A (25 mg) (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide) | N/A |
| 1609895 | Schisandrin (15 mg) | 7432-28-2 |
| 1609909 | Schisandra chinensis Fruit Dry Extract (1 g) | N/A |
| 1610001 | Scopolamine Hydrobromide (500 mg) | 6533-68-2 |
| 1610090 | Scopoletin (20 mg) | 92-61-5 |
| 1611004 | Secobarbital CII (200 mg) | 76-73-3 |
| 1611117 | Secoxyloganin (50 mg) ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) | 58822-47-2 |
| 1611729 | Selamectin (350 mg) | 220119-17-5 |
| 1611900 | Selegiline Hydrochloride (200 mg) | 14611-52-0 |
| 1611944 | Selegiline Related Compound D (15 mg) ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride) | 56862-28-3 |
| 1611955 | Selenomethionine (100 mg) | 1464-42-2 |
| 1612007 | Sennosides (500 mg) | N/A |
| 1612018 | Sennoside A (20 mg) ((9R,9’R)-5,5′-Bis(beta-d-glucopyranosyloxy)-4,4′-dihydroxy-10,10′-dioxo-9,9′,10,10′-tetrahydro-9,9′-bianthracene-2,2′-dicarboxylic acid) | 81-27-6 |
| 1612029 | Sennoside B (20 mg) | 128-57-4 |
| 1612404 | Sesame Oil (1 g) | 8008-74-0 |
| 1612415 | Sesame Oil Related Compound A (12 mg/vial; 2 vials) (1,2-dilinoleoyl-3-oleoyl-rac-glycerol) (OLL) | 2190-21-8 |
| 1612426 | Sesame Oil Related Compound B (12 mg x 2 ampules) (1,2-dilinoleoyl-3-palmitoyl-rac-glycerol)(PLL) | 2190-15-0 |
| 1612506 | L-Serine (200 mg) | 56-45-1 |
| 1612517 | Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | 79617-89-3 |
| 1612528 | Sertraline Hydrochloride Related Compound A (25 mg) (1:1 mixture of (1R, 4S) and (1S, 4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) | N/A |
| 1612539 | Sertraline Hydrochloride (100 mg) | 79559-97-0 |
| 1612540 | Sevoflurane (1 mL) | 28523-86-6 |
| 1612550 | Sevoflurane Related Compound A (0.2 mL) (1,1,1,3,3-Pentafluoroisopropenyl fluoromethyl ether) | 58109-34-5 |
| 1612561 | Sildenafil Citrate (100 mg) | 171599-83-0 |
| 1612572 | Sevoflurane Related Compound B (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-methoxy-propane) | 13171-18-1 |
| 1612594 | Sevoflurane Related Compound C (0.2 mL) (1,1,1,3,3,3-hexafluoro-2-propanol) | 920-66-1 |
| 1612608 | Silver Sulfadiazine (200 mg) | 22199-08-2 |
| 1612619 | N-Acetylneuraminic Acid (200 mg) | 50795-27-2 |
| 1612630 | Silybin (50 mg) | 22888-70-6 |
| 1612641 | Silydianin (30 mg) | 29782-68-1 |
| 1612652 | Simethicone (50 g) | 8050-81-5 |
| 1612685 | Sildenafil Related Compound A (10 mg) (5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one) | N/A |
| 1612700 | Simvastatin (200 mg) | 79902-63-9 |
| 1612719 | Tenivastatin Calcium (30 mg) (Calcium (3R,5R)-7-{(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}-3,5-dihydroxyheptanoate (1:2) monohydrate) | 530112-57-3 |
| 1612801 | Sisomicin Sulfate (500 mg) | 53179-09-2 |
| 1612845 | Sibutramine Hydrochloride CIV (125 mg) | 125494-59-9 |
| 1612856 | Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) | N/A |
| 1612867 | Sibutramine Related Compound B (20 mg) (N-{1-[1-(3-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) | N/A |
| 1612878 | Sibutramine Related Compound C (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]pentyl}-N,N-dimethylamine hydrochloride) | N/A |
| 1612889 | Sibutramine Related Compound D (20 mg) (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N-methylamine hydrochloride) | 84467-94-7 |
| 1612903 | Sitagliptin Phosphate (200 mg) | 654671-77-9 |
| 1612914 | Sitagliptin System Suitability Mixture (20 mg) (Sitagliptin Phosphate containing about 0.2% of S-enantiomer) | N/A |
| 1612947 | Beta-Sitosterol (100 mg) | 83-46-5 |
| 1613407 | Sodium Acetate (1 g) | 127-09-3 |
| 1613429 | Sodium Acetate Trihydrate (1 g) | 6131-90-4 |
| 1613509 | Sodium Ascorbate (200 mg) | 134-03-2 |
| 1613564 | Sodium Benzoate (1 g) | 532-32-1 |
| 1613597 | Sodium Bromide (1 g) | 7647-15-6 |
| 1613600 | Sodium Butyrate (25 mg) | 156-54-7 |
| 1613655 | Sodium Bicarbonate (3 g) | 144-55-8 |
| 1613757 | Sodium Carbonate Anhydrous (1 g) (AS) | 497-19-8 |
| 1613804 | Sodium Chloride (1 g) | 7647-14-5 |
| 1613859 | Sodium Citrate (1 g) | 6132-04-3 |
| 1613860 | Sodium Cyclamate (200 mg) | 139-05-9 |
| 1613881 | Sodium D,L-Malate (50 mg) | 63474-37-3 |
| 1613928 | Sodium D-Pantoate (100 mg) | 60979-68-2 |
| 1614002 | Sodium Fluoride (1 g) (International Restricted Sales Item) | 7681-49-4 |
| 1614159 | Sodium Hyaluronate for IR Identification (250 mg) | 9067-32-7 |
| 1614239 | Sodium Iron EDTA (200 mg) | 15708-41-5 |
| 1614308 | Sodium Lactate (200 mg) | 867-56-1 |
| 1614363 | Sodium Lauryl Sulfate (1 g) | 151-21-3 |
| 1614396 | Sodium Metabisulfite (2 X 500 mg) | 7681-57-4 |
| 1614421 | Sodium Molybdate Dihydrate (200 mg) | 10102-40-6 |
| 1614454 | Sodium Nitrite (1 g) | 7632-00-0 |
| 1614501 | Sodium Nitroprusside (500 mg) | 13755-38-9 |
| 1614512 | Sodium Phenylbutyrate (200 mg) | 1716-12-7 |
| 1614523 | Phenylbutyrate Related Compound A (25 mg) (4-oxo-4-phenylbutanoic acid) | 2051-95-8 |
| 1614534 | Phenylbutyrate Related Compound C (25 mg) (4-cyclohexylbutanoic acid) (COLD SHIPMENT REQUIRED) | 4441-63-8 |
| 1614556 | Phenylbutyrate Related Compound B (100 mg) (3,4-dihydronaphthalen-1(2H)-one) | 529-34-0 |
| 1614578 | Sodium Picosulfate (50 mg) | 10040-45-6 |
| 1614589 | Sodium Picosulfate Related Compound A (20 mg) (Sodium 4-((4-hydroxyphenyl)(pyridin-2-yl)methyl)phenyl sulfate) | 32500-19-9 |
| 1614603 | Sodium Propionate (200 mg) | 137-40-6 |
| 1614636 | Sodium Salicylate (500 mg) | 54-21-7 |
| 1614669 | Sodium Starch Glycolate Type A (400 mg) | 9063-38-1 |
| 1614670 | Sodium Starch Glycolate Type B (400 mg) | 9063-38-1 |
| 1614705 | Sodium Stearyl Fumarate (200 mg) | 4070-80-8 |
| 1614716 | Anhydrous Sodium Succinate (250 mg) | 150-90-3 |
| 1614807 | Sodium Sulfate Anhydrous (1 g) | 7757-82-6 |
| 1614909 | Sodium Tartrate Dihydrate (500 mg/vial; 4 vials) | 6106-24-7 |
| 1615107 | Sodium Thiosulfate (1 g) | 10102-17-7 |
| 1615138 | Sodium Trifluoroacetate (500 mg) | 2923-18-4 |
| 1615300 | Solifenacin Succinate (100 mg) | 242478-38-2 |
| 1615311 | Solifenacin Identification Mixture A (15 mg) | N/A |
| 1615322 | Solifenacin Identification Mixture B (20 mg) | N/A |
| 1615708 | Somatropin (11.58 USP Somatropin Units/vial) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 12629-01-5 |
| 1615956 | Sorbic Acid (1 g) | 110-44-1 |
| 1616008 | 1,4-Sorbitan (300 mg) | 27299-12-3 |
| 1617000 | Sorbitol (125 mg) | 50-70-4 |
| 1617408 | Sotalol Hydrochloride (300 mg) | 959-24-0 |
| 1617419 | Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride) | N/A |
| 1617420 | Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide) | N/A |
| 1617430 | Sotalol Related Compound C (50 mg) (N-[4-[2-[(1-Methylethyl)amino]ethyl]phenyl]methanesulfonamide monohydrochloride) | 16974-42-8 |
| 1617474 | Defatted Powdered Soy (2.5 g) | 68513-95-1 |
| 1617500 | Soybean Oil (1 g) | 8001-22-7 |
| 1618003 | Spectinomycin Hydrochloride (200 mg) | 22189-32-8 |
| 1619006 | Spironolactone (125 mg) | 52-01-7 |
| 1619017 | Spironolactone Related Compound A (100 mg) (17alpha-(2-Carboxyethyl)-17beta-hydroxyandrosta-4,6-dien-3-one lactone) (AS) | 976-71-6 |
| 1619028 | Spironolactone Related Compound B (30 mg) ((2’R)-7alpha-(Acetylthio)-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | 132458-33-4 |
| 1619039 | Spironolactone Related Compound C (30 mg) ((2’R)-3′,4′-Dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | 976-70-5 |
| 1619040 | Spironolactone Related Compound D (30 mg) ((2’R)-7alpha-(Acetyldisulfanyl)-3′,4′-dihydro-5’H-spiro[androst-4-ene-17,2′-furan]-3,5′-dione) | N/A |
| 1619051 | Spironolactone Epimer Mixture (30 mg) (7-Epispironolactone approximately 56% and Spironolactone approximately 39% mixture) | N/A |
| 1619094 | Spironolactone Related Compound I (30 mg) (S-[17alpha-(Ethoxymethyl)-17-hydroxy-3-oxoandrost-4-en-7alpha-yl]ethanethioate) | N/A |
| 1619185 | Spirulina (2 x 100 mg) | 724424-92-4 |
| 1619505 | Squalane (500 mg) | 111-01-3 |
| 1620005 | Stanozolol CIII (200 mg) | 10418-03-8 |
| 1620209 | Stavudine (250 mg) | 3056-17-5 |
| 1620220 | Stavudine System Suitability Mixture (10 mg) | N/A |
| 1621008 | Stearic Acid (500 mg) | 57-11-4 |
| 1621507 | Stearoyl Polyoxylglycerides (100 mg) | N/A |
| 1622000 | Stearyl Alcohol (125 mg) | 112-92-5 |
| 1622317 | Steviol Glycosides System Suitability (50 mg) | 91722-21-3 |
| 1622350 | Steviolbioside (100 mg) | 41093-60-1 |
| 1622408 | Stevioside (30 mg) | 57817-89-7 |
| 1623003 | Streptomycin Sulfate (200 mg) | 3810-74-0 |
| 1623386 | Compressible Sugar (200 mg) | N/A |
| 1623411 | Succinic Acid (300 mg) | 110-15-6 |
| 1623502 | Succinylcholine Chloride (500 mg) | 6101-15-5 |
| 1623604 | Succinylmonocholine Chloride (125 mg) | N/A |
| 1623615 | Sucrose Octaacetate (500 mg) | 126-14-7 |
| 1623626 | Sucralose (400 mg) | 56038-13-2 |
| 1623637 | Sucrose (100 mg) | 57-50-1 |
| 1623648 | Sufentanil Citrate CII (25 mg) | 60561-17-3 |
| 1623659 | Sucromalt (200 mg) | 911432-63-8 |
| 1623670 | Sulbactam (250 mg) (COLD SHIPMENT REQUIRED) | 68373-14-8 |
| 1623681 | Sulconazole Nitrate (200 mg) | 61318-91-0 |
| 1623692 | Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate) | 77279-29-9 |
| 1623706 | Sulfabenzamide (200 mg) | 127-71-9 |
| 1623749 | Sulbactam Related Compound A (15 mg) ((2S)-2-Amino-3-methyl-3-sulfinobutanoic acid) | 23315-18-6 |
| 1623772 | Sulbactam Related Compound D (15 mg) (Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate) | 4027-64-9 |
| 1623783 | Sulbactam Related Compound E (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide) | 76646-91-8 |
| 1623794 | Sulbactam Related Compound F (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) | 24158-88-1 |
| 1623808 | Sulfacetamide (300 mg) | 144-80-9 |
| 1624006 | Sulfacetamide Sodium (500 mg) | 6209-17-2 |
| 1624505 | Sulfachlorpyridazine (200 mg) | 80-32-0 |
| 1625009 | Sulfadiazine (200 mg) | 68-35-9 |
| 1626001 | Sulfadimethoxine (200 mg) | 122-11-2 |
| 1626500 | Sulfadoxine (200 mg) | 2447-57-6 |
| 1628007 | Sulfamerazine (500 mg) | 127-79-7 |
| 1629000 | Sulfamethazine (1 g) | 57-68-1 |
| 1629019 | Sulfamethazine Related Compound A (100 mg) (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) | 6190-55-2 |
| 1629021 | Sulfamethazine Related Compound B (50 mg) (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide) | N/A |
| 1630009 | Sulfamethizole (200 mg) | 144-82-1 |
| 1631001 | Sulfamethoxazole (200 mg) | 723-46-6 |
| 1631500 | Sulfamethoxazole N4-glucoside (25 mg) | N/A |
| 1631511 | Sulfamethoxazole Related Compound A (15 mg) (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide) | 21312-10-7 |
| 1631522 | Sulfamethoxazole Related Compound B (15 mg) (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide) | 135529-16-7 |
| 1631533 | Sulfamethoxazole Related Compound C (15 mg) (5-methylisoxazol-3-amine) | 1072-67-9 |
| 1631566 | Sulfamethoxazole Related Compound F (15 mg) (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide) | 17103-52-5 |
| 1632004 | Sulfanilamide (5 g) | 63-74-1 |
| 1633007 | Sulfanilamide Melting Point Standard (1 g) (Approximately 165 degrees) | 63-74-1 |
| 1633506 | Sulfanilic Acid (200 mg) | 121-57-3 |
| 1634000 | Sulfapyridine (200 mg) | 144-83-2 |
| 1635002 | Sulfapyridine Melting Point Standard (1 g) (Approximately 191 degrees) | 144-83-2 |
| 1635206 | Sulfaquinoxaline (200 mg) | 59-40-5 |
| 1635228 | Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide) | N/A |
| 1636005 | Sulfasalazine (125 mg) | 599-79-1 |
| 1636504 | Sulfathiazole (350 mg) | 72-14-0 |
| 1636800 | Allyl Sulfide (5 x 0.5 mL) | 592-88-1 |
| 1637008 | Sulfinpyrazone (200 mg) | 57-96-5 |
| 1638000 | Sulfisoxazole (200 mg) | 127-69-5 |
| 1639003 | Sulfisoxazole Acetyl (200 mg) | 80-74-0 |
| 1642008 | Sulindac (200 mg) | 38194-50-2 |
| 1642019 | Sulindac Related Compound A (20 mg) ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid) | 53933-60-1 |
| 1642020 | Sulindac Related Compound B (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid) | 59973-80-7 |
| 1642031 | Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid) | 49627-27-2 |
| 1642100 | Sulisobenzone (500 mg) | 4065-45-6 |
| 1642154 | Sumatriptan (50 mg) | 103628-46-2 |
| 1642201 | Sumatriptan Succinate (200 mg) | 103628-48-4 |
| 1642212 | Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide, succinate salt) | N/A |
| 1642223 | Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt) | N/A |
| 1642256 | Sumatriptan Succinate Related Impurities (25 mg) | N/A |
| 1642347 | Sunflower Oil (1 g) | 8001-21-6 |
| 1642507 | Suprofen (200 mg) | 40828-46-4 |
| 1642802 | Tacrolimus (150 mg) | 109581-93-3 |
| 1642813 | Tacrolimus Related Compound A (15 mg) (See USP Certificate for full Chemical Name) | 135635-46-0 |
| 1642824 | Tacrolimus 8-epimer (15 mg) (See USP Certificate for full Chemical Name) | 129212-35-7 |
| 1642835 | Tacrolimus 8-propyl analog (15 mg) (See USP Certificate for full Chemical Name) | 104987-30-6 |
| 1642857 | Tacrolimus System Suitability Mixture (10 mg) (A mixture consisting of tacrolimus, tacrolimus 19-epimer, ascomycin and tacrolimus 8-propyl analog) | N/A |
| 1642879 | Tadalafil (200 mg) | 171596-29-5 |
| 1642904 | Tagatose (200 mg) | 87-81-0 |
| 1643260 | Tamsulosin Hydrochloride (200 mg) | 106463-17-6 |
| 1643281 | Racemic Tamsulosin Hydrochloride (50 mg) | 80223-99-0 |
| 1643292 | Racemethionine (200 mg) | 59-51-8 |
| 1643306 | Tamoxifen Citrate (200 mg) | 54965-24-1 |
| 1643317 | Citrus reticulata Pericarp Dry Extract (1 g) | 8016-85-1 |
| 1643328 | Tannic Acid (2 g) (AS) | 1401-55-4 |
| 1643339 | Tanshinone IIA (20 mg) | 568-72-9 |
| 1643340 | Tartaric Acid (1 g) | 87-69-4 |
| 1643361 | Taurine (100 mg) | 107-35-7 |
| 1643383 | Tazobactam (200 mg) | 89786-04-9 |
| 1643394 | Tazobactam Related Compound A (20 mg) ((2S,3S)-2-Amino-3-methyl-3-sulfino-4-(1H-1,2,3-triazol-1-yl)butyric acid) | 118175-11-4 |
| 1643408 | Temazepam CIV (200 mg) | 846-50-4 |
| 1643419 | Telmisartan (200 mg) | 144701-48-4 |
| 1643420 | Telmisartan Related Compound A (20 mg) (1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzo[d]imidazole monohydrate) | 1282554-35-1 |
| 1643437 | Telmisartan Related Compound B (15 mg) (4′-[(1,7′-dimethyl-2′-propyl-1H,1’H-2,5′-bibenzo[d]imidazol-1′-yl)methyl]biphenyl-2-carboxylic acid) | 1026353-20-7 |
| 1643452 | Terazosin Hydrochloride (200 mg) | 70024-40-7 |
| 1643463 | Terazosin Related Compound A (50 mg) (6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride) | N/A |
| 1643474 | Terazosin Related Compound B (50 mg) (1-(4-hydroxy-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine) | N/A |
| 1643485 | Terazosin Related Compound C (25 mg) (1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride) | N/A |
| 1643496 | Terbinafine Hydrochloride (200 mg) | 78628-80-5 |
| 1643500 | Terbutaline Sulfate (125 mg) | 23031-32-5 |
| 1643510 | Terbutaline Related Compound A (50 mg) (tert-butylamino-3,5-dihydroxyacetophenone sulfate) | N/A |
| 1643532 | Terbinafine Related Compound B (25 mg) ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride) | 176168-78-8 |
| 1643543 | Temozolomide (200 mg) | 85622-93-1 |
| 1643554 | Temozolomide Related Compound A (15 mg) (4-diazo-4H-imidazole-5-carboxamide) | 7008-85-7 |
| 1643565 | Temozolomide Related Compound B (15 mg) (3-methyl-1,1-diphenylurea) | 13114-72-2 |
| 1643576 | Temozolomide Related Compound C (15 mg) (diphenylcarbamic chloride) | 83-01-2 |
| 1643601 | Tenofovir (15 mg) | 206184-49-8 |
| 1643612 | Tenofovir Disoproxil Related Compound A (10 mg) ((S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic acid, bis(1-methylethyl) ester, 5-oxide, (E)-2-butenedioate (1:1)) | N/A |
| 1643623 | Tenofovir Disoproxil Related Compound B (10 mg) ((E)-9-(Prop-1-enyl)-9H-purin-6-amine) | 1446486-33-4 |
| 1643656 | Tenofovir Disoproxil Fumarate (200 mg) | 202138-50-9 |
| 1643678 | Tenofovir Disoproxil Related Compound G (15 mg) (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate) fumarate) | 1422284-15-8 |
| 1643703 | Terconazole (200 mg) | 67915-31-5 |
| 1643736 | Teniposide (200 mg) | 29767-20-2 |
| 1643747 | Teniposide Related Compound A (10 mg) (4′-Demethylepipodophyllotoxin) | 6559-91-7 |
| 1643805 | Terfenadine (200 mg) | 50679-08-8 |
| 1643962 | Teriparatide (1 mg) (COLD SHIPMENT REQUIRED) | 52232-67-4 |
| 1644003 | Terpin Hydrate (750 mg) | 2451-01-6 |
| 1644319 | Temazepam Related Compound A (15 mg) (5-chloro-2-methylaminobenzophenone) | 1022-13-5 |
| 1644364 | Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) | 3294-96-0 |
| 1645006 | Testolactone CIII (125 mg) | 968-93-4 |
| 1646009 | Testosterone CIII (125 mg) | 58-22-0 |
| 1646010 | Testosterone Related Compound A CIII (20 mg) (Androst-4-ene-3,17-dione) | 63-05-8 |
| 1646031 | Testosterone Related Compound C (15 mg) (17alpha-Hydroxyandrost-4-en-3-one) | 481-30-1 |
| 1646042 | Testosterone Enanthate Related Compound F (50 mg) (Androst-4,6-dien-3-one-17Beta-yl heptanoate) | N/A |
| 1646097 | Testosterone Related Compound I (15 mg) (17beta-Hydroxyandrosta-4,6-dien-3-one) | 2484-30-2 |
| 1646375 | Temazepam Related Compound G (15 mg) (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) | 93329-92-1 |
| 1647001 | Testosterone Cypionate CIII (200 mg) | 58-20-8 |
| 1648004 | Testosterone Enanthate CIII (200 mg) | 315-37-7 |
| 1648081 | Testosterone Enanthate Related Compound H CIII (25 mg) (Androst-5-ene-3Beta,17Beta-diyl diheptanoate) | 162890-98-4 |
| 1649007 | Testosterone Propionate CIII (200 mg) | 57-85-2 |
| 1649991 | Tetracaine (50 mg) | 94-24-6 |
| 1650006 | Tetracaine Hydrochloride (200 mg) | 136-47-0 |
| 1650017 | Tetracaine Related Compound B (25 mg) (4-(Butylamino)benzoic acid) | 4740-24-3 |
| 1650028 | Tetracaine Related Compound C (25 mg) (methyl 4-(butylamino)benzoate) | 71839-12-8 |
| 1651009 | Tetracycline Hydrochloride (200 mg) | 64-75-5 |
| 1651621 | Delta-9-Tetrahydrocannabinol 1 mL (1 mg/mL) | N/A |
| 1651654 | 2,3,5,4′-Tetrahydroxystilbene-2-O-Beta-D-Glucoside (50 mg) ((E)-2,4-dihydroxy-6-(4-hydroxystyryl)phenyl beta-D-glucopyranoside) | 82373-94-2 |
| 1652001 | Tetrahydrozoline Hydrochloride (200 mg) | 522-48-5 |
| 1652500 | Thalidomide (200 mg) | 50-35-1 |
| 1652704 | L-Theanine (200 mg) | 3081-61-6 |
| 1653004 | Theophylline (200 mg) | 58-55-9 |
| 1653026 | Theophylline Related Compound B (25 mg) (3-Methyl-1H-purine-2,6-dione) | 1076-22-8 |
| 1653037 | Theophylline Related Compound C (25 mg) (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide) | 7597-60-6 |
| 1653048 | Theophylline Related Compound D (30 mg) (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate) | N/A |
| 1653060 | Theophylline Related Compound F (25 mg) (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione) | 519-37-9 |
| 1653117 | Theophylline Melting Point Standard (2 x 500 mg) (Approximately 271 degrees) | 58-55-9 |
| 1653285 | Thermolysin | 9073-78-3 |
| 1655000 | Thiabendazole (100 mg) | 148-79-8 |
| 1656002 | Thiamine Hydrochloride (500 mg) (Vitamin B1 Hydrochloride) | 67-03-8 |
| 1658008 | Thiethylperazine Maleate (200 mg) | 1179-69-7 |
| 1659000 | Thimerosal (500 mg) | 54-64-8 |
| 1659001 | Thimerosal Related Compound A (50 mg) (2,2′-Disulfanediyldibenzoic acid) | 119-80-2 |
| 1660000 | Thioguanine (200 mg) | 154-42-7 |
| 1661002 | Thiopental CIII (250 mg) | 76-75-5 |
| 1662504 | Thioridazine (200 mg) | 50-52-2 |
| 1663008 | Thioridazine Hydrochloride (200 mg) | 130-61-0 |
| 1663063 | Thioridazine Related Compound F (20 mg) (2-(Methylthio)-10-[2-(piperidin-2-yl)ethyl]-10H-phenothiazine hydrochloride) | 13002-81-8 |
| 1663700 | Thiostrepton (200 mg) | 1393-48-2 |
| 1664000 | Thiotepa (500 mg) | 52-24-4 |
| 1665003 | Thiothixene (250 mg) | 3313-26-6 |
| 1666006 | (E)-Thiothixene (100 mg) | 3313-27-7 |
| 1667100 | Thonzonium Bromide (200 mg) | 553-08-2 |
| 1667144 | Ticlopidine Hydrochloride (150 mg) | 53885-35-1 |
| 1667155 | Ticlopidine Related Compound A (20 mg) (4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) | 68559-60-4 |
| 1667166 | Ticlopidine Related Compound B (20 mg) (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine) | 68559-55-7 |
| 1667202 | L-Threonine (200 mg) | 72-19-5 |
| 1667213 | Thymol (500 mg) | 89-83-8 |
| 1667224 | Tiagabine Related Compound A (15 mg) ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride) | N/A |
| 1667235 | Racemic Tiagabine Hydrochloride Mixture (25 mg) ((S)-(+),(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid, hydrochloride) | N/A |
| 1667280 | Tiagabine Hydrochloride (300 mg) | 145821-57-4 |
| 1667290 | Tiamulin Fumarate (250 mg) | 55297-96-6 |
| 1667304 | Ticarcillin Monosodium Monohydrate (350 mg) | 74682-62-5 |
| 1667315 | Timolol Related Compound B (20 mg) (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol) | 59697-06-2 |
| 1667326 | Timolol Related Compound C (20 mg) (N-(tert-Butyl)-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine maleate) | 610271-57-3 |
| 1667337 | Tiamulin Related Compound A (50 mg) (Tosyl pleuromutilin) | 31716-01-5 |
| 1667348 | Timolol Related Compound F (20 mg) (3-Chloro-4-morpholino-1,2,5-thiadiazol) | 30165-96-9 |
| 1667355 | Tiamulin (100 mg) | 55297-95-5 |
| 1667359 | Tiletamine Hydrochloride (200 mg) | 14176-50-2 |
| 1667369 | Timolol Related Compound D (20 mg) (4-Morpholino-1,2,5-thiadiazol-3-ol) | 30165-97-0 |
| 1667370 | Tilmicosin (250 mg) | 108050-54-0 |
| 1667381 | Timolol Related Compound A (20 mg) ((R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol maleate) | 26839-77-0 |
| 1667406 | Timolol Maleate (200 mg) | 26921-17-5 |
| 1667439 | Tioconazole (200 mg) | 65899-73-2 |
| 1667443 | Timolol Related Compound E (20 mg) ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)) | N/A |
| 1667450 | Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) | N/A |
| 1667461 | Tioconazole Related Compound B (25 mg) (1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole hydrochloride) | N/A |
| 1667472 | Tioconazole Related Compound C (25 mg) (1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride) | N/A |
| 1667508 | Tobramycin (350 mg) | 32986-56-4 |
| 1667520 | Tinidazole (200 mg) | 19387-91-8 |
| 1667530 | Tinidazole Related Compound A (100 mg) (2-methyl-5-nitroimidazole) | 696-23-1 |
| 1667541 | Tinidazole Related Compound B (20 mg) (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) | 25459-12-5 |
| 1667552 | Tocainide Hydrochloride (125 mg) | 35891-93-1 |
| 1667585 | Titanium Dioxide (2 g) | 13463-67-7 |
| 1667600 | Alpha Tocopherol (250 mg) | 10191-41-0 |
| 1667643 | Tigecycline (300 mg) (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 220620-09-7 |
| 1667665 | Tigecycline Related Compound B (25 mg) ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride) | 149934-21-4 |
| 1667701 | Alpha Tocopheryl Acetate (250 mg) (Vitamin E Acetate) (COLD SHIPMENT REQUIRED) | 7695-91-2 |
| 1667803 | Alpha Tocopheryl Acid Succinate (250 mg) (Vitamin E Succinate) | 4345-03-3 |
| 1667905 | Tizanidine Hydrochloride (200 mg) | 64461-82-1 |
| 1667916 | Tizanidine Related Compound A (50 mg) (4-amino-5-chloro-2,1,3-benzothiadiazole) | 30536-19-7 |
| 1667924 | Tizanidine Related Compound B (50 mg) (N-acetyltizanidine) | 173532-15-5 |
| 1667938 | Tizanidine Related Compound C (50 mg) (1-acetylimidazolidine-2-thione) | 5391-52-6 |
| 1668001 | Tolazamide (200 mg) | 1156-19-0 |
| 1669004 | Tolazoline Hydrochloride (300 mg) | 59-97-2 |
| 1670003 | Tolbutamide (200 mg) | 64-77-7 |
| 1670207 | Tolcapone (200 mg) | 134308-13-7 |
| 1670218 | Tolcapone Related Compound A (25 mg) (4′-methyl-3,4-dihydroxybenzophenone) | N/A |
| 1670229 | Tolcapone Related Compound B (25 mg) (4-hydroxy-3-methoxy-4′-methyl-5-nitrobenzophenone) | N/A |
| 1670502 | Tolmetin Sodium (500 mg) | 64490-92-2 |
| 1671006 | Tolnaftate (200 mg) | 2398-96-1 |
| 1671468 | Tolterodine S-Enantiomer (15 mg) ((S)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol tartrate) | 873551-03-2 |
| 1671479 | Tolterodine System Suitability Mixture (15 mg) | NA |
| 1671480 | Tolterodine Tartrate (200 mg) | 124937-52-6 |
| 1672010 | o-Toluenesulfonamide (200 mg) | 88-19-7 |
| 1672020 | p-Toluenesulfonamide (200 mg) | 70-55-3 |
| 1672053 | p-Toluidine (50 mg) (COLD SHIPMENT REQUIRED) | 106-49-0 |
| 1672100 | Tomato Extract Containing Lycopene (1 g) | N/A |
| 1672206 | Topiramate (150 mg) | 97240-79-4 |
| 1672210 | Topiramate Related Compound A (25 mg) (2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose) | 20880-92-6 |
| 1672257 | Topotecan Hydrochloride (350 mg) | 119413-54-6 |
| 1672268 | Topotecan Related Compound A (25 mg) ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | N/A |
| 1672280 | Topotecan Related Compound C (25 mg) ((S)-4-Ethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) | 7689-03-4 |
| 1672304 | Torsemide (200 mg) | 56211-40-6 |
| 1672315 | Torsemide Related Compound A (75 mg) (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | N/A |
| 1672326 | Torsemide Related Compound B (50 mg) (N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | 160972-33-8 |
| 1672337 | Torsemide Related Compound C (30 mg) (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | N/A |
| 1672359 | Torsemide Related Compound E (20 mg) (4-m-tolyl-2H-pyrido[4,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide) | 72810-61-8 |
| 1672600 | Tramadol Hydrochloride CIV (100 mg) | 36282-47-0 |
| 1672610 | Tramadol Related Compound A CIV (25 mg) ((RS,SR)-1-(3-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexanol hydrochloride) | 73806-49-2 |
| 1672621 | Tramadol Related Compound B (25 mg) (2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride) | 42036-65-7 |
| 1672687 | Trandolapril (125 mg) | 87679-37-6 |
| 1672698 | Trandolapril Related Compound A (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester) | N/A |
| 1672701 | Trandolapril Related Compound C (25 mg) ((2S, 3aR, 7aS)-1-[N-[(S)-1-Carboxy-3-cyclohexylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-ethyl ester hydrochloride) | N/A |
| 1672712 | Trandolapril Related Compound D (25 mg) ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate) | 149881-40-3 |
| 1672723 | Trandolapril Related Compound E (25 mg) ((2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid) | 87679-71-8 |
| 1672745 | Tranexamic Acid (200 mg) | 1197-18-8 |
| 1672756 | Tranexamic Acid Related Compound C (15 mg) ((RS)-4-(aminomethyl)cyclohex-1-enecarboxylic acid) | 330838-52-3 |
| 1672803 | Transplatin (25 mg) | 14913-33-8 |
| 1672905 | Tranylcypromine Sulfate (125 mg) | 13492-01-8 |
| 1672916 | Tranylcypromine Related Compound A (40 mg) ((+/-)-cis-2-phenylcyclopropanamine hydrochloride; cis-tranylcypromine hydrochloride) | 54779-58-7 |
| 1672927 | Tranylcypromine Related Compound B (40 mg) (trans-3-phenylallylamine hydrochloride; cinnamylamine hydrochloride) | 17480-08-9 |
| 1673001 | Travoprost (3 mL) (COLD SHIPMENT REQUIRED) | 157283-68-6 |
| 1673012 | Travoprost Related Compound A (1.5 mL) ((Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-{(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl)hept-5-enoic acid) (COLD SHIPMENT REQUIRED) | 54276-17-4 |
| 1673500 | Trazodone Hydrochloride (200 mg) | 25332-39-2 |
| 1673533 | Trazodone Related Compound C (20 mg) (2-{3-[4-(4-chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride) | 1263278-77-8 |
| 1673544 | Trazodone Related Compound D (20 mg) (2-{3-[4-(3-bromophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride) | 1263278-80-3 |
| 1673566 | Trazodone Related Compound F (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride) | 52605-52-4 |
| 1673715 | Trehalose (400 mg) | 6138-23-4 |
| 1673828 | Trenbolone Acetate CIII (200 mg) (COLD SHIPMENT REQUIRED) | 10161-34-9 |
| 1673839 | Trenbolone Acetate System Suitability Mixture CIII (30 mg) (COLD SHIPMENT REQUIRED) | N/A |
| 1674004 | Tretinoin (30 mg/ampule; 5 ampules) | 302-79-4 |
| 1675007 | Triacetin (1 g) | 102-76-1 |
| 1676000 | Triamcinolone (250 mg) | 124-94-7 |
| 1677002 | Triamcinolone Acetonide (500 mg) | 76-25-5 |
| 1678005 | Triamcinolone Diacetate (350 mg) | 67-78-7 |
| 1679008 | Triamcinolone Hexacetonide (200 mg) | 5611-51-8 |
| 1679020 | Triamcinolone Acetonide Related Compound B (15 mg) (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4,14-triene-3,20-dione) | 1260149-96-9 |
| 1679037 | Triamcinolone Acetonide Related Compound C (15 mg) (9-Fluoro-11,21,21-trihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11beta,16alpha)-pregna-1,4-diene-3,20-dione) | 161740-69-8 |
| 1680007 | Triamterene (200 mg) | 396-01-0 |
| 1680018 | Triamterene Related Compound A (50 mg) (2,4,6-triamino-5-nitrosopyrimidine) | 1006-23-1 |
| 1680029 | Triamterene Related Compound B (50 mg) (2,7-diamino-4-hydroxy-6-phenylpteridine) | 19375-89-4 |
| 1680030 | Triamterene Related Compound C (50 mg) (2,4-diamino-7-hydroxy-6-phenylpteridine) | 19152-93-3 |
| 1680506 | Triazolam CIV (200 mg) | 28911-01-5 |
| 1680608 | Tributyl Citrate (500 mg) | 77-94-1 |
| 1680685 | Tributyl Phosphine Oxide (25 mg) | 814-29-9 |
| 1680801 | Trichlorfon (200 mg) | 52-68-6 |
| 1681000 | Trichlormethiazide (200 mg) | 133-67-5 |
| 1681800 | Triclocarban (200 mg) | 101-20-2 |
| 1681815 | Triclocarban Related Compound A (15 mg) (1,3-Bis(4-chlorophenyl)urea) | 1219-99-4 |
| 1681845 | Triclocarban Related Compound C (15 mg) (1,3-Bis(3,4-dichlorophenyl)urea) | 4300-43-0 |
| 1681856 | Triclocarban Related Compound D Mixture (15 mg) (Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)-3-(3,4-dichlorophenyl)biuret) | N/A |
| 1682206 | Triclosan (200 mg) | 3380-34-5 |
| 1682217 | Triclosan Related Compounds Mixture A (1.2 mL/ampule; 3 ampules) | N/A |
| 1683504 | Trientine Hydrochloride (200 mg) | 38260-01-4 |
| 1683559 | Triethylamine (2 mL/ampule; 4 ampules) (N,N-diethylethanamine) | 121-44-8 |
| 1683606 | Triethyl Citrate (5 x 100 mg) | 77-93-0 |
| 1683708 | Triethylene Glycol (0.5 mL) | 112-27-6 |
| 1685000 | Trifluoperazine Hydrochloride (200 mg) | 440-17-5 |
| 1685500 | 2-[N-(2,2,2-Trifluoroethyl)amino-5]-chlorobenzophenone (25 mg) | N/A |
| 1686003 | Triflupromazine Hydrochloride (200 mg) | 1098-60-8 |
| 1686309 | Trifluridine (100 mg) | 70-00-8 |
| 1686310 | Trifluridine Related Compound A (10 mg) (5-Carboxy-2′-deoxyuridine) | 14599-46-3 |
| 1686386 | Triglycine (50 mg) (glycylglycylglycine) | 556-33-2 |
| 1686411 | Trigonelline (20 mg) (1-Methylpyridinium-3-carboxylate monohydrate) | N/A |
| 1687006 | Trihexyphenidyl Hydrochloride (200 mg) | 52-49-3 |
| 1687017 | Trihexyphenidyl Related Compound A (20 mg) (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride) | 886-06-6 |
| 1689001 | Trimeprazine Tartrate (200 mg) | 4330-99-8 |
| 1690000 | Trimethadione (200 mg) | 127-48-0 |
| 1692006 | Trimethobenzamide Hydrochloride (200 mg) | 554-92-7 |
| 1692505 | Trimethoprim (300 mg) | 738-70-5 |
| 1692516 | Trimethoprim Related Compound A (25 mg) (4-amino-5-(3,4,5-trimethoxybenzyl)pyrimidin-2-ol) | 60729-91-1 |
| 1692527 | Trimethoprim Related Compound B (25 mg) ((2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone) | 30806-86-1 |
| 1692709 | Trimipramine Maleate (100 mg) | 521-78-8 |
| 1692710 | Trimipramine Related Compound A (25 mg) (dehydro trimipramine) | 315-69-5 |
| 1692913 | Triolein (2 x 50 mg) | 122-32-7 |
| 1693009 | Trioxsalen (200 mg) | 3902-71-4 |
| 1695004 | Tripelennamine Hydrochloride (200 mg) | 154-69-8 |
| 1695343 | Triphenylmethanol (50 mg) | 76-84-6 |
| 1696007 | Triprolidine Hydrochloride (300 mg) | 6138-79-0 |
| 1696109 | Triprolidine Hydrochloride Z-Isomer (50 mg) | N/A |
| 1696110 | Triptorelin Related Compound A | 102992-39-2 |
| 1696128 | Triptorelin Related Compound B | 321709-35-7 |
| 1696142 | Triptorelin Related Compound C | 129418-54-8 |
| 1696153 | Tritricosanoin (50 mg) | 86850-72-8 |
| 1696175 | Triuret (300 mg) (Tricarbonodiimidic diamide) | 556-99-0 |
| 1696200 | Trisalicylic Acid (100 mg) | N/A |
| 1696958 | Trolamine (3 mL) (International Restricted Sales Item) | 102-71-6 |
| 1698002 | Tromethamine (125 mg) | 77-86-1 |
| 1699005 | Tropicamide (200 mg) | 1508-75-4 |
| 1699016 | Tropicamide Related Compound A (100 mg) (N-(pyridin-4-ylmethyl)ethanamine) | 33403-97-3 |
| 1699027 | Tropicamide Related Compound B (50 mg) (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide) | 57322-50-6 |
| 1699038 | Tropicamide Related Compound C (25 mg) (3-hydroxy-2-phenylpropionic acid) | 529-64-6 |
| 1699049 | Tropicamide Related Compound D (15 mg) (List Chemical) (2-phenylacetic acid) | 103-82-2 |
| 1699300 | Trospium Chloride (100 mg) | 10405-02-4 |
| 1699311 | Trospium Chloride Related Compound A (20 mg) (Benzilic Acid) (International Restricted Sales Item) | 76-93-7 |
| 1699322 | Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate) | 63516-30-3 |
| 1699333 | Trospium Chloride Related Compound C (20 mg) ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1′-pyrrolidinium]chloride) | 3464-71-9 |
| 1700002 | Trypsin Crystallized (300 mg) (COLD SHIPMENT REQUIRED) | 9002-07-7 |
| 1700013 | Trypsin Recombinant Porcine (2 x 1 mL) (COLD SHIPMENT REQUIRED) | 9002-07-7 |
| 1700501 | L-Tryptophan (200 mg) | 73-22-3 |
| 1700512 | Tryptophan Related Compound A (15 mg) ((2S,2’S)-3,3′-[Ethane-1,1-diylbis(1H-indole-1,3-diyl)]bis(2-aminopropanoic acid)) | 132685-02-0 |
| 1700523 | Tryptophan Related Compound B (25 mg) (N-Acetyl-L-Tryptophan) | 1218-34-4 |
| 1702008 | Tubocurarine Chloride (175 mg) | 6989-98-6 |
| 1703805 | Tylosin (250 mg) | 1401-69-0 |
| 1703850 | Tylosin Tartrate (100 mg) | 1405-54-5 |
| 1704003 | Tyloxapol (3 x 200 mg) | 25301-02-4 |
| 1705006 | L-Tyrosine (500 mg) | 60-18-4 |
| 1705301 | Ubidecarenone (200 mg) (COLD SHIPMENT REQUIRED) | 303-98-0 |
| 1705312 | Ubidecarenone for System Suitability (25 mg) (COLD SHIPMENT REQUIRED) | 303-98-0 |
| 1705323 | Ubidecarenone Related Compound A (15 mg) (Coenzyme Q9) (COLD SHIPMENT REQUIRED) | 303-97-9 |
| 1705334 | Ubiquinol (5 x 50 mg) | 992-78-9 |
| 1705505 | Undecylenic Acid (200 mg) | 112-38-9 |
| 1705753 | Uracil (15 mg) | 66-22-8 |
| 1705800 | Uracil Arabinoside (50 mg) | 3083-77-0 |
| 1706698 | Urea (200 mg) | 57-13-6 |
| 1706701 | Urea C 13 (150 mg) | 58069-82-2 |
| 1706712 | Urea Related Compound A (15 mg) (Dicarbonimidic diamide) | 108-19-0 |
| 1707114 | Uridine (30 mg) (1-Beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione) | 58-96-8 |
| 1707770 | Ursolic Acid (25 mg) | 77-52-1 |
| 1707806 | Ursodiol (125 mg) | 128-13-2 |
| 1707817 | D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) | 142963-60-8 |
| 1707828 | Valacyclovir Related Compound M (15 mg) (9-[(2-Hydroxyethoxy)methyl]guanine N-formyl-l-valinate) | 847670-62-6 |
| 1707839 | Valacyclovir Hydrochloride (200 mg) | 124832-27-5 |
| 1707855 | Valacyclovir Related Compound C (10 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride) | N/A |
| 1707861 | Valacyclovir Related Compound D (15 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate) | N/A |
| 1707872 | Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate) | 124832-31-1 |
| 1707883 | Valacyclovir Related Compound F (25 mg) (2-hydroxyethyl valinate para-toluenesulfonate salt) | 86150-61-0 |
| 1707894 | Valacyclovir Related Compound G (50 mg) (N,N-dimethylpyridin-4-amine) | 1122-58-3 |
| 1707908 | Valerenic Acid (30 mg) | 3569-10-6 |
| 1707931 | Powdered Valerian Extract (1 g) | 8057-49-6 |
| 1708004 | Valganciclovir Hydrochloride (500 mg) | 175865-59-5 |
| 1708015 | D-Valganciclovir (10 mg) (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride) | N/A |
| 1708503 | L-Valine (200 mg) | 72-18-4 |
| 1708707 | Valproic Acid (500 mg) | 99-66-1 |
| 1708718 | Valproic Acid Related Compound B (50 mg) ((2RS)-2-(1-methylethyl)pentanoic acid) | 62391-99-5 |
| 1708729 | Valproic Acid Related Compound A (0.25 mL) (diallyl acetic acid) | 99-67-2 |
| 1708730 | Valrubicin (100 mg) | 56124-62-0 |
| 1708751 | Valrubicin Resolution Mixture (25 mg) (valrubicin spiked with seven related substances) | N/A |
| 1708762 | Valsartan (350 mg) | 137862-53-4 |
| 1708773 | Valsartan Related Compound A (10 mg) (N-valeryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl)}D-valine) | 137862-87-4 |
| 1708784 | Valsartan Related Compound B (10 mg) (N-butyryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine) | N/A |
| 1708795 | Valsartan Related Compound C (10 mg) (N-valeryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester) | 137863-20-8 |
| 1708810 | Valsartan Related Compound E (15 mg) (N-valeryl-N-{[2′-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester) | 137863-17-3 |
| 1709007 | Vancomycin Hydrochloride (4 vials, each vial contains 98,800 mcg of vancomycin activity) | 1404-93-9 |
| 1709018 | Vancomycin B with Monodechlorovancomycin (300 mg) | 1404-93-9 |
| 1710006 | Vanillin (200 mg) | 121-33-5 |
| 1711009 | Vanillin Melting Point Standard (1 g) (Approximately 82 degrees) | 121-33-5 |
| 1711010 | Vardenafil Hydrochloride (200 mg) | 330808-88-3 |
| 1711029 | Vardenafil System Suitability (20 mg) | N/A |
| 1711031 | Vasicine (20 mg) | 6159-55-3 |
| 1711100 | Vasopressin (1.70 mg) (8-L-arginine vasopressin) (COLD SHIPMENT REQUIRED) | 113-79-1 |
| 1711133 | Lypressin (2 mg) (8-L-lysine vasopressin) (COLD SHIPMENT REQUIRED) | 50-57-7 |
| 1711155 | Vecuronium Bromide (50 mg) | 50700-72-6 |
| 1711166 | Vecuronium Bromide Related Compound A (25 mg) (3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan) | N/A |
| 1711177 | Vecuronium Bromide Related Compound B (15 mg) (Piperidinium, 1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | 50587-95-6 |
| 1711188 | Vecuronium Bromide Related Compound C (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | 73319-30-9 |
| 1711202 | Verapamil Hydrochloride (200 mg) | 152-11-4 |
| 1711224 | Vecuronium Bromide Related Compound F (15 mg) (Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide) | N/A |
| 1711268 | Venlafaxine Hydrochloride (100 mg) | 99300-78-4 |
| 1711279 | Venlafaxine Related Compound A (10 mg) (1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride) | 93413-90-2 |
| 1711304 | Verapamil Related Compound A (50 mg) (3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride) | 67775-97-7 |
| 1711406 | Verapamil Related Compound B (50 mg) (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride) | 1794-55-4 |
| 1711439 | Verapamil Related Compound E (50 mg) (3,4-dimethoxybenzaldehyde) | 120-14-9 |
| 1711440 | Verapamil Related Compound F (150 mg) ((3,4-Dimethoxyphenyl)methanol) | 93-03-8 |
| 1711455 | Verbascoside (15 mg) (2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-Beta-D-glucopyranoside) | 61276-17-3 |
| 1711461 | Verteporfin (200 mg) | 129497-78-5 |
| 1711472 | Verteporfin Related Compound A (50 mg) ((+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic acid) | N/A |
| 1712001 | Vigabatrin (200 mg) | 68506-86-5 |
| 1712012 | Vigabatrin Related Compound A (50 mg) (5-vinylpyrrolidin-2-one) | 7529-16-0 |
| 1712023 | Vigabatrin Related Compound B (30 mg) ((E)-2-(2-aminoethyl)but-2-enoic acid hydrochloride) | N/A |
| 1712045 | Vigabatrin Related Compound E (30 mg) (2-(2-aminobut-3-enyl)malonic acid) | N/A |
| 1713004 | Vinblastine Sulfate (50 mg) | 143-67-9 |
| 1714007 | Vincristine Sulfate (50 mg) | 2068-78-2 |
| 1714018 | Vincristine Sulfate (Assay) (29.8 mg/vial) | 2068-78-2 |
| 1714506 | Vinorelbine Tartrate (200 mg) | 125317-39-7 |
| 1714528 | Vinorelbine Related Compound A (25 mg) (4-O-Deacetylvinorelbine tartrate) | N/A |
| 1714608 | Vinpocetine (100 mg) | 42971-09-5 |
| 1714619 | Vinpocetine Related Compound A (30 mg) (ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) | 40163-56-2 |
| 1714620 | Vinpocetine Related Compound B (30 mg) (Methyl(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]-naphthyridine-12-carboxylate) | 4880-92-6 |
| 1714641 | Vinpocetine Related Compound C (30 mg) (ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) | N/A |
| 1714652 | Vinpocetine Related Compound D (30 mg) (ethyl(12R,13aS,13bS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate) | 57327-92-1 |
| 1716002 | Retinyl Acetate (Vitamin A) (10 ampuls x 0.5 g) | 127-47-9 |
| 1717504 | Vitamin D Assay System Suitability (1.5 g) | 67-97-0 |
| 1717708 | Vitexin (25 mg) ((1S)-1,5-Anhydro-1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol) | 3681-93-4 |
| 1718008 | Voriconazole (100 mg) | 137234-62-9 |
| 1718019 | Voriconazole Related Compound A (10 mg) ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | 182230-43-9 |
| 1718020 | Voriconazole Related Compound B (10 mg) ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | 137234-63-0 |
| 1718039 | Voriconazole Related Compound C (10 mg) (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone) | N/A |
| 1718041 | Voriconazole Related Compound D (10 mg) ((2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | N/A |
| 1718063 | Voriconazole Related Compound F (50 mg) ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulphonic acid) | 5872-08-2 |
| 1719000 | Warfarin (200 mg) | 81-81-2 |
| 1719102 | Warfarin Related Compound A (50 mg) (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one) | 37209-23-7 |
| 1719135 | Cetyl Esters Wax (125 mg) | N/A |
| 1719339 | Salix Species Bark Dry Extract (1 g) | N/A |
| 1719500 | Withanolide A (15 mg) | 32911-62-9 |
| 1719532 | Withanoside IV (15 mg) | 362472-81-9 |
| 1720000 | Xanthanoic Acid (100 mg) | 82-07-5 |
| 1720203 | Xanthone (100 mg) | 90-47-1 |
| 1720407 | Xylazine (200 mg) | 7361-61-7 |
| 1720429 | Xylazine Hydrochloride (200 mg) | 23076-35-9 |
| 1720600 | Xylitol (1 g) | 87-99-0 |
| 1721002 | Xylometazoline Hydrochloride (250 mg) | 1218-35-5 |
| 1721013 | Xylometazoline Related Compound A (25 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-2,6-dimethylphenyl]acetamide) | 94266-17-8 |
| 1722005 | Xylose (1 g) | 7261-26-9 |
| 1724000 | Yohimbine Hydrochloride (200 mg) | 65-19-0 |
| 1724066 | Zanamivir Resolution Mixture (0.25 mg) (Mixture of zanamivir and talo-zanamivir) | N/A |
| 1724077 | Zanamivir Related Compounds Mixture (2.5 mg) | N/A |
| 1724088 | Zanamivir (200 mg) | 139110-80-8 |
| 1724306 | Zalcitabine (200 mg) | 7481-89-2 |
| 1724317 | Zalcitabine Related Compound A (50 mg) (2′,3′-Didehydro-2′,3′-dideoxycytidine) | 7481-88-1 |
| 1724350 | Zaleplon CIV (200 mg) | 151319-34-5 |
| 1724361 | Zaleplon Related Compound A (15 mg) ((E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide) | 96605-66-2 |
| 1724372 | Zaleplon Related Compound B (15 mg) (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide) | N/A |
| 1724383 | Zaleplon Related Compound C (25 mg) (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) | 940951-54-2 |
| 1724408 | Ziprasidone Hydrochloride (200 mg) | 138982-67-9 |
| 1724419 | Ziprasidone Related Compound A (10 mg) (3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride) | 87691-88-1 |
| 1724420 | Ziprasidone Related Compound B (10 mg) (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione) | N/A |
| 1724441 | Ziprasidone Related Compound C (10 mg) (5,5′-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6′-dichloro-3-hydroxy-3,3′-biindoline-2,2′-dione) | 1303996-68-0 |
| 1724452 | Ziprasidone Related Compound D (10 mg) (3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one) | N/A |
| 1724474 | Ziprasidone Related Compound F (15 mg) (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate) | N/A |
| 1724500 | Zidovudine (400 mg) | 30516-87-1 |
| 1724521 | Zidovudine Related Compound B (25 mg) (3′-chloro-3′-deoxythymidine) | 25526-94-7 |
| 1724532 | Zidovudine Related Compound C (100 mg) (thymine) | 65-71-4 |
| 1724543 | Zidovudine Related Compound D (50 mg) ([1-(2-Deoxy-beta-D-ribofuranosyl)]thymine) | 50-89-5 |
| 1724656 | Zileuton (150 mg) | 111406-87-2 |
| 1724667 | Zileuton Related Compound A (50 mg) (N-(1-Benzo[b]thien-2-ylethyl) urea) | N/A |
| 1724678 | Zileuton Related Compound B (50 mg) (2-(Benzo[b]thien-2-oyl)benzo[b]thiophene) | N/A |
| 1724689 | Zileuton Related Compound C (50 mg) (1-Benzo[b]thien-2-ylethanone) | N/A |
| 1724703 | Zinc Acetate (50 mg) | 5970-45-6 |
| 1724747 | Zinc Oxide (200 mg) | 1314-13-2 |
| 1724758 | Zinc Stearate (200 mg) (Mixture of zinc stearate and zinc palmitate) | N/A |
| 1724769 | Zinc Sulfate (1 g) (AS) | 7446-20-2 |
| 1724805 | Zolazepam Hydrochloride (500 mg) | 33754-49-3 |
| 1724827 | Zoledronic Acid (150 mg) | 118072-93-8 |
| 1724838 | Zoledronic Acid Related Compound A (30 mg) (2-(1H-Imidazol-1-yl)acetic acid) | N/A |
| 1724893 | Zolpidem CIV (10 mg) | 82626-48-0 |
| 1724907 | Zolpidem Tartrate CIV (200 mg) (COLD SHIPMENT REQUIRED) | 99294-93-6 |
| 1724918 | Zolpidem Related Compound A (15 mg) (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide) | N/A |
| 1724951 | Zolpidem Impurities Mixture CIV (15 mg) | N/A |
| 1725003 | Zonisamide (200 mg) | 68291-97-4 |
| 1725014 | Zonisamide Related Compound A (20 mg) (1,2-benzisoxazole-3-methanesulfonic acid sodium salt) | 73101-64-1 |
| 1725036 | Zonisamide Related Compound C (20 mg) (N’-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide) | N/A |
| 1727009 | Zolmitriptan (200 mg) | 139264-17-8 |
| 1727018 | Zolmitriptan R-Isomer (20 mg) ((R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one) | 139264-24-7 |
| 1727020 | Zolmitriptan Related Compound A (20 mg) ((S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one) | 139264-35-0 |
| 1727031 | Zolmitriptan Related Compound B (20 mg) ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol) | 139264-69-0 |
| 1727053 | Zolmitriptan Related Compound D (20 mg) ((S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate) | 191864-24-1 |
| 1727064 | Zolmitriptan Related Compound E (25 mg) ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide) | 251451-30-6 |
| 1727075 | Zolmitriptan Related Compound F (25 mg) (2,2′-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole}) | 1350928-05-0 |
| 1727086 | Zolmitriptan Related Compound G (25 mg) ((S)-4-(4-Aminobenzyl)oxazolidin-2-one) | 152305-23-2 |
| 1727097 | Zolmitriptan Related Compound H (50 mg) (4,4-Diethoxy-N,N-dimethylbutan-1-amine) | 1116-77-4 |
| 1729118 | Zopiclone R-Isomer CIV (10 mg) ((-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate) | 43200-80-2 (racemic mixture) |
| 1733119 | Meso-Zeaxanthin (5x 30 mg) (Beta-Beta-Carotene-3,3′-diol, (3R ,3′ S)-) | 31272-50-1 |
| 1733122 | Aztec Marigold Zeaxanthin Extract (4 x 50 mg) | 148-68-3 |
3 đánh giá cho Chuẩn dược điển USP
Thêm đánh giá
Bạn phải bđăng nhập để gửi đánh giá.
Sản phẩm tương tự
-5%
Original price was: 355,000 ₫.337,000 ₫Current price is: 337,000 ₫.
tuan –
cho minh Levomepromazine maleatebao
khuong –
co may chuan nay bao gia cho toi nhe
le nhan –
ban gui cho toi CoA cua tap Sevoflurane